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What better microbial challenge to unite agricultural and medical microbiologists than an organism 
that reduces an onion to a macerated pulp, protects other crops from bacterial and fungal disease, 
devastates the health and social life of cystic fibrosis (CF) patients and not only is resistant to the 
most famous of antibiotics, penicillin, but can use it as a nutrient. 
JR Govan [1] 
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1. BURKHOLDERIA CEPACIA COMPLEX BACTERIA 
1.1. INTRODUCTION 
The Burkholderia cepacia complex (Bcc) is a group of 18 closely related and phenotypically similar 
species [2]. These Gram-negative, obligate aerobic, non-spore-forming bacilli were identified in 1950 
by W.H. Burkholder as the causative agent of soft onion rot [1]. Until 1992, when they were 
transferred to a new genus Burkholderia, they were referred to as Pseudomonas cepacia [3]. Further 
taxonomic studies demonstrated that bacteria identified as B. cepacia actually compromised several 
distinct species [4]. This first led to the subdivision in genomovars, a designation used to refer to 
phenotypically similar but genetically distinct species.   
Although originally identified as plant pathogens, Bcc bacteria generally participate in ecologically 
beneficial interactions with plants [5]. They can promote plant growth and crop production and 
protect crops and seeds against fungal diseases. Besides their possible application as biopesticides, 
they can be used as bioremediation agents, since they can degrade recalcitrant xenobiotics such as 
chlorinated aromatic comounds present in pesticides and herbicides. However, caution is needed, as 
they are also opportunistic pathogens that can cause severe lung infections in immunocompromised 
patients [5]. Particularly susceptible are people with cystic fibrosis (CF) and people suffering from 
chronic granulomatous disease (CGD). 
Table 1: Overview of the Bcc [2,6] 
Species Genomovar Natural environment Clinical environment 
B. cepacia I Rhizosphere, soil, water CF 
B. multivorans II Rhizosphere, soil, water CF, CGD, non-CF 
B. cenocepacia III Rhizosphere, plant, soil, water, animal CF, non-CF 
B. stabilis IV Rhizosphere CF 
B. vietnamiensis V Rhizosphere, plant, soil, water, animal CF 
B. dolosa VI Maize, rhizosphere, plant CF 
B. ambifaria VII Rhizosphere, soil CF 
B. anthina VIII Rhizosphere, soil CF 
B. pyrrocinia IX Rhizosphere, soil, water, plant CF, non-CF 
B. ubonensis  Soil Nosocomial infection 
B. arboris  Rhizosphere, soil, water CF, non-CF 
B. diffusa  Soil, water CF, hospital materials, 
non-CF 
B. latens  / CF 
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B. metallica  / CF 
B. seminalis  Rice, rhizosphere, soil CF, nosocomial 
B. contaminans  Soil, water, animal CF, non-CF 
B. lata  Soil, water, flower CF, non-CF 
B. pseudomultivorans  Rhizosphere CF, non-CF 
1.2. INFECTIONS WITH BCC BACTERIA 
Bcc bacteria are not carried as commensal organisms, but infections are acquired nosocomially, 
through social contacts outside hospitals, from contaminated cosmetics, pharmaceutics or from the 
environment [5,7]. Although the prevalence of Bcc bacteria is relatively low (approximately 3 % of CF 
patients in the US [8]), their impact can be very important [9]. While infections can be asymptomatic 
or the lung function can decline chronically [3], in about 10 % of the patients an acute infection with 
a rapid and uncontrollable clinical deterioration, characterized by a necrotizing pneumonia, 
bacteremia and sepsis is observed. This phenomenon is known as ‘cepacia syndrome’ and can 
eventually result in an early death [3].   
1.3. EPIDEMIOLOGY OF BCC INFECTIONS 
Besides the negative impact of Bcc infections on morbidity and mortality, the high transmissibility of 
strains from one patient to another make these species feared among CF patients [10]. All Bcc 
species, except B. ubonensis have been isolated from CF patients, but B. cenocepacia and B. 
multivorans are most frequently recovered from CF sputum samples [8]. The incidence varies and 
depends on the geographic location [11]. Three clonal B. cenocepacia complexes are responsible for 
major epidemic outbreaks. 
1.3.1.  ET-12 lineage 
Strains belonging to the highly transmissible electrophoretic type 12 (ET-12) lineage, e. g. B. ceno-
cepacia J2315 have infected patients in Canada, United Kingdom and other European countries in the 
late 1980s and throughout much of the 1990s [12]. Isolates belonging to this clone are characterized 
by the presence of the cblA gene (encoding the cable pilus), a 22-kDa adhesin [13] and the “B. 
cepacia epidemic strain marker” (BCESM) [14].  
Cable pili are large peritrichous adherence organelles which appear to tether aggregates of cells [5]. 
Together with an associated 22-kDa adhesin, they have been shown to use mucins and cytokeratin 
13, an intermediate filament protein, the expression of which is increased in CF airway epithelial cells 
as a host cell receptor. The presence of cable pili and 22-kDa adhesins is thought to contribute to the 
invasive properties of Bcc bacteria.  
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The BCESM genetic marker is located on a genomic island (GI), BcenGI11 [15]. This GI was the first 
pathogenicity island identified in Bcc bacteria and contains genes involved both in metabolism and 
virulence. For example, genes encoding proteins involved in fatty acid biosynthesis, amino acid 
metabolism, and quorum sensing (CciI, CciR) are located on this GI [15]. It also contains an open 
reading frame, known as the esmR gene, which shows homology to negative transcriptional 
regulators [14].  
1.3.2. PHDC clone 
By analyzing CF isolates obtained from two different CF centers in the mid-Atlantic region of the USA 
between 1980 and 2000, Chen et al. (2001) noticed that the majority of the patients were infected 
with the same strain [16]. This strain did not contain cblA or BCESM and was designated Philadelphia-
District Columbia (PHDC). It was found to represent a second transatlantic B. cenocepacia strain 
infecting patients both in the United States and in Europe [17,18]. Moreover, PHDC clonal isolates 
were recovered from soils in agricultural fields [19], suggesting infections with Bcc strains can be 
acquired from the environment. 
1.3.3. Midwest clone 
A third epidemic lineage, referred to as the Midwest clone has infected numerous patients in CF 
centers in the Midwestern region of the USA [12].  
1.3.4. Other strains 
Although the majority of problematic strains belong to the species B. cenocepacia, other strains 
shared by multiple patients are for example a B. dolosa strain, SLC6, which was identified in several 
patients in a CF center in the US and the “Glasgow strain” of B. multivorans identified from an 
outbreak in Scotland [8]. Those strains have generally infected fewer patients compared to B. 
cenocepacia strains and the majority of CF patients are still infected by genetically distinct strains [8]. 
Nevertheless, epidemiological studies have demonstrated that isolation of infected patients and the 
implementation of strict infection control guidelines are important to limit the spread of infections 
through social contacts [3]. 
1.4. GENOMICS 
These highly versatile bacteria have large genomes (6 to 9 Mb) made up of multiple replicons [20]. 
The large size and repartition are thought to increase their flexibility to acquire and lose genes [11]. 
The Bcc genomes sequenced so far are organized in three large chromosomal replicons and one to 
five plasmids, together encoding on average over 7000 genes [11]. Most housekeeping genes are 
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located on the largest chromosomal replicon, but each chromosome seems to encode other essential 
genes [21]. A significant part of the genomes has likely been acquired through horizontal gene 
transfer, which contributes to their metabolic diversity. They contain several types of insertion 
sequences, small transposable mobile DNA fragments which are involved in genome plasticity and 
regulation of gene expression, and nearly 10 % of the genomes is in the form of GIs. These regions 
are thought to be acquired during evolution, since they have a distinct GC-content percentage. 
Overall the genomes have a high average GC- content (67 %).   
1.5. VIRULENCE FACTORS  
1.5.1. Quorum sensing 
Quorum sensing (QS) is a density-dependent bacterial cell-to-cell communication system [22]. When 
a bacterial population reaches a critical density, signal molecules are released which can modulate 
gene expression in neighboring cells. The first QS system described in Bcc bacteria was identified in B. 
cenocepacia K56-2 and called CepIR [5]. CepI is an acyl homoserine lactone (AHL) synthase and CepR 
a transcriptional regulator which can detect AHLs. Since then, homologous systems have been 
identified in all Bcc species. Certain B. cenocepacia strains possess a second system, CciIR, encoded in 
the BSESM region. More recently, a third regulator was discovered, CepR2, an orphan LuxR analogue 
which has been identified in all B. cenocepacia strains examined so far [23]. The majority of genes 
controlled by QS are regulated by CepR [24]. While CepR primarily functions as a positive regulator, 
CciR mainly inhibits gene expression and approximately 200 genes are reciprocally co-regulated by 
these systems. CepR2 influences the expression of several CepR or CciR regulated genes, but does not 
require AHLs for its activity [23]. Bcc bacteria predominantly synthesize N-octanoyl-homoserine-
lactone and smaller amounts of N-hexanoyl-homoserine-lactone. In addition to this AHL based QS 
system, other QS systems found in Bcc bacteria employ 4-hydroxy-2-alkylquinolines or cis-2-
dodecenoic acids (= the Burkholderia diffusible signal factor (BDSF)) [25]. QS regulated genes are e.g. 
genes encoding proteins involved in siderophore synthesis, protease production, motility, biofilm 
formation and a type III secretion system [24]. Besides to their own QS systems Bcc bacteria can also 
respond to P. aeruginosa QS molecules [25] and several regulators (CepS, ShvR, YciR, SuhB, YciL, 
BCAM1871, AtsR) have been shown to influence QS regulation [26-29]. 
1.5.2. Biofilm formation  
Biofilms are assumed to be responsible for the onset of chronic infections [30,31]. Since Bcc bacteria 
are described to form biofilms on abiotic surfaces but also on biotic surfaces such as epithelial cells, 
biofilm formation is thought to be important in chronic Bcc lung infections [25]. However, the exact 
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mechanisms involved in biofilm formation remain to be determined. Fimbriae, pili and flagella play a 
role in initial adhesion with RpoN regulating flagellar motility [25]. Other regulators involved in 
biofilm formation include AtsR, a putative sensor kinase response regulator and ShvR, a LysR-type 
regulator [27,32]. Lectins are thought to be important for structural development and, according to 
Inhülsen et al. (2012) BapA, a large surface protein plays a major role in biofilm formation [33]. 
Screening of a random insertion mutant library of B. cenocepacia H111 identified 13 mutants 
defective in biofilm formation [26]. The genes involved encoded surface proteins, regulatory 
proteins, and proteins required for the biosynthesis and maintenance of the outer membrane. 
Moreover, QS was confirmed to play a role in biofilm formation [26].  
Exopolysaccharides are branched, repeating polysaccharide units secreted into the extracellular 
milieu and part of the biofilm matrix [32]. Five different exopolysaccharides have been identified in 
Bcc bacteria, with cepacian being most abundantly produced [11]. It is composed of a branched 
acetylated heptasaccharide repeat unit with D-glucose, D-rhamnose, D-mannose, D-galactose and D-
glucuronic acid in a ratio of 1:1:1:3:1, respectively. The expression is strain-specific, with some strains 
exclusively producing cepacian, whereas others also produce other extracellular polysaccharides. 
Besides its role in the formation of thick and mature biofilms, cepacian can interfere with 
phagocytosis by human neutrophils, inhibit neutrophil chemotaxis and scavenge reactive oxygen 
species (ROS) [11]. However, Bcc strains, lacking cepacian production may still cause severe 
infections. For example, B. cenocepacia J2315 is thought not to produce cepacian due to a frameshift 
mutation in one of the genes involved in cepacian synthesis [11]. 
1.5.3. Lipopolysaccharides 
Like in many Gram-negative bacteria, lipopolysaccharides (LPS), composed of a lipid A, a core 
oligosaccharide and an O-antigen play an important role in Bcc infections [5]. However, LPS from Bcc 
bacteria have some distinct properties. The core oligosaccharide does not contain as much 
phosphate or 3-deoxy-D-manno-oct-2-ulosonic acid as in other Gram-negative bacteria and 4-amino-
4-deoxyarabinose moieties are attached to the phosphate residues in the lipid A backbone. The latter 
reduces binding of cationic antibiotics such as polymyxin B [5]. Compared to P. aeruginosa LPS, Bcc 
LPS are more endotoxic [5]. Bcc LPS induce an increased respiratory burst in neutrophils and lead to 
an increased production of interleukin-8 in epithelial cells.  
1.5.4. Antimicrobial resistance 
Bcc bacteria are highly resistant against many antibacterial agents [10]. They are intrinsically 
resistant to polymyxins, aminoglycosides and most β-lactams, and can develop in vivo resistance 
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against essentially all classes of antibiotics. They have a trimethoprim (Tp) resistant dihydrofolate 
reductase and altered penicillin binding proteins, they produce antibiotic modifying and inactivating 
enzymes (β-lactamases, aminoglycoside-inactivating enzymes) and can extrude antibiotics by 
multidrug efflux pumps [21]. Six different families of transport systems have been identified: major 
facilitator superfamily, ATP binding cassette, resistance nodulation division, multidrug and toxic 
compound extrusion, small multidrug resistance and fusaric acid resistance family proteins. 
Furthermore, the permeability of the outer membrane is decreased compared to other species and 
the specific structure of their LPS results in resistance to positively charged molecules like 
aminoglycosides and cationic peptides [5]. Besides resistance to clinically used antibacterial agents, 
their innate resistance to antimicrobial neutrophil peptides also impedes immune responses [5]. 
Their resistance is maybe best illustrated by the fact that they can use penicillin G as a sole carbon 
source and survive in solutions of disinfectants and preservatives [1,3]. 
1.5.5. Siderophores 
Iron is essential for several important bacterial metabolic processes such as respiration and DNA 
synthesis [34]. However, the bioavailability of iron is low due to the very low solubility of the Fe3+ ion 
[34]. For example, in mammalian hosts iron is tightly bound to proteins such as hemoglobin, 
transferrin, lactoferrin and ferritin. Upon iron depletion bacteria produce siderophores, high affinity 
iron chelating compounds to scavenge iron. The resulting soluble Fe3+ complexes can be taken up 
by active transport mechanisms. Bcc bacteria can produce several siderophores [32]. While B. 
cenocepacia strains mainly produce ornibactin and pyochelin, the pyochelin production in B. 
cenocepacia J2315 is thought to be defective due to a frameshift mutation in pchF. However, several 
pyochelin synthesis genes were found to be upregulated when B. cenocepacia J2315 was grown in a 
CF-sputum containing growth medium, suggesting that the pyochelin pathway is still functional [10].  
1.5.6. Other factors 
Other virulence factors include flagella, which contribute to invasion of lung epithelial cells by making 
bacteria motile and serving as an adhesin, cable pili and adhesins, proteases, phospholipases C, 
hemolysins, secretion systems, melanin-like pigment, which is involved in survival in macrophages 
and several antioxidant enzymes [5,10,21] (Fig. 1). Superoxide dismutases (SOD) and catalases are 
important in the protection against ROS and therefore also for intracellular survival. SODs are 
responsible for the conversion of superoxide to hydrogen peroxide which is further degraded to 
water and oxygen by catalases [35] 
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Figure 1. Schematic overview of virulence factors present in Bcc bacteria. After [5].
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United we stand, divided we fall 
Aesopus 
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2. BIOFILMS 
2.1. INTRODUCTION 
Although most research has focused on planktonically growing bacteria, in nature less than 1 % of 
the total microbial biomass is thought to be present in the planktonic state [30]. In 1684, Antonie van 
Leeuwenhoek first reported on surface-associated bacteria, describing ‘animals’ present in dental 
plaques [30] and Claude Zobell and others noticed in 1943 that aquatic bacteria preferably grew on 
surfaces [36]. Since then more research started to describe microbial aggregates, until in 1981 
Costerton and co-workers introduced the term “biofilm” [37].  
A biofilm is a collection of microorganisms attached to a surface and embedded in an extracellular 
matrix [38]. Biofilms can consist of a single species, but in natural environments they are almost 
invariably multispecies communities. In mixed biofilms bacteria distribute themselves according to 
the microenvironment in which they can survive best and based on symbiotic relationships between 
groups of microorganisms [38]. Cells can attach to a biological or non-biological surface or to each 
other [39]. Interestingly, biofilm cells exhibit an altered phenotype [39]. For example, genes encoding 
proteins involved in metabolism, the regulation of membrane permeability, the production of the 
extracellular polymeric matrix, cell-cell signaling and motility are differentially expressed in biofilms 
[40]. However, differences seem to be species dependent [41] and by comparing data reported in 
various studies, Coenye (2010) revealed that even between studies on the same species only a few 
differentially expressed genes are common [42].  
Biofilms are present throughout the environment and are thought to be involved in more than 60 % 
of all microbial infections [43]. While acute infections are assumed to involve planktonic bacteria, 
known biofilm related infections are for example pneumonia in CF patients, chronic wounds, chronic 
otitis media, endocarditis and device-associated infections [44].  
2.2. BIOFILM FORMATION  
Biofilms are formed in different steps in a process that involves intercellular signaling [38] (Fig. 2). In 
a first step motility decreases, bacteria approach closely to a surface and form a transient association 
with the surface and/or previously attached microorganisms. This step is mediated by flagella and/or 
pili. Bacteria can still redistribute through surface motility, called twitching. In a second step, the 
transient association becomes stable and bacteria start to aggregate into microcolonies. They start to 
multiply and produce an extracellular matrix. Different bacteria produce different matrix 
components, but generally extracellular polymeric substances (EPS) consist of polysaccharides, 
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extracellular DNA and other macromolecular compounds such as proteins and lipids [30]. EPS play a 
role in adhesion and give the biofilm its stability. In living, fully hydrated biofilms, EPS represent most 
of the biomass [39]. Microcolonies are separated by a network of open water channels, allowing the 
distribution of nutrients and signaling molecules [40]. Subsequently, mature biofilms are formed with 
an own three-dimensional structure, which can be flat and undifferentiated or for example tower- or 
mushroom-shaped, depending on the available nutrients and the environmental conditions [44]. In a 
last step, bacteria become motile again and spread to other locations where new biofilms can be 
formed [44]. Either single cells or small microcolonies can detach from the biofilm. While dispersal of 
single cells may be a programmed process, probably involving QS, clusters can be torn away by shear 
forces. According to Webb et al. (2003), a mechanism of prophage-mediated cell death may also be 
involved in cluster detachment [45]. Via growth and dispersal biofilms are thought to maintain an 
equilibrium, but dispersal can have severe clinical implications since it provides a mechanism that 
enables biofilm bacteria to spread to another organ or even through the whole body [30]. A chronic 
infection can thus again lead to an acute bloodstream infection. 
 
Figure 2. Schematic overview of the different steps involved in biofilm formation [40].  
2.3. BIOFILM RESISTANCE AND TOLERANCE 
Biofilm cells are often reported to be more resistant than their planktonic counterparts [43]. This 
would mean that the minimal inhibitory concentration (MIC) of antibiotics would be higher in 
biofilms compared to planktonic cultures. However, generally biofilm cells do not grow better than 
planktonic cells in the presence of antibiotics. For example, Peeters et al. (2009) found that biofilm 
and stationary phase Bcc species had the same susceptibility towards a broad range of antibiotics 
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[46]. However, biofilms do show an increased resistance to killing [43]. Considering the 
heterogeneous structure of a biofilm, multiple mechanisms may play a role and their contribution 
may depend on the bacteria present in the biofilm and the antibiotics used [47]. Since bacterial 
biofilms are so difficult to treat, prevention is highly important and a well-known example of that is 
our daily toothbrushing to remove young dental biofilms. 
2.3.1. Biofilm heterogeneity and decreased growth rate 
The three-dimensional biofilm architecture promotes the development of nutrient and oxygen 
gradients and several studies have demonstrated the presence of areas of stationary phase or even 
dormant bacteria [39]. Since most antibiotics target active processes, slowly growing or non-growing 
biofilm bacteria are inherently resistant [39]. Unlike penicillin and ampicillin, cephalosporins, 
aminoglycosides and fluoroquinolones can kill non-dividing cells, but they are still more effective in 
killing rapidly dividing cells [43]. Besides indirect effects on bacterial killing by influencing bacterial 
growth, differences in pH, pCO2 or pO2 may also directly influence the efficacy of antimicrobials [39]. 
For example, at low pH the activity of macrolides and tetracyclines is compromised and 
aminoglycoside killing depends on the availability of oxygen.   
2.3.2. The general stress response 
Slow growth may not only result from nutrient limitation. It has also been suggested that biofilm 
growth initiates a general stress response which results in physiological changes to protect cells from 
various stresses [47]. The central regulator of this response is RpoS, the primary regulator of 
stationary phase genes.  
2.3.3. The biofilm matrix  
The matrix not only protects a biofilm against components of the immune system, it also forms a 
barrier for charged or large antimicrobials [39]. In this way antimicrobials are diluted to sublethal 
concentrations before they reach bacterial cells or bacteria can adapt to treatment since exposure to 
antibiotics is delayed. Moreover, compounds secreted or present in the EPS can degrade antibiotics. 
Several matrix components can bind and/or neutralize antimicrobial agents. For example, 
extracellular β-lactamases neutralize β-lactams and extracellular DNA binds to cationic antimicrobials 
such as tobramycin. While administration of DNase and alginate lyase was indeed shown to enhance 
the activity of tobramycin towards P. aeruginosa biofilms [39], addition of DNase did not increase 
tobramycin-mediated killing in Bcc species [48]. Overall, EPS may play a species dependent role in 
resistance and only against certain antimicrobials [25].  
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2.3.4. Persister cells 
Biofilms are thought to contain a subpopulation of cells tolerant to antimicrobial treatment [49]. 
Those so-called persister cells are present in both sessile and planktonic cultures, but are especially 
problematic in a protected biofilm environment [50] (Fig. 3). While antibiotics kill most cells and the 
immune system eliminates remaining persisters outside the biofilm, persisters in the biofilm are 
protected in the matrix. Once the antibiotic treatment is stopped, they can repopulate the biofilm 
and give rise to recurrence of the infection. More information on these persisters can be found in 
chapter I.3.  
  
 
 
 
 
 
 
 
 
Figure 3. A model of the establishment of chronic infections, after [51]. Biofilms contain a small fraction of persister cells 
that survive antibiotic treatment and in the absence of antibiotics give rise to a new infection.  
2.3.5. The acquisition of resistance 
Since the physical proximity of cells in a biofilm favors the exchange of mobile genetic elements, 
biofilms are a perfect place to acquire genes encoding proteins involved in environmental survival, 
virulence and antibiotic resistance [38]. Moreover, biofilm growth is associated with an increased 
frequency of mutations [52,53]. The latter is probably due to alterations in repair systems [52]. 
Oxidative stress is also considered to contribute to mutability in biofilms and downregulation of 
antioxidant enzymes in biofilm cells may further enhance DNA damage [53]. For example, ROS from 
activated polymorphonuclear leukocytes together with endogenous generated oxidative stress was 
linked to the occurrence of hypermutable P. aeruginosa strains in CF patients [52,54,55]. 
Chapter I: Introduction                                             Biofilms 
 
  17 
2.3.6. Quorum sensing 
QS allows bacteria to sense the number of bacteria present in a limited space and to respond by 
activating or downregulating certain genes [52]. QS is thought to be involved in various stages of 
biofilm formation and in biofilm resistance [52]. Tolerance of P. aeruginosa biofilms is described to 
be QS-mediated [56]. Brackman et al. (2011) found that QS inhibitors increased the susceptibility of 
P. aeruginosa, B. cenocepacia and S. aureus biofilms towards antibiotic therapy in vitro and in vivo 
[57].   
2.3.7. A biofilm specific phenotype 
Differential gene expression between sessile and planktonic cells likely contributes to biofilm 
resistance [42]. tolA, encoding a protein which affects the lipopolysaccharide structure and hereby 
decreases the affinity of the outer membrane for aminoglycoside antibiotics was found to be 
upregulated in untreated P. aeruginosa PAO1 sessile cells compared to planktonic cells [58]. 
Furthermore, susceptibility to tobramycin was shown to be decreased in a P. aeruginosa PA14 
mutant deleted in ndvB when grown in a biofilm, but not when grown planktonically [59]. Semi-
quantitative polymerase chain reaction (PCR) confirmed that ndvB is preferentially expressed in 
sessile cells. NvdB is a periplasmic glucosyltransferase required for the synthesis of cyclic-β-(1,3)-
glucans. Those glucans sequester various antibiotics and as such interfere with their mobility through 
the periplasmic space. Besides this direct effect on antibacterial susceptibility, NdvB was shown to 
(co-) regulate the expression of at least 24 genes in P. aeruginosa PA14.  
Other genes found to be involved in biofilm resistance include genes encoding e.g. porins and 
multidrug efflux pumps [47]. 
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Chronic infections are often caused by pathogens that are susceptible to antibiotics, but the disease 
may be difficult or even impossible to eradicate with antimicrobial therapy. 
Paradox of chronic infections. Kim Lewis 
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3. PERSISTENCE 
3.1. INTRODUCTION  
In 1942, Hobby et al. discovered that a S. aureus culture could not be sterilized even after treatment 
with high concentrations of penicillin [60]. A few years later, Joseph Bigger found that these surviving 
cells were non-growing phenotypic variants of the wild type and called them persisters [60]. While 
resistance is the ability to prevent interaction of an antibiotic with a target by a variety of 
mechanisms, persistence is the ability to survive antibiotic treatment, without expressing a specific 
resistance mechanism [51] (Fig. 4). Although Harris Moyed already identified a hyperpersistent 
mutant, hipA7, in 1983 by consecutively treating bacterial cultures with high concentrations of 
antibiotics and subsequently re-inoculating surviving persisters in fresh medium [61], only by the 
1990s research started to focus on persistence [51].  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Resistance versus persistence. Resistance mechanisms prevent antibiotics from binding to their targets, hereby 
not only preventing cell killing, but also increasing the minimal antibiotic concentration needed to inhibit cell growth (MIC). 
In contrast in persisters targets are inhibited (green bar), thus preventing the production of corrupted products. After[51]. 
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3.2. CLINICAL RELEVANCE OF PERSISTENCE 
Persister cells have been described in all bacteria examined so far and persisters present in biofilms 
are thought to be an important reason for treatment failure [51]. While most cells in a biofilm are 
susceptible to killing by antimicrobial agents, a small fraction of cells is not. In the bloodstream both 
regular and tolerant cells can be eliminated by the immune system. However, in a biofilm they are 
protected against components of the immune system and once the level of antimicrobials has 
dropped, persisters can be resuscitated, repopulate the biofilm and give rise to a new infection. 
Moreover, persisters pose a serious threat whenever the immune response is limited. This is not only 
the case in immunocompromised patients or when pathogens like Mycobacterium tuberculosis evade 
the immune system, but also when pathogens are located at sites poorly accessible by components 
of the immune system, like the central nervous system or the gastrointestinal tract [51].  
An argument against the involvement of persister cells in chronic infections is that infections relapse 
because antimicrobials fail to reach at least some cells [51]. However, Mulcahy et al. (2010) noticed 
that late P. aeruginosa isolates from CF patients with airway infections produced increased levels of 
drug-tolerant persisters [62]. Analysis of a set of longitudinal isolates from a single patient showed a 
100-fold increase in survival for a 96-month isolate compared to an early isolate. Similarly, isolates 
from patients chronically infected with Candida albicans, a fungal opportunistic pathogen, were 
almost invariably high persistence (hip) mutants [63]. This natural selection for high persistence 
mutants in chronic infection suggests causality between persistence and therapy failure. Persisters 
may thus contribute to the recalcitrance of both bacterial and fungal infections. 
3.3. CHARACTERISTICS OF PERSISTER CELLS 
When a bacterial culture is treated with increasing concentrations of an antibiotic or when samples 
are taken at different time points, survival curves show a biphasic pattern with an initial rapid killing 
and a plateau of surviving cells, called persisters [51] (Fig. 5A). Persisters form a small subpopulation 
that is able to survive lethal antibiotic treatment [51]. They are not mutants, but phenotypic variants 
of the wild type that upon re-inoculation produce a culture that again contains both persister and 
non-persister bacteria like the original population [50] (Fig. 5B). Unlike antibiotic resistant bacteria, 
they do not grow in the presence of bactericidal agents, but resume growth after the antibiotics have 
been removed [51]. Since antibiotics rather kill cells by corrupting specific targets than by inhibiting 
them, dormant persisters in which the antibiotic targets are inactive, can escape killing [51]. Non-
growing or slowly growing bacteria are generally less sensitive to antibiotics [64]. This phenomenon 
is called “drug indifference”[64]. However, persistence and drug indifference refer to different 
observations since drug indifference reflects the overall reduced sensitivity of dormant/slow-growing 
Chapter I: Introduction                                      Persistence 
 
  21 
microbial populations without a specific mechanistic basis, e.g. stationary phase bacterial cultures 
surviving treatment with β-lactams, while persisters form a subpopulation with a different 
phenotype [64]. These specialized surviving cells ensure survival of the population [43].  
While fungal persisters are only found in biofilms, bacterial persisters are present in biofilms as well 
as in planktonic cultures [49]. Singh et al. (2009) reported a higher frequency of persisters in S. 
aureus biofilms [65], but Spoering et al. (2001) detected an equal fraction of persisters in stationary 
phase P. aeruginosa planktonic and sessile cultures [66]. This may be explained by the fact that the 
fraction of surviving cells is highly dependent on the growth phase [67]. While cultures only contain a 
few persisters during the early exponential phase, the number of persisters increases sharply during 
the exponential phase and reaches a maximum of up to 1 % in the stationary phase. Keren et al. 
(2004) stated that maintenance of E. coli cultures in the early exponential phase through repeated 
re-inoculation leads to loss of detectable persister cells, suggesting that persisters found in early 
actively growing, low-stress populations may be leftover cells from high-stress stationary phase 
inocula [68,69]. Besides the influence of the growth phase, other culture conditions are also very 
important when studying persisters. While Fung et al. (2010) already demonstrated the complexity of 
factors that can influence antibiotic tolerance, Luidalepp et al. (2011) more recently emphasized that 
the frequency of persisters heavily depends on the age of the inoculum, the medium in which they 
have been grown and the antibiotics used to isolate them [70,71] .  
 
Figure 5.  A/ Survival curve with a biphasic pattern: an initial rapid killing and a plateau of surviving cells, called persisters. 
B/ Difference between persisters and resistant mutants. Figure adapted from [72].  
A B 
Chapter I: Introduction                                      Persistence 
 
 22 
3.4. ISOLATION OF PERSISTER CELLS FOR TRANSCRIPTOME ANALYSIS 
Persisters are often defined as cells surviving antibiotic treatment that kills most of the population 
[51]. Since they form small and temporary populations it is a challenge to isolate them. The simplest 
approach is to lyse a growing population with a β-lactam and to collect surviving persisters [68]. Shah 
et al. (2006) developed a more advanced method in which persisters and non-persisters were sorted 
based on differences in fluorescence. Fluorescence was derived from the expression of a degradable 
green fluorescent protein placed under the control of a ribosomal promoter, only active in dividing 
cells [73]. Fluorescence was thus expected to be lower in persister cells and after cell sorting dim 
cells were indeed enriched in cells tolerant to ofloxacin.   
3.5. IDENTIFICATION OF PERSISTER GENES 
The exact mechanisms leading to persistence are still largely unknown. Screening knockout libraries 
has not led to the identification of mutants completely lacking the ability to form persisters, 
indicating that the mechanisms involved are redundant [51]. However, various studies have 
identified putative persister genes.  
3.5.1. Stress responses and metabolism 
Initial screening studies primarily identified genes encoding proteins involved in stress responses or 
in metabolism [74,75]. Using the E. coli Keio mutant library screen, Hansen et al. (2008) found that 
genes encoding chaperones, global regulators, genes involved in stress resistance and stationary 
phase survival were involved in persistence [74]. Deletion of yfgA and yigB reduced persistence, 
whereas overexpression of these genes induces dormancy by depleting the folate and flavin 
mononucleotide pools, respectively. spoT, relA and dksA (involved in the stringent response) and 
rpoS (general stress-response regulator and regulator of many stationary phase-inducible genes) 
were shown to be involved in persistence in P. aeruginosa [76,77]. Additionally, by screening of a 
transposon insertion library and subsequent genetic experiments in PA01 and PA14, De Groote et al. 
(2009) found that diverse functional classes including global regulators, but also enzymes involved in 
different cellular processes such as amino acid synthesis and metabolism, DNA repair, nutrient 
uptake or phospholipid metabolism, play a role in P. aeruginosa persistence [75].  
Keren et al. (2004) performed a microarray analysis of E. coli hipA7 persisters lysed with ampicillin 
[68]. Among the upregulated genes were genes encoding proteins involved in the SOS stress 
response, phage-shock proteins, heat and cold shock proteins, toxin antitoxin (TA)-modules and 
other proteins inhibiting macromolecular synthesis (Rmf, UmuDC). Expression of genes encoding 
proteins involved in metabolism and flagellar synthesis gradually diminished in cells treated with 
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increasing doses of ampicillin. Similarly, genes encoding proteins involved in metabolic and 
biosynthetic pathways were downregulated in M. tuberculosis persisters [78].  
phoU, encoding a repressor of phosphate uptake, was identified as a persister gene the deletion of 
which reduced persistence [79]. Inactivation of phoU was shown to lead to a hyperactive metabolic 
state [79]. However, mutations in sucB or ubiF, leading to a defective energy production also 
negatively affected survival of persisters [80]. SucB is a key enzyme of the TCA cycle, whereas UbiB is 
involved in the biosynthesis of ubiquinone, an acceptor of electrons in the respiratory electron 
transport chain, which plays a role in the generation of ATP and maintenance of membrane 
potential.  
3.5.2. Glycerol metabolism 
Spoering et al. (2006) suggested a role for glycerol-3-phospate (G3P) metabolism in tolerance in E. 
coli [81]. Overexpression of GlpD, a glycerol-3-phosphate dehydrogenase which converts G3P to 
dihydroxyacetone phosphate was shown to generate a moderate increase in the frequency of 
persisters, whereas deletion of glpD decreased persister levels approximately 50-fold. High levels of 
G3P, caused by a lack of catabolism by GlpD, and derepression of the Glp regulon by interaction of 
G3P with the GlpR repressor, would lead to suppression of the formation or maintenance of 
persisters. Further analysis of proteins that affect G3P metabolism also identified glpABC, the 
anaerobic sn-glycerol-3-phosphate dehydrogenase and plsB, an essential enzyme responsible for the 
conversion of G3P to 1-acyl-G3P for subsequent phospholipid biosynthesis, as putative persister 
genes [81].  
De Groote et al. (2011) found that a knockout mutation of glpT, encoding a transporter of G3P or 
overexpression of fosA, encoding a glutathione transferase gives rise to a decrease in P. aeruginosa 
persisters. This suggests the involvement of one or more substrates transported by GlpT in 
persistence [82]. Possible candidates are glycerol-2-phosphate, G3P or phosphate, but also other 
phosphates or phosphonates since GlpT, although originally identified as a glycerol-3-phospate 
transporter, is considered to have a relatively low substrate specificity [82]. Whether these findings 
are connected to the study by Spoering et al. (2006) remains to be determined. Deletion of glpT did 
not reduce persistence in E. coli [81], but unlike in P. aeruginosa there are several possible 
transporters for G3P in E. coli [83]. Consequently, it would be interesting to test the effects of glpT 
deletion on persistence in the absence of other G3P transporters. Intriguingly, this study on fosA and 
glpT reveals interplay between antibiotic resistance and persistence, since mutations in fosA and glpT 
also resulted in an increased resistance against fosfomycin [82].  
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3.5.3. TA-modules and other toxic compounds  
Several studies have indicated that TA-modules are primarily responsible for the induction of 
persistence [84]. TA systems typically consist of a toxin which can disrupt a cellular process and an 
antitoxin which can prevent toxicity [84]. If a bactericidal antibiotic targets translation, and if 
translation is already repressed by a toxin then those cells can escape antibiotic killing. In chapter I.4 
more details are provided about these modules. Besides TA-modules, Vazquez-laslop et al. (2006) 
observed that overexpression of proteins becoming toxic when ectopically produced, like the heat 
shock protein DnaJ and PmrC, also caused higher levels of persisters in E. coli [85]. By pretreating E. 
coli cultures with different chemicals, Kwan et al. (2013) noticed that the number of bacterial 
persisters depended on the extent of halted protein synthesis [86]. In line with the latter observation 
Shah et al. (2006) demonstrated earlier that E. coli cells exhibiting low levels of translation were 
more likely to be persisters [73]. They sorted cells based on fluorescence, as described above and 
dimmer cells with a lower level of translation turned out to be 20-fold enriched in persister cells. This 
likewise suggests a correlation between persisters and reduced protein synthesis. However, activated 
toxins may selectively arrest protein synthesis and allow the synthesis of a few selected proteins to 
be continued [86]. Whether or not this plays a role in the viability of persisters remains to be 
determined.  
More recently, Ya et al. (2013) found that 2’-amino-acetophenone (2AA), a small, volatile molecule 
produced by P. aeruginosa also induced persistence by altering the expression of genes encoding 
proteins involved in translation [87]. Upon addition of 2AA transcription of almost all ribosomal 
protein genes, most tRNA synthesis genes, and translational factors were found to be downregulated 
whereas rmf encoding the ribosomal modulation factor, which is known to promote ribosomal 
inactivity was upregulated. 
3.5.4. The SOS response 
The SOS response is triggered by DNA damage [88]. Damage is recognized by the RecA protein which 
causes self-cleavage of the LexA repressor, hereby activating SOS genes [88]. Based on microarray 
analysis and screening of mutant libraries, lexA and recA were found to be involved in E. coli 
persistence [68,72]. In line with this observation, deletion of the tisAB/istr1 TA-module, which 
contains a Lex box dramatically reduced the number of surviving persisters in E. coli after treatment 
with fluoroquinolones, but not after treatment with antibiotics that do not cause DNA-damage [89]. 
Moreover, a functional RecA protein was needed, confirming dependency on the SOS pathway. The 
induction of persisters by the SOS-induced TisB toxin links two strategies of survival: active repair and 
shutdown into a dormant state. This suggests that in the presence of DNA-damaging agents the 
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optimal strategy is to both induce repair and increase the number of dormant cells which will survive 
when repair fails [51]. 
3.5.5. Oxidative stress 
Since several bactericidal antibiotics are thought to induce oxidative stress (chapter I.5), lowering 
cellular hydroxyl radical levels by decreasing their production or increasing the activity of detoxifying 
mechanisms, could counteract bactericidal activity. Based on flow cytometry experiments, Kim et al. 
(2011) reported that persisters were indeed cells in which the production of hydroxyl radicals was 
not increased upon bactericidal treatment [90]. However, the authors also indicated that E. coli cells 
generally displayed a filamentous morphology after antibiotic treatment, whereas persisters retained 
a normal morphology. Based on a more recent study describing the influence of cell shape on 
autofluorescence, differences in cell morphology may have biased these results [91] (chapter I.5). 
Shatalin et al. (2011) showed in several bacterial species including E. coli, P. aeruginosa and S. aureus 
that H2S induced tolerance by reducing oxidative stress through sequestration of ferrous iron and 
stimulation of catalases and SODs [92]. Similarly, Nguyen et al. (2011) found that the active limitation 
of cellular hydroxyl levels, played a role in planktonic and sessile P. aeruginosa persistence during 
starvation [93]. Activation of the stringent response increased catalase and SOD levels and repressed 
the production of hydroxy-alkylquinolines, intercellular signaling molecules with pro-oxidant 
properties [93]. Finally, small decreases in dissolved oxygen were demonstrated to promote survival 
of M. smegmatis persisters [94]. Reduced oxygen levels did not increase persister formation, but 
significantly facilitated their survival. These results likewise suggest that persisters are to some extent 
protected against the detrimental effects of ROS produced upon antibiotic treatment.    
3.5.6. Conclusion  
A general picture starts to emerge in which multiple mechanisms of varying hierarchy and 
importance play a role. The presence of several regulators among the putative persister genes 
confirms the proposed mechanism of redundancy. Other pathways are also likely involved depending 
on the conditions studied. For example, different genes were identified in different studies, the 
antibiotics used to isolate persister cells played a role and overexpression of the toxin, TisB, was 
shown to induce persistence in the exponential phase, but not in the stationary phase [89].  
Taking in mind the persister phenotype, an obvious question is whether or not those cells can be 
considered as dormant given the mechanisms involved. Based on studies indicating the role of 
different stress responses (heat shock, oxidative stress, envelope stress, stringent response, SOS 
response, phage shock response) in persister cells, Cohen et al. (2013) suggested that persistence is 
an actively maintained state [69]. Wood et al. (2013) reviewed current literature dealing with this 
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question and they concluded that most evidence points to a state of dormancy, toxin induction, 
downregulation of metabolic pathways, shutdown of protein synthesis, … [60]. However, active 
responses to stress may play a role in the achievement of dormancy since most stress responses lead 
directly or indirectly to slowing down or inhibition of cell growth [60,69]. Based on persistence assays 
and FACS sorting of cells fluorescently labelled according to their metabolic activity, Orman and 
Brynildsen (2013) suggested that a low metabolic activity prior to antibiotic exposure only increases 
the likelihood of a cell to be a persister [95]. However, more research is needed to confirm this 
hypothesis.   
3.6. IS PERSISTENCE A STOCHASTIC PROCESS OR IS IT INDUCED BY 
ENVIRONMENTAL FACTORS?  
3.6.1. Stochastic process 
Intrinsic noise is inherent in the nature of biochemical processes involved in gene expression [96]. 
Persistence was thus first thought of as a stochastic process, resulting from random switching in gene 
expression and protein levels within individual cells of an isogenic population [97]. Balaban et al. 
(2004) linked persistence to a pre-existing heterogeneity in bacterial populations due to phenotypic 
switching between normally growing cells and persister cells with a reduced growth rate [97]. By 
investigating persistence at single cell level using microfluidic devices, they identified three 
subpopulations in an E. coli wild type culture: normal cells, continuously generated slowly growing 
persisters and non-growing persisters generated in the stationary phase. Additionally, Rotem et al. 
(2010) indicated that fluctuations in toxin levels could result in the coexistence of dormant and 
growing cells. Bacterial cells would become dormant when the toxin level is higher than a threshold 
and the amount by which the threshold is exceeded determines the duration of dormancy [98].  
In addition to stochastic variations in gene expression, it has been shown for M. smegmatis that 
physiologically distinct subpopulations, which are differentially susceptible to antibiotics can arise 
through asymmetric growth and division, so through a build-in deterministic mechanism [99].  
3.6.2. Environmental factors 
Recent studies have proven that persistence can also be favored by environmental factors. 
3.6.2.1. Quorum sensing molecules 
The increase in persistence when going from mid-exponential to stationary phase resembles the 
dynamics of QS. Although the addition of spent medium to an early exponential culture of E. coli 
failed to increase the number of persisters [51], Möker et al. (2010) noticed that the addition of 
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pyocyanin or 3-OC12-HSL significantly increased the number of persisters in logarithmic P. 
aeruginosa PAO1 or PA14 cultures [100]. Mutations in lasR and lasI which disabled the QS response, 
reduced persistence [101]. Another QS system described in P. aeruginosa involves hydroxyl-2-
heptylquinolone and 3,4-dihydroxy-2-heptylquinoline and is controlled by the multiple virulence 
factor regulator, MvfR. The latter also controls the synthesis of 2AA, a small excreted volatile 
molecule found to induce persistence not only in P. aeruginosa, but also in Acinetobacter baumannii 
and B. thailandensis cultures [87]. Furthermore, in Streptococcus mutans the competence-
stimulating peptide, a stress-inducible pheromone, was shown to be involved in persistence [102]. 
Finally, Vega et al. (2012) indicated that bacterial communication through indole signaling 
contributed to persistence in E. coli by inducing OxyR and phage shock responses [103]. Since OxyR is 
involved in the response against oxidative stress caused by H2O2, this provides a possible link 
between indole and the role of oxidative stress responses in tolerance to antibiotics [103].  
3.6.2.2. (p)ppGpp  
Several studies have specified a role for the alarmone, guanosine tetra- or pentaphosphate, 
(p)ppGpp, the central mediator of the stringent response, in persistence [84,104-106]. The relA-spoT 
gene pair, involved in the synthesis of (p)ppGpp was linked to persistence in various studies [72,76] 
and Korch et al. (2003) reported a reduced level of persisters in E. coli cells deficient in (p)ppGpp 
synthesis [107]. More recently, Gerdes et al. (2012) proposed a model in which (p)ppGpp induces 
persistence by activating TA-modules via polyphosphate (PolyP) and Lon proteases [84] (Fig. 6). It 
was previously demonstrated that deletion of lon dramatically reduces persistence, while a moderate 
overproduction stimulates persistence by degrading antitoxins and hereby activating their cognate 
toxins [108]. Lon can be physiologically activated by PolyP, a linear polymer of orthophosphate 
residues [84]. PolyP in turn is synthesized by polyphosphate kinase (PPK) and degraded by 
exopolyphosphatase (PPX). In E. coli it functions as an intracellular signaling molecule controlled by 
the stringent response [84]. (p)ppGpp controls the cellular levels of PolyP by competitively inhibiting 
PPX. Thus, an increase in (p)ppGpp would inhibit the degradation of PolyP thereby activating TA-
modules through Lon [84]. This model also provides a link between growth rate and the generation 
of persisters since cellular levels of (p)ppGpp vary inversely with growth rates [84]. 
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Figure 6. Model of how an increase in (p)ppGpp induces persistence by activating TA-modules via PolyP and Lon proteases. 
After [84]. (p)ppGpp controls the cellular levels of PolyP by competitively inhibiting PPX. PolyP in turn activates Lon 
proteases which degrade antitoxins. Activation of the corresponding toxins leads to inhibition of cellular functions. 
3.6.2.3. Antimicrobial treatment 
Besides these signaling molecules, treatment with ciprofloxacin was shown to increase persistence in 
E. coli by induction of tisB [89]. Kwan et al. (2013) described in E. coli that chemical treatment which 
arrests transcription (rifampicin), translation (tetracycline) or ATP synthesis (carbonyl cyanide m-
chlorophenyl hydrazone), thereby mimicking the effects of toxins, likewise dramatically increased 
persistence [86].  
3.6.2.4. Oxidative stress 
During infection, pathogens encounter oxidative stresses produced by activated macrophages [109]. 
Wu et al. (2012) investigated the role of oxidative stress in E. coli persister cells and found that 
induction of a classical resistance mechanism, i.e. multidrug efflux, by oxidative stress increased 
persistence [109]. Pretreatment with paraquat increased the number of surviving persisters after 
treatment with fluoroquinolones by inducing the multidrug efflux pump AcrAB-tolC which extrudes 
them from the cell. This pretreatment did not affect killing by kanamycin or ampicillin, but persisters 
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surviving fluoroquinolone treatment were also tolerant to other antibiotics, suggesting that 
fluoroquinolones induced persister formation [109]. 
3.6.2.5. Conclusion 
Although persistence was originally considered as a stochastic process, several studies have 
illustrated the role of environmental factors in persistence [84,86,89,100,103,109]. Hence, Kint et al. 
(2012) proposed a so called noise-amplification theory in which environmental triggers determine 
the mean expression levels of key persistence regulatory genes in a population, whereas stochastic 
fluctuations in the expression levels in individual cells introduce population heterogeneity [110] (Fig. 
7). At an elevated mean expression level, persister proteins will more frequently exceed a certain 
threshold leading to persistence in cells with a stochastically higher expression.  
Although a population of persisters is often still regarded as a homogeneous entity [110], variability 
among single cells probably generates a collection of cells with distinct physiologies [110,111]. This 
may explain why overexpression of specific persister genes only affects the persistence phenotype 
towards a specific set of antibiotics and why treatment effective in killing persister cells only reduces 
the persister fraction instead of eradicating all persister cells. For example, overexpression of mqsR 
increased tolerance to ofloxacin and cefotaxim in E. coli, but not to tobramycin, whereas 
overexpression of relE increased tolerance to these three antibiotics [67,73].  
 
 
 
 
 
 
 
 
 
Figure 7. Graphical representation of the so-called noise-amplification theory. Environmental triggers determine the mean 
expression levels of key persistence regulatory genes in a population, whereas stochastic fluctuations in the expression 
levels in individual cells introduce population heterogeneity. Upon an elevated mean expression level, a threshold leading 
to persistence will be more frequently exceeded.  
Persistence 
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3.7. IMPLICATIONS OF KNOWLEDGE ON PERSISTENCE 
3.7.1. Identification of putative targets and anti-persister compounds 
Despite the clinical relevance of persistence, no treatment of related infections has been identified 
yet. Since persister cells probably do not form a homogenous population, a single treatment that can 
kill all persisters may not even exist. However, various strategies have already been explored with 
variable successes.  
Because persisters are only transiently refractory to killing, De Leenheer and Cogan (2009) suggested 
that bacterial populations could be sterilized through periodic dosing of antibiotics [112]. Considering 
the risks of developing resistance when the antibiotic concentration in plasma drops and the fact 
that the specific parameters have to be determined experimentally, the practical use of these 
predictions is limited.  
Keren et al. (2012) reported that certain antibacterial agents are able to kill persisters [113]. 
Mitomycin is a prodrug that, once converted into a reactive compound, forms adducts with DNA, 
hereby inducing cell death [113]. Rifampicin, an inhibitor of RNA polymerase is thought to sterilize a 
culture by preventing resuscitation of persisters. Prolonged treatment with aminoglycosides which 
cause mistranslation leading to misfolded toxic peptides was found to sterilize stationary cultures of 
P. aeruginosa [113]. However, these effects may depend on the conditions used as other studies did 
report the presence of persisters after treatment with these antibacterial agents [114,115].  
While traditional antibiotics function by interfering with cellular processes, antimicrobial peptides act 
by directly disrupting the cell structure. Therefore, using these peptides the inherent problems 
related to traditional antibiotics in treating persisters can be overcome. Some successes have already 
been made with tryptophan/arginine containing cationic membrane-penetrating peptides [116]. In 
this regard the use of prodrugs that enter into the cell where they are converted to a generally 
reactive compound by bacteria-specific enzymes is also worth exploring [49].  
A general principle for killing dormant cells may be activation and corruption of a target, rather than 
only corruption. The acyldepsipeptide antibiotic (ADEP4) is an example of how activation of a target 
can kill persisters [114]. This antibiotic has been used to activate the ClpP protease which not only 
resulted in the death of growing S. aureus cells, but also killed persisters by degrading over 400 
proteins, forcing self-digestion of cells. As ClpP is not essential in S. aureus, combination with 
traditional antibiotics has been tested to suppress resistant mutants. A combination of ADEP4 and 
rifampicin for example, not only led to the complete eradication of S. aureus biofilms in vitro but also 
in a chronic infection mouse model. 
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Several other studies have also focused on combination therapy with currently used antibiotics. 
Cadaverine, a polyamine which impacts bacterial adaptation to physiological stress, was shown to 
increase the effectiveness of carboxypenicillins against P. aeruginosa [117], whereas Kim et al. (2011) 
identified a chemical compound able to selectively kill bacterial persisters by reverting persisters 
back to antibiotic sensitive cells [118]. Unfortunately, the mechanism underlying this reversion has 
not yet been determined. Similarly, brominated furanones, studied for the inhibition of QS, were 
found to “awaken” P. aeruginosa planktonic and sessile persister cells [119,120]. Finally, glycolysis 
intermediates which generate a proton motive force were proven to render persisters more 
susceptible to aminoglycosides by facilitating aminoglycoside uptake [115]. Glycerol and glucose 
were identified as the preferred carbon sources of E. coli persister cells [121], whereas mannitol 
enhanced the susceptibility of persisters towards tobramycin in P. aeruginosa biofilms. Moreover, 
addition of mannitol to pre-grown biofilms was able to revert the persister phenotype [122]. 
Another possible approach is to search for conserved proteins essential for the formation of persister 
cells or the maintenance of dormancy (PhoU, PlsB, SucB, UbiF, RpoS, RecA…)[51]. However, 
redundancy may be a problem and targeting persisters without affecting additional processes may be 
difficult, since several regulators are among the identified persister genes. Kim et al. (2013) 
engineered a dual-control inducible genetic switch that combines transcriptional repression of a 
target gene and proteolysis of the encoded protein. This switch may be used to identify and 
eliminate proteins required for persistence [123]. They demonstrated that depletion of the 
nicotinamide adenine dinucleotide synthetase resulted in growth arrest and cell death in replicating 
M. tuberculosis, but also led to the eradication of non-replicating cells induced during starvation and 
under hypoxic condition. Moreover, a substantial reduction in M. tuberculosis colonization during 
both acute and chronic infections in mice was observed.  
Considering the presumed important role of TA-modules in persistence, controlling toxin activity 
would theoretically control persistence [60]. Putative approaches are further discussed in chapter I.4.  
Based on the proposed mechanism of antibiotic induced ROS-mediated cell death, mechanisms 
enhancing ROS production or disabling protection against ROS may also improve killing. Grant et al. 
(2012) found that the combination of clofazimine, which increases ROS production via a NADH-
dependent redox cycling pathway, with antibiotics successfully eradicated persisters [94]. Similarly, 
inhibition of the SOS response would also potentiate killing. Small-molecule screens identified RecA 
inhibitors as potential agents enhancing antibiotic activity [124]. In a murine model of acute E. coli 
infection increased survival of infected mice was observed upon combination of a conventional 
antibiotic with an engineered bacteriophage, constitutively expressing an uncleavable LexA repressor 
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[125]. Furthermore, bacteriophages engineered to overexpress SoxR and to interfere with the 
oxidative stress response likewise potentiated bacterial killing [125].  
Besides strategies to avoid persistence or revert the persister state, it may be possible to sterilize 
bacterial cultures by interfering with the residual metabolic activity in persisters. For example, M. 
tuberculosis non-growing cells were killed by inhibition of the mycobacterial proteasome or ATP 
synthase [126-128].  
Since disinfectants can kill persisters, the covalent binding of a relatively non-toxic disinfectant may 
lead to sterile surfaces that will prevent growth of biofilms on catheters and indwelling devices [50]. 
Covalent binding prevents leaching of the disinfectants and limits contact with tissue cells, but makes 
it also impossible for the disinfectants to reach and kill pathogens. However, this problem was solved 
by linking the antimicrobial compounds to long, flexible polymeric chains covalently anchored to the 
surface of a material [50]. 
Finally, approaches inhibiting biofilm formation in vivo may also enhance treatment of infections, 
since biofilms protect persister cells against components of the immune system [69].   
3.7.2. Identification of possible pitfalls in current treatment methods 
As we begin to understand the mechanisms involved in persistence, this may not only lead to the 
discovery of novel mechanisms to eradicate those surviving cells, it may also point to potential risks 
in current methods of treatment. Antibiotics may induce persistence and thus promote recurrent 
infections [86]. Pretreatment with low fluoroquinolone concentrations was demonstrated to induce 
the SOS response and to lead to an increase in tolerance not only to fluoroquinolones but also to 
unrelated antibiotics like β-lactams and aminoglycosides [89]. Similarly, Vega et al. (2012) showed 
that induction of the oxyR regulon by treatment with moderate concentrations of H2O2 was involved 
in persistence [103].  
Moreover, repeated exposure to antimicrobials may lead to the generation of high persistence 
mutants [62], while persistence itself provides a solid base for the development of resistant mutants 
or the acquisition of resistance determinants through horizontal gene transfer [69,129]. Residual low 
rates of cell division under drug pressure favor the generation of resistant mutants and stress 
responses contributing to survival of persister cells, can accelerate this process [69]. Activation of the 
stringent response for example has been shown to increase the basal mutation rate in E. coli through 
activation of the error prone DinB polymerase [130]. In S. aureus and P. aeruginosa, mutagenic 
polymerases were similarly induced upon induction of the SOS response [131,132]. Horizontal gene 
transfer of SXT, an integrating conjugative element described in Vibrio cholerae, was found to be 
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increased upon induction of the SOS response by fluoroquinolones [133]. Upon DNA damage, the 
SOS response alleviated the repression of SXT transfer activators, thereby increasing the expression 
of genes necessary for transfer and, hence the frequency of transfer.  
 
Chapter I: Introduction                    Toxin antitoxin-modules 
 
 34 
 
 
 
 
 
 
 
 
 
 
Adopting the right attitude can convert a negative stress into a positive one. 
Hans Selye 
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4. TOXIN ANTITOXIN-MODULES  
4.1. INTRODUCTION 
TA-modules are small episomally or chromosomally encoded genetic modules present in bacteria, 
archaea and possibly also fungi [134]. They usually consist of two genes: a toxin which can inhibit an 
important cellular function and an antitoxin which can form a complex with the toxin and hence 
inactivates it [134]. The antitoxin is typically proteolysed during stress and as a result the free toxin 
can impede cellular processes like DNA replication, translation, ATP or cell wall synthesis [84,135]. 
TA-modules were first described on plasmids e.g. ccdAB, hok sok where they ensure faithful plasmid 
partitioning upon cell division [134]. Chromosomally encoded TA-modules, although initially thought 
to be only involved in cell death, have been shown to play a role in various essential cellular 
processes, including regulation of gene expression, growth control, programmed cell death, biofilm 
formation, the stabilization of mobile elements and persistence [84]. As these multifunctional 
modules are present in prokaryotes but absent in humans, they form a potentially alternative 
antimicrobial target [136].  
4.2. THE DIFFERENT TYPES OF TA-MODULES 
TA-modules can be classified based on various criteria: (i) location on chromosomes or plasmids, (ii) 
physiological function, (iii) mode of action, (iv) the mechanisms of inhibition by the cognate 
antitoxins and, (v) the structure of the toxins or antitoxins. Currently, five types of TA-modules have 
been described based on the function of the antitoxin [137]. Whereas the toxins are always low 
molecular weight proteins, the antitoxins are either proteins (types II, IV, V) or small non-coding RNA 
molecules (types I and III) [134] (Fig. 8).  
In type I TA-modules a protein coding toxin gene lies adjacent to an antitoxin sRNA gene of opposite 
orientation. This antitoxin binds to the mRNA of the toxin and inhibits its translation. The toxins are 
small, hydrophobic proteins, often membrane associated, that cause proton-motive force 
perturbations and impediment of ATP synthesis [138,139].  
Type II TA modules are most studied and will be described more in detail in section 4.4. They usually 
consist of two genes together in an operon, one encoding a stable toxic protein and the other an 
unstable antitoxin protein [134]. In addition to toxin inactivation, antitoxins also reduce the 
expression of the toxins through negative feedback [134].   
Until now ToxIN has been the only described type III TA-module [140-142]. It is found in 
Pectobacterium atrosepticum and consists of an endoribunuclease (ToxN) and an RNA antitoxin 
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(ToxI) which can inhibit ToxN by protein-RNA interaction [140-142]. It is involved in phage defense 
since ToxN prevents the spread of viruses in the bacterial population by inducing bacterial cell death 
[142].  
Type IV TA systems consist of an antitoxin which rather interacts with the toxin’s target than with the 
toxin itself [143]. While CbtA was in E. coli shown to inhibit cell division by interfering with the 
polymerization of essential cytoskeletal proteins, i.e. MreB and FtsZ [144], the antitoxin CbeA was 
demonstrated to stabilize MreB and FtsZ polymers and to aid in the formation of filaments, 
counteracting not only CbtA but all MreB/FtsZ polymerization inhibitors [143].  
A last group is genetically similar to type II TA-modules, but toxin activity is inhibited post-
transcriptionally [137]. This type of TA-module was discovered in E. coli where the module was called 
GhoST because the toxin GhoT can cause damage to cell membranes, which ultimately leads to lysis 
and the formation of so called ghost cells. The antitoxin (GhoS) is a sequence specific 
endoribonuclease primed for GhoT mRNA degradation.   
In a recent review, parallels between TA-modules and restriction-modification systems were 
described [145]. In a broad sense, the roles of restriction enzymes are similar to those of toxins and 
modification enzymes fulfill the role of antitoxins. More specifically, Type II restriction-modification 
systems act as type IV TA systems, because the modification enzyme prevents cleavage by the 
restriction enzyme through protection of its target.  
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Figure 8. Schematic overview of the different types of TA-modules. Whereas the toxins are always low molecular weight 
proteins, the antitoxins are either proteins (types II, IV, V) or small non-coding RNA molecules (types I and III).
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4.3. PRESENCE OF TA-MODULES 
4.3.1. Differences in prevalence between different species 
TA-modules are present in most prokaryotes, but their distribution differs between species [134]. In 
their search for known TA-modules in 126 completely sequenced prokaryotic genomes (16 archaea 
and 110 bacteria) Pandey and Gerdes (2005) found that obligate intracellular organisms were devoid 
of TA loci, whereas free-living, slowly growing prokaryotes contained at least 8 TA-modules (for 
example 38 were found in M. tuberculosis and 43 in Nitrosomonas europaea) [146]. TA-modules can 
be seen as stress response loci and free living bacteria can especially benefit from such systems as 
they frequently encounter environmental stresses. Because different TA-modules respond to other 
stresses, it is tempting to speculate that the reason for redundancy is that each TA system allows the 
cell to respond to a specific type of stress [147]. Overlap between different stresses and TA-modules 
may be explained by the fact that antibiotics also have a common mechanism of action through the 
induction of ROS [147] (see chapter I.5).  
In a comparative genomic study with the aim to identify genome specificities associated with the 
virulence capacity of pathogenic bacteria, Georgiades and Raoult (2011) identified a large number of 
TA-modules in pathogenic bacteria [148]. These pathogenic bacteria had small genomes, suggesting 
that they were unable to lose the TA-modules. Whether this is solely due to their addiction 
properties or also to an actual role in virulence remains to be determined. 
4.3.2. Intraspecies diversity 
 Type II TA loci are often clustered and linked to mobile genetic elements [149]. They can be acquired 
by horizontal gene transfer and this may explain differences observed between isolates of the same 
species [150]. Type I TA systems, however, do not move from one genome to another by horizontal 
gene transfer, but have evolved by lineage-specific duplication [150]. This may explain why they are 
less widespread and less abundant than type II TA-modules. However, type I TA-modules are also 
more difficult to detect in silico as sRNAs and peptides are smaller than 60 amino acids [150]. 
Isolates often harbor several copies of the same TA family and some families are more prevalent 
among isolates than others [149]. PCR analysis of the genomes of 75 isolates of vancomycin resistant 
enterococci (61 Enterococcus faecium isolates, 8 E. faecalis isolates and 6 isolates denoted as 
Enterococcus species that were not typed) identified the presence of the mazEF TA locus in 100 % of 
the isolates, whereas axe-txe, relBE and ωεζ TA modules were present in 75, 47 and 44 % of the 
isolates, respectively [151]. In a study investigating the presence of TA-modules in methicillin 
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resistant S. aureus isolates, mazEF was similarly present in all 78 isolates examined [152]. 42 
examined P. aeruginosa clinical isolates were all found in the same study to contain relBE and higBA 
[152].  
4.4. TYPE II TA- MODULES  
Based on amino acid sequences and three-dimensional structure similarities, type II toxins and 
antitoxins are classified in 12 and 20 super-families, respectively [149]. Different cellular targets are 
described, but mostly toxins interfere with translation, which is mild and reversible. However, the 
specific mode of action differs between families. 
4.4.1. Mode of action of type II toxins 
4.4.1.1. Inhibition of translation 
The most common mechanism of action of toxins relies on mRNAs cleavage in a translation 
dependent or independent manner. Toxins belonging to the RelE family are endoribonucleases that 
cleave mRNA positioned at the ribosomal A-site and inhibit translation elongation [153]. The toxins 
themselves have no or only a very weak endoribonuclease activity, but they are thought to stimulate 
the endogenous ribonuclease activity of the ribosomes [153].  
This is unlike ribosome independent mRNA interferases, like toxins belonging to the MazF family, 
which cleave mRNA specifically at ACA motifs in a ribosome-independent manner [153]. The specific 
cleavage site varies between homologues, i.e. from 3 up to 7 nucleotides [153]. rRNA and tRNA are 
protected against MazF cleavage by ribosomal proteins and secondary structures [135]. While mRNA 
cleavage generally results in translation inhibition and dormancy, specific cleavage can also allow 
translation of a specific subset of genes. For example in S. aureus, MazF-like toxins are shown to 
regulate the expression of genes involved in virulence [154,155]. S. aureus MazF and PemK toxins 
recognize UACAU and UAUU sequences, respectively. While UACAU is abundant in transcripts 
encoding virulence factors, UAUU is rather underrepresented. Induction of MazF or PemK and 
subsequent specific cleavage, thus affects virulence in opposite ways.  
Toxins belonging to the VapC family are site-specific endoribonucleases that cleave initiator tRNA 
[84]. By cleaving initiator tRNA VapC toxins not only inhibit translation, but also stimulate translation 
initiation at elongation codons, resulting in the translation of otherwise silent genes [156].  
Toxins belonging to the HipA family are serine kinases previously thought to inhibit the translation 
elongation factor EF-Tu [84], but recently reported to inhibit a glutamyl-tRNA synthetase [104]. 
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Inhibition of glutamyl-tRNA synthetase leads to the accumulation of uncharged tRNAglu and thus 
inhibition of translation. 
One of the smallest TA families is the Phd/Doc family. This family was first discovered as plasmid 
addiction modules on E. coli bacteriophage P1. Doc toxins were previously thought to inhibit 
translation by interfering with the 30 S subunit of the ribosome and thus blocking the A-site [157]. 
However, Castro-Roa et al. (2013) discovered that Doc actually is a new type of kinase which inhibits 
translation by phosphorylating EF-Tu [158]. Phosporylated EF-Tu is unable to bind to aminoacylated 
tRNA, leading to inhibition of translation. They suggested that Doc not only reduces the metabolic 
state of a cell by inhibiting translation, but also by mimicking the stationary phase through 
accumulation of EF-Tu in the cytoskeleton. This hypothesis is based on the observation that cells 
become shorter compared to normally growing cells upon Doc induction and on a study by Defeu et 
al. (2010), which indicated that EF-Tu in Bacillus subtilis is not only required to maintain translation, 
but is also involved in the formation of the cytoskeletal structure [158,159].  
Finally, translation elongation is also inhibited by toxins which interact with the 50 S subunit of 
ribosomes and inhibit 70 S ribosome formation, like toxins belonging to the RatA family [157,160].  
4.4.1.2. Inhibition of DNA replication  
CcdB, although structurally related to the endoribonuclease MazF, and ParE both target GyrA, a 
subunit of DNA gyrase [160,161]. E. coli CcdB was shown to stabilize DNA-gyrase complexes [161]. 
This leads to the formation of DNA double-strand breaks, SOS induction, inhibition of replication, cell 
filamentation and eventually cell death. ParE2, identified in V. cholerae similarly stabilizes DNA-
gyrase complexes, but interacts with distinct sites and, unlike quinolones and CcdB, ParE2 requires 
ATP to stabilize DNA-gyrase complexes [162].  
4.4.1.3. Inhibition of peptidoglycan synthesis 
Toxins belonging to the ζ family target the bacterial cell envelope. PezT was shown in E. coli to 
phosporylate the cell wall precursor uridine diphosphate-N-acetylglucosamine, leading to inhibition 
of MurA. Since MurA catalyzes the first step in peptidoglycan synthesis, inhibition of MurA causes 
impaired cell wall synthesis and eventually cell lysis [163].  
4.4.2.  Characteristics of type II TA-modules 
Genes encoding type II toxins are between 80 and 630 nucleotides long. Antitoxin encoding genes 
are between 120 and 510 nucleotides and usually shorter than the cognate toxin coding genes [146]. 
Generally, the antitoxin gene is located upstream of the toxin gene so that the antitoxin is produced 
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first [146]. However, the toxins higB, hicA and mqsR are located upstream of their corresponding 
antitoxin [149]. Toxin and antitoxin coding genes often overlap (1 to 20 nucleotides) and the 
intergenic region rarely extends beyond 30 nucleotides [164]. Although type II TA-modules usually 
consist of two genes, operons with a toxin, an antitoxin and an additional gene have been described 
[165-168]. For example, in E. coli PaaA and ParE form an operon together with a transcriptional 
regulator (PaaR) [165]. Similarly, in Bacillus subtilis ζε TA-modules are organized in an operon 
together with the ω gene, coding for a global transcriptional regulator [167]. The M. smegmatis 
Phd/Doc TA-module is located in a larger operon with two additional genes [168]. Finally, in M. 
tuberculosis a novel type II TA system was identified containing, besides a toxin and an antitoxin a 
chaperone essential for antitoxin activity [169]. Toxins and antitoxins are co-transcribed and form 
under normal growth conditions stable protein complexes that prevent the toxins from exerting their 
toxicity [135]. For example, the antitoxin MazE is highly efficient in neutralizing MazF, as one MazE 
dimer can form a complex with two MazF dimers, whereas RelB and RelE form one to one dimers or 
a ternary RelB2-RelE complex depending on the concentration of RelB [134,135,153]. In general, 
antitoxins consist of two distinct domains: a toxin-binding domain to specifically neutralize the 
toxicity of their cognate toxins and a DNA-binding domain, which has a specific structure to bind to 
double-stranded DNA [135]. Antitoxins repress transcription of their own TA operons by binding to 
the operator site, alone or even more efficiently in complexes with their cognate toxins [135].  
4.4.3.  Regulation of expression of type II TA-modules 
4.4.3.1. Autoregulation 
In normally growing cells, type II TA-modules are constitutively transcribed and negatively 
autoregulated by a mechanism called conditional cooperativity [108]. This means that the 
stoichiometry between toxin and antitoxin proteins dictates the repression state of the operon. 
When the amount of antitoxin is in excess or equal to that of the toxin, transcription is repressed and 
the toxin serves as a co-repressor. Boggild et al. (2012) found that, when the antitoxin RelB was 
present in excess of the toxin RelE, the formation of RelB:RelE (2:1) complexes binding to the 
operator site and repressing transcription was favoured. However, an excess of RelE led 
preferentially to the formation of RelB:RelE (2:2) complexes unable to bind DNA [170]. Similarly, an 
excess of VapC leads to the formation of VapC monomers and those monomers can break VapC 
dimers which are responsible for strong binding of the VapBC complex to the operator site [171]. This 
mechanism prevents that toxicity is accidentally unleashed, as cells can rapidly switch back to low 
free toxin levels. Degradation of the antitoxins by Clp or Lon proteases ensures rapid adaptation to 
stress and maintenance of a high level of free toxins as long as the conditions supporting antitoxin 
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degradation are sustained [172]. Besides autoregulation at the level of transcription, the expression 
of e.g. MazF is also negatively autoregulated at the level of mRNA stability [135,153]. The toxin MazF 
itself contains 11 ACA cleavage sites, whereas the antitoxin MazE contains only 2 ACA sequences 
[153]. Conversely, MqsR and MqsA both have the same number of MqsR cleaving sites [153] (section 
4.4.4). 
4.4.3.2. Interaction with other TA-modules 
TA-modules of different families can also interact. Several studies have indicated that overexpression 
of a specific toxin induces the expression of another TA-module [173-177] and Kasari et al. (2010) 
observed that several TA-modules in E. coli mutually affected each other’s expression [178]. 
Additionally, toxins with endoribonuclease activity were found to cleave TA mRNA, leading to 
degradation of the antitoxin-encoding part and accumulation of the toxin encoding part. These toxin 
encoding mRNA fragments were shown to be translated and to shift the T/AT balance towards the 
toxins. An excess of toxins may induce a positive feedback loop, resulting in even more cleavage, 
cross-activation of other TA-modules and inhibition of protein synthesis. This cross-activation also 
occurs during natural physiological stress, e.g. RelBE activates MazEF during amino acid starvation, 
and this is not dependent on major proteases like Lon, ClpP and HslV and nor is it the result of a 
decrease in antitoxin production.  
Moreover, even TA systems from different types interact [179]. Recent work has identified an 
interaction between MqsRA, a type II TA-module and the type V GhoST module. MqsR was shown to 
degrade antitoxin ghoS mRNA by cleavage at 5’GCU sites, thereby allowing translation of ghoT which 
lacks MqsR cleavage sites. This observation not only confirms interaction, it furthermore points to a 
regulatory hierarchy of TA systems.  
Theoretically, three types of functional interactions are possible. Homologous systems may interact, 
toxins may bind to non-cognate antitoxins belonging to a different family or toxins can be inhibited 
by non-TA-related proteins [180]. Some studies indeed found functional interactions between toxins 
and non-cognate antitoxins [173,181], whereas others did not [182,183]. While in M. tuberculosis no 
homologous cross-interactions were observed between the 30 functional VapBC systems [184], 
interactions were noted between non-homologous MazF and VapB systems [173]. Cross-interactions 
between homologous or non-homologous systems could lead to large cooperative networks, but 
could also result in a strong negative effect [180]. Interaction of antitoxins with toxins from different 
systems could lead to an excess of free toxins and, consequently growth inhibition and/or cell death. 
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In conclusion, TA-modules are proven to influence each other’s expression, but whether or not they 
also functionally interact remains to be determined and more research is needed to reveal the 
regulatory networks involved. 
4.4.3.3. Additional regulatory mechanisms 
TA systems are also controlled by general or specific regulators and/or environmental factors. 
Several stress conditions (antibiotic treatment, amino acid or carbon limitation, DNA damage…) can 
induce transcription of TA-modules. In addition, (p)ppGpp is thought to be involved in the activation 
of TA loci [84]. By adding supernatant of a dense culture to a diluted one, Kolodkin-Gal et al. (2007) 
discovered an “extracellular death factor” (EDF) required for MazEF-mediated cell death [185]. This 
factor was identified as a linear pentapeptide having the amino acid sequence asparagine-
asparagine-tryptophan-asparagine-asparagine. In this regard MazEF-mediated cell death can be seen 
as a QS process in which the EDF peptide is the autoinducer.  
4.4.4.  MqsRA: an example of a type II TA-module 
One of the most-studied type II TA-modules is the MqsRA-module. This module was first described in 
E. coli K-12 as YgiUT, but has been renamed MqsRA, as MqsR (motility quorum sensing regulator) is 
involved in cross-species QS autoinducer-2 mediated biofilm growth [186]. Although its three- 
dimensional structure revealed that MqsR is similar to RelE, this operon, with homologs in different 
species, has some unique characteristics [187]. The antitoxin mqsA is larger than mqsR and located 
downstream of the toxin. Whereas most antitoxins have a domain that changes its conformation or 
acquires structure only upon binding to the corresponding toxin [135], MsqA is already structured in 
its free form and does not seem to change conformation upon binding [187]. Antitoxins typically bind 
DNA via their N-terminal domain and their cognate toxins via their C-terminal domain. However, 
MqsA conversely binds to MqsR and DNA via its N- and C-terminal domains, respectively [187]. 
Finally, MqsA was the first antitoxin found to regulate more than its own transcription as its binds to 
the promoters of mqsRA, cspD, mcbR, rpoS and spy [188]. Like MqsA, MqsR is atypical as it is 
structurally related to RelE, but cuts mRNA ribosome-independently [189]. Besides, it is a GCU and 
GCA-specific endoribonuclease that can also degrade its own mRNA [189] and it does not function as 
a transcriptional co-repressor inhibiting expression of the operon [190]. Instead it destabilizes the 
antitoxin-operator complex in all conditions due to the fact that the MqsA/DNA and MqsR/MqsA 
complexes have comparable strong affinities and that the binding sites of DNA and MqsR on MqsA 
partially overlap [190]. 
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4.5. ROLE OF TA-MODULES IN PHYSIOLOGY 
TA systems are not essential for normal cell growth and, although they might just be selfish elements 
devoid of a physiological role, their high prevalence suggests that they are beneficial for cells or cell 
populations. The presence of 88 TA-modules in M. tuberculosis and only three in M. smegmatis 
furthermore suggests that they are not only involved in normal bacterial physiology, but also in 
pathogenicity [168,182]. 
4.5.1. Stabilization of episomal elements 
Plasmid encoded TA-modules not only ensure faithful plasmid partitioning upon cell division, in a 
process known as postsegregational killing, they also aid in plasmid/plasmid competition during 
horizontal gene transfer [134,191]. Moreover, other mobile genetic elements are stabilized by TA 
systems. For example, the MosAT TA-module in V. cholerae stabilizes SXT, an integrative and 
conjugative element present in many clinical V. cholerae isolates [192]. 
4.5.2. Defense against invading DNA 
Apart from their involvement in the stabilization of other genetic elements, the role of 
chromosomally encoded TA systems is less obvious. Chromosomally encoded CcdA was shown to 
inhibit toxic activity of CcdB encoded on a plasmid, suggesting that chromosomally encoded TA-
modules can act as anti-addiction systems protecting the cell against postsegregational killing [193]. 
However, evolution selects against functional interference between plasmid encoded toxins and 
chromosomally encoded antitoxins and some TA systems may only be remnants of past evolutionary 
events.  
TA-modules were demonstrated to play a role in anti-phage infection mechanisms [134]. Inhibition of 
host gene expression upon phage infection can activate the toxins which as a result exclude phages 
from the bacterial culture by killing individual cells. Consequently, TA-modules ensure bacterial 
population survival [194]. Moreover, the RnlA toxin described in E. coli was shown to abort infection 
by directly degrading phage late mRNAs [195]. 
4.5.3. Regulation of cell growth and gene expression 
TA-modules are induced under different stress conditions and they are thought to shut down 
metabolism and arrest cell growth [134]. Whether such changes are reversible or initiate a 
programmed cell death pathway is still under debate.  
The toxin MazF was originally identified as a destructive enzyme leading to programmed cell death 
[196]. However, as it degrades mRNAs with substrate specificity and generates a unique translation 
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machinery in response to environmental changes, it can also be viewed as a global stress regulator, 
regulating gene expression at a post-transcriptional level [197]. While under stress conditions MazF 
cleaves mRNAs and thus inhibits the synthesis of most proteins, it also selectively enables the 
translation of about 10 % of the proteins. Some of them are required for cell death of most of the 
population, but others permit survival of a small subpopulation [197]. The mechanism leading to this 
selective translation includes the generation of leaderless mRNAs and the formation of “stress 
ribosomes” that selectively translate leaderless mRNAs formed by MazF [198]. For this purpose, 
MazF cleaves ACA sites at or closely upstream of AUG start codons of specific mRNAs and removes 
the 3’-terminal 43 nucleotides, including the anti-Shine-Dalgarno sequence of the 16S rRNA of 
ribosomes [198]. In this way, a distinct pool of stress proteins is produced, required both for cell 
death and survival. Surviving cells retain the capacity to produce mRNAs and proteins, and they may 
recover if, upon stress relief enough antitoxins are produced to neutralize the toxins [198].  
In conclusion, MazF induces selective translation during stress and should be viewed as a regulator of 
cell death rather than as a destructive toxin. Since specific mRNA degradation as a means to control 
protein activity has also been described for other mRNA interferases like MqsR, post-transcriptional 
gene regulation may be an important and general mechanism to control cell physiology [147]. 
4.5.4. Persistence 
Since bactericidal antibiotics kill cells by corrupting cellular functions, which are inhibited by toxins, 
the role of TA-modules in persistence has been documented in various studies [84]. Toxin inhibition 
of important mechanisms like cell wall synthesis, translation, replication,… would prevent antibiotics 
from killing and give rise to persister cells. HipAB was the first TA-module linked to persistence [68] 
and key insights on persistence were obtained with HipAB. Rotem et al. (2010) noticed that 
persistence occurred once the toxin HipA reached a certain threshold level and that the amount by 
which the threshold was exceeded determined the duration of dormancy [98]. Since the 
identification of HipAB, various studies have reported an upregulation of TA-modules in persister 
cells [68,73]. For example, DNA microarrays performed on dormant E. coli cells carefully isolated via 
fluorescence-activated cell sorting, identified mqsR as the most highly induced gene in persister cells 
compared to non-persisters [73]. Although overproduction of almost any toxin may increase 
persistence, only two TA pairs have been shown to decrease persistence in planktonic cells upon 
deletion. Deletion of tisAB-istR, a type I TA-module and part of the SOS-regulon (section 4.5.6) 
reduced the persister fraction in E. coli upon treatment with ciprofloxacin [89] and deletion of mqsR 
alone or the entire mqsRA operon decreased the number of E. coli persisters after treatment with 
ampicillin [147]. Subsequently, simultaneous deletion of multiple other TA systems was also 
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demonstrated to decrease the number of persisters in E. coli [108]. The latter confirms the role of 
TA-modules in persistence, but also suggests redundancy of these mechanisms.   
4.5.5. Biofilm formation 
Although early reports on S. mutans strains lacking homologues of mazF and relE suggested that TA-
modules were not involved in biofilm formation [199], more recent studies have indicated a role for 
TA systems in the switch from planktonic to sessile cultures.  
MqsRA was the first TA-module linked to biofilm formation. In a transcriptome study comparing 
sessile and planktonic cells mqsR was found to be induced [200]. Gonzalez et al. (2006) observed that 
autoinducer-2 induced biofilm formation in E. coli was mediated through MqsRA [186]. In support of 
these observations, the antitoxin MqsA was more recently found to repress rpoS, thereby reducing 
the c-di-GMP concentration which leads to increased motility and decreased biofilm formation [147]. 
Degradation of MqsA by Lon proteases in turn resulted in rpoS induction and a switch from the 
planktonic to the biofilm state. In addition, Wang et al. (2011) proposed a model in which there is a 
spectrum of MqsR activities and, depending on the activity of MqsR, a cell would respond to stress by 
biofilm formation and the production of proteins to withstand stress or become dormant [147]. In 
this regard persister cell formation can be seen as an extreme example of the general stress response 
mediated by MqsR. Further evidence for the involvement of TA-modules in E. coli biofilm formation 
was obtained by studying Δ 5, a strain in which five different TA-modules (mazEF, relBE, chpBS, 
yoeB/yefM, yafQ/dinJ) were deleted. Deletion of these systems reduced biofilm formation after 8 h 
and then increased biofilm formation after 24 h [201]. Transcriptome profiling revealed that deletion 
of these TA-modules induced the expression of an uncharacterized gene, yjgK, which repressed 
fimbriae at 8 h [201]. While this repression of fimbriae may explain the decrease in biofilm formation 
at 8 h, a reduction in biofilm dispersal may explain the increase in biofilm formation at 24 h.  
4.5.6. SOS response 
Several type I (symE-symR, tisAB-istR, hokE-sokE) and type II (yafO-yafN, yafQ-dinJ) TA-modules have 
been found to be upregulated during the SOS response [153]. The SOS response, regulated by RecA 
and LexA, is induced by the accumulation of single-stranded DNA, usually produced by stresses and 
chemical agents that cause DNA damage or disruption of the DNA replication fork [153]. The 
involvement of the SOS response in TisB induction has already been described in section 3.5.4. 
Similarly, it has been observed that LexA binds to the dinJ/yafQ promoter region, indicating that 
dinJ/yafQ transcription is directly linked to DNA damage [153]. DinJ is stress-susceptible like other 
antitoxins, so upon DNA damage YafQ is activated. Toxin activation may facilitate temporary growth 
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arrest and allow cells to repair their DNA [153]. However, YafQ does not seem to affect the overall 
DNA repair efficiency and other TA systems may have the same function, since deletion of the 
dinJ/yafQ operon did not affect viability after ultraviolet irradiation or mitomycin C treatment [153]. 
4.5.7. Thymineless death 
A lack of thymine, an essential precursor of DNA, results in cell death, known as thymineless death 
[202]. The mechanisms involved in this process largely remain to be elucidated, but it has been 
suggested that the MazEF TA-module is involved [203]. Thymine depletion would activate MazF and 
thus lead to cell death. Interestingly, RecA and the SOS response are also thought to be involved in 
this process [202]. However, how these processes are connected is currently not known [153].  
4.5.8. Starvation 
The stringent response is a response induced by amino acid limitation and characterized by a 
reduction in amino acid consumption and a metabolic shift towards essential survival pathways 
[153]. Upon amino acid starvation, an increase in the intracellular concentrations of (p)ppGpp 
activates Lon proteases and results in protein degradation. Released amino acids can then again be 
used in protein biosynthesis [153]. As antitoxins are also degraded by Lon proteases, toxins are 
released during the stringent response. Moreover, in E. coli the mazEF TA-module has been linked to 
this response because this operon is located downstream of relA, the gene encoding (p)ppGpp 
synthase [153]. MazF and other mRNA interferases cleave mRNA, thereby inhibiting translation. 
However, specific mRNA cleavage upon ribosome stalling has been shown to occur independently of 
toxin interferases. Li et al. (2008) found that relE was not induced in modest starvation conditions 
and that mRNA cleavage in a mutant, in which 5 TA systems were deleted occurred as well as in the 
wild type [204]. However, toxins may still contribute to cleavage upon ribosome stalling during 
strong amino acid starvation conditions.   
Several studies have indicated the involvement of (p)ppGpp in HipA-mediated growth arrest 
[107,205] and more recently Germain et al. (2013) suggested that HipA, inhibiting aminoacylation 
mediates persistence by the generation of “hungry” codons at the ribosomal A site that trigger the 
synthesis of (p)ppGpp [104]. 
4.5.9. Other roles 
Under adverse growth conditions, TA-modules may act as suicidal molecules. For example, in 
Myxococcus xanthus a solitary MazF homologue is required for the obligatory cell death during 
fruiting body formation, a specialized spore-producing structure [206].  
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A S. enterica serovar Typhimurium strain deleted in the sehAB TA-module was attenuated for 
virulence in mice when inoculated orally. This observation together with data linking TA-modules to 
virulence of Rickettsia spp. and to enhanced colonization by uropathogenic E. coli strains, suggests 
that TA-modules are also related to bacterial pathogenicity and are involved in host-pathogen 
interactions [207]. 
To conclude, TA-modules may exert different functions and those functions may depend on the 
location of the TA-modules in the genome, the mode of action of the toxin and the fact whether it 
imparts a selective advantage to the host. 
4.6. APPLICATIONS  
TA-modules are attractive alternative antimicrobial targets as they are present in bacteria, archeae 
[208] and possibly also in yeasts [209] and other fungi [135], but absent in humans [135]. Different 
approaches are worth examining. The inherent toxicity may be exploited to directly kill cells or 
support antibiotic treatment, or the formation of persister cells may be inhibited [210]. To activate 
toxicity, several strategies are possible [210]. Toxin inhibition by its cognate antitoxin may be 
prevented or established TA complexes may be disrupted. Antitoxins could be degraded and 
formation of novel antitoxin transcripts inhibited.  
However, as TA-modules are heterogeneously distributed among clinical isolates, more research is 
needed on the presence, prevalence and functionality of TA-modules in different isolates to identify 
the optimal toxin target [210]. Furthermore, the mode of action of the targeted toxin is important. 
While resistance to CcdB is already conferred by a single-point mutation in its target DNA gyrase, 
resistance against a toxin like MazF, which cleaves mRNA is less likely [210].  
In conclusion, a general approach, unlikely to easily induce resistance is required. Caution is needed 
as an inhomogeneous distribution of TA systems among infective strains could give those strains 
lacking TA-modules a selective growth advantage. Moreover, interactions with other TA-modules 
should be examined and overall induction of persistence should be avoided [210].   
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It would be an illusion to think that what we are aware of at present is 
any more than a fraction of the full extent of biological design. 
Michael Denton  
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5. IS OXIDATIVE STRESS INVOLVED IN ANTIBIOTIC-MEDIATED CELL 
DEATH? 
5.1. INTRODUCTION 
A natural side effect of aerobic respiration is the generation of ROS [211]. ROS are generated via 
successive single-electron reductions, producing superoxide (O2.-), hydrogen peroxide (H2O2) and 
hydroxyl radicals (OH.) (Fig. 9). All three are cytotoxic, but to a different extent [212]. While 
superoxide and hydrogen peroxide can be enzymatically degraded by SODs and catalases, 
respectively, no known enzyme can catalyze the cellular detoxification of hydroxyl radicals. 
Enzymatic or spontaneous dismutation of superoxide radicals leads to the formation of peroxides. 
Those peroxides can be detoxified by catalases or induce the formation of extremely toxic and lethal 
hydroxyl radicals through the Fenton reaction. The latter depends on the Haber-Weiss reaction 
during which ferric iron is reduced by superoxide radicals to yield again ferrous iron [212]. 
Figuur 9. Generation of ROS. Hyperactivation of the electron transport chain induces the production of superoxide radicals. 
Enzymatic or spontaneous dismutation of superoxide radicals leads to the formation of peroxides.Those peroxides can be 
detoxified by catalases or induce the formation of extremely toxic and lethal hydroxyl radicals through the Fenton reaction. 
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Interestingly, in 2007 Kohanski et al. identified a common mechanism involving the production of 
hydroxyl radicals whereby all bactericidal antibiotics could induce cellular death [213]. However, 
more recently this theory has become the subject of much debate [214,215].  
5.2. PROPOSED MECHANISM OF ANTIBIOTIC-MEDIATED ROS INDUCTION  
5.2.1. Mechanisms leading to ROS production 
The mechanism leading to antibiotic induced production of ROS would depend on a metabolism-
related NADH depletion, the tricarboxylic acid (TCA) cycle, the electron transport chain, damage of 
iron sulfur clusters and stimulation of the Fenton reaction [213] (Fig. 10). After treatment with 
bactericidal and bacteriostatic antibiotics belonging to the three major classes (DNA replication and 
repair, cell-wall turnover, protein synthesis), Kohanski et al. (2007) measured ROS by flow cytometry 
using the dye hydroxyphenyl fluorescein (HPF). Hydroxyl radical production was observed both in 
Gram-positive and Gram-negative bacteria and only after treatment with bactericidal antibiotics. 
Addition of the iron chelator 2,2’-dipyridyl or thiourea, a radical quencher significantly reduced both 
ROS production and bactericidal killing. Intracellular ferrous iron was found to be the key source for 
Fenton-mediated hydroxyl radical formation and a surge in NADH consumption upon antibiotic 
treatment probably induced a burst in superoxide generation via the respiratory chain. Blocking the 
TCA cycle before formation of the first NADH led to increased survival and genes involved in NADH-
coupled electron transport were upregulated after treatment. Since hydroxyl radicals damage 
proteins, lipids and DNA, the SOS activity was, as expected also significantly increased after 
treatment. 
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Figure 10. Proposed mechanism of antibiotic induced ROS-mediated cell death [216]. Antibiotics belonging to different 
classes have an influence on the TCA cycle, and induce respiration. Hyperactivation of the electron transport chain causes 
the formation of superoxide radicals which can damage iron-sulfur clusters. Released ferrous iron can react with hydrogen 
peroxide in the Fenton reaction and lead to the generation of hydroxyl radicals which damage DNA, lipids and proteins.   
5.2.2. How antibiotics trigger ROS formation 
In a follow-up study, additional insight in how antibiotics ultimately trigger the formation of ROS was 
provided [217] (Fig. 11). Aminoglycoside treatment results in mistranslation and misfolding of 
proteins. Some of them are membrane bound proteins which will be located in the periplasmic space 
or inserted into the membrane where they can activate the envelope stress-response two-
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component sensor, CpxA. Activated CpxA will phosphorylate CpxR. In order to protect the cell against 
an increase of misfolded proteins, phosphorylated CpxR will induce the expression of envelope 
stress-response proteins, such as the periplasmic protease DegP. CpxA may also activate the redox-
response two-component system, ArcAB. Activation of the envelope stress-response system and 
ArcA-regulated changes in metabolic and respiratory systems, will eventually result in ROS formation 
and cell death. CpxAR and ArcAB likely play a general role in antibiotic-mediated generation of ROS 
[217]. While β-lactam antibiotics directly affect membrane integrity by inhibiting cell wall 
biosynthesis, it is less clear how quinolones disturb the cell membrane.  
 
 
 
Figure 11. Proposed mechanism how antibiotics trigger ROS formation [216]. Treatment with aminoglycosides results in 
mistranslation and misfolding of proteins. Subsequent insertion of those proteins into the cytoplasmic membrane triggers 
the envelope two-component stress-response sensor, which induces proteases like DegP, but also activates the Arc 
regulatory system. The redox response regulator in turn accelerates respiration, leading to superoxide formation and 
eventually cell death. 
 
A study by Foti et al. (2012) suggested that cell death following ROS-mediated killing is 
predominantly caused by specific oxidation of the guanine nucleotide pool and its subsequent use in 
nucleic acid transactions [218]. Because of its low redox potential, guanine is particularly susceptible 
to oxidation and 8-oxo-deoxyguanine is potentially mutagenic because of its ability to form base 
pairs with cytosine and adenine [219].
5.2.3. Summary 
In summary, a mechanism is proposed in which bacterial membrane disturbance triggers envelope 
stress and subsequent perturbation of the Arc regulatory system accelerates respiration. 
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Hyperactivation of the electron transport chain induces the formation of superoxide and hydrogen 
peroxide which damage iron-sulfur clusters, thereby releasing ferrous iron. This iron can then react 
with hydrogen peroxide in the Fenton reaction and generate hydroxyl radicals which can directly 
damage DNA, lipids and proteins or oxidize the deoxynucleotide pool and indirectly damage DNA 
[213,216,217,220].   
5.2.4. Consequences 
An interesting consequence of this theory is that all major classes of bactericidal antibiotics could be 
potentiated by inhibiting the DNA stress response network (the SOS response), which is crucial in 
biological responses to hydroxyl radical-induced DNA damage [216]. Besides impairment of 
detoxification and repair systems, amplification of endogenous ROS production might increase the 
sensitivity of bacteria to oxidative attack. Using metabolic models, Brynildsen et al. (2013) identified 
targets predicted to increase ROS production and validated them experimentally. Those targets were 
proven to increase susceptibility not only to known oxidants, but also towards bactericidal antibiotics 
[221]. Moreover, carboxin, which inhibits succinate dehydrogenase (SDH) was shown to potentiate 
the effects of ampicillin. Despite these promising results, it should be noticed that carboxin is toxic to 
humans and that overall the identified targets are involved in respiration. Unfortunately, agents that 
target respiratory enzymes are often harmfull to human health [222].  
5.3. STUDIES CONFIRMING ROS INDUCTION 
In 2004 Albesa et al. already reported the generation of superoxides in S. aureus, E. coli, E. faecalis 
and P. aeruginosa after treatment with different antibiotics [223]. Resistant strains did not produce 
superoxides and a higher concentration of antibiotics was needed to increase superoxide production 
in P. aeruginosa biofilms compared to planktonic cultures. A follow-up study confirmed these first 
results by indicating that ciprofloxacin stimulated a higher production of ROS and nitric oxide in 
susceptible S. aureus strains than in resistant ones [224]. Dwyer et al. (2007) similarly reported the 
formation of ROS after addition of DNA gyrase inhibitors [225].  
Besides these initial reports, several studies reported the production of ROS following treatment with 
antibiotics and further detailed the mechanisms leading to cell death. Wang and Zhao (2009) showed 
that in E. coli the lethal activity of fluoruoquinolones was reduced in the absence of both SODs (SodA 
and SodB), indicating that hydrogen peroxide formation is involved in fluoroquinolone-mediated cell 
killing [212]. A deficiency in KatG, which detoxifies hydrogen peroxide increased norfloxacin lethality, 
whereas a peroxidase mutant deficient in AhpC, was more susceptible to killing by ampicillin and 
kanamycin. In line with these observations, Tamae et al. (2008) reported that in E. coli killing by 
rifampicin and metronidazole was increased when ROS defenses were impaired [226]. Girgis et al. 
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(2009) showed that inhibition of aerobic respiration reduced the susceptibility of E. coli towards 
aminoglycosides [227], whereas Schurek et al. (2008) stated that P. aeruginosa was less susceptible 
to tobramycin upon mutations in genes encoding proteins involved in the TCA cycle or the 
respiratory electron transport chain [228]. Yeom et al. (2010) emphasized the importance of the iron 
concentration in antibiotic induced ROS-mediated cell death and showed that ferric reductases might 
accelerate antibacterial effects [229]. Furthermore, using microarray analysis they found that genes 
encoding proteins involved in many oxidative stress defenses or DNA repair were upregulated after 
antibiotic treatment in P. putida and P. aeruginosa. A Δdps S. enterica mutant was shown to be more 
susceptible to antibiotics [230]. Dps (DNA-binding protein of starved cells), is an iron-binding protein 
which can remove an excess of ferrous iron from the cytosol making it unavailable for participation in 
the Fenton reaction. In addition, Dps also physically binds to DNA and protects DNA against hydroxyl 
radical damage. When an iron chelator was added, the increased killing of the Δdps mutant was fully 
alleviated, confirming that Fenton-mediated oxidative stress was a major factor in the reduced 
survival rate of the Δdps mutant. Deletion of recA, encoding the DNA damage-induced repair protein 
increased killing in the Δdps mutant, suggesting synergy between Dps and RecA [230].  
Chittezham et al. (2013) found that TCA-dependent ROS generation contributed to the susceptibility 
of S. epidermidis towards β-lactams [231]. Addition of sub-MIC concentrations of oxacillin resulted in 
an increase in ROS production, as measured by electron paramagnetic resonance spectroscopy, in 
the WT and not in a mutant defective in the TCA cycle (Δ TCA). Similarly, oxacillin treatment did not 
result in cell lysis in the Δ TCA mutant. Moreover, several S. epidermidis clinical isolates were 
demonstrated to exhibit TCA cycle dysfunctions. These results are in favor of a mechanism of ROS-
mediated killing, although other mechanisms like reduced susceptibility to autolysis and a more 
positively charged cell surface, which impairs binding of autolysins may have contributed to the 
increased resistance of Δ TCA mutants. A reduction in TCA activity has been shown to enhance 
biofilm formation [232] and modulation of the TCA cycle activity may represent a common 
mechanism of adaptation against various stresses. 
While the latter study confirms the detrimental role of superoxide in antimicrobial stress responses, 
a study by Mosel et al. (2013) recognizes the involvement of ROS in antibiotic-mediated cell death by 
pointing to a protective effect of superoxide radicals [233]. By pretreating E. coli cultures with sub-
inhibitory concentrations of metabolic generators of superoxide, i.e. plumbagin or paraquat, they 
found that exposure to moderate levels of superoxide before antibiotic treatment reduced antibiotic-
stimulated accumulation of ROS and cell death. These results are similar to the observation that the 
stringent response and the moderate production of toxic molecules like H2S, both stress conditions, 
can activate antioxidant responses and protect against oxidative stress caused by bactericidal 
antibiotics (Chapter I.3.5.5). 
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Finally, Liu et al. (2012) noticed that 2,2’-dipyridyl plus thiourea reduced killing of S. aureus strains by 
three different antibiotics [234]. They raised the question whether growth inhibition might be 
responsible for the reduced antimicrobial killing, but the concentrations used did not have an effect 
on growth rate and only slightly reduced the number of colony forming units. Moreover glutathione, 
a natural antioxidant provided a similar level of protection to oxacillin-mediated killing. However, for 
two antibiotics tested differences between strains were observed, suggesting that strain-to-strain 
variation plays a role in antibiotic induced ROS-mediated killing. In addition, Kolodkin-Gal et al. 
(2008) pointed to variation between different antibiotics: MazEF-mediated cell death was reportedly 
ROS dependent after treatment with bactericidal agents inhibiting transcription and/or translation, 
but ROS-independent after treatment with DNA damaging agents [235].  
5.4. ARGUMENTS AGAINST THE ROLE OF ROS IN ANTIBIOTIC-MEDIATED KILLING 
Feld et al. (2012) suggested that the production of ROS generally does not contribute to antibiotic-
mediated killing since bactericidal agents failed to cause oxidative stress in Listeria monocytogenes, a 
species with a non-cyclic TCA cycle [236].   
Liu and Imlay (2013) reported that under their experimental conditions antibiotic treatment did not 
accelerate the formation of hydrogen peroxide in E. coli and nor did it elevate the intracellular free 
iron concentration. Moreover, lethality persisted in the absence of oxygen and DNA repair mutants 
were not hypersensitive [214]. Fluorescein-based dyes, such as the ones used to measure hydroxyl 
peroxide concentrations, may be predominantly oxidized by oxidized enzymatic metal centers, unlike 
by hydroxyl radicals. These oxidized enzymatic metal centers may be more prominent when 
metabolism fails as is the case with antibiotic-treated cells. Thiourea, a sulfur compound, may have 
re-reduced the metal before it could oxidize the dye. Moreover, both thiourea and iron chelators 
were shown to suppress antibiotic sensitivity even under anaerobic conditions, suggesting that other 
mechanisms are involved. Iron chelators possibly repress the TCA cycle and respiratory enzymes, 
hereby diminishing the membrane potential which is important in aminoglycoside uptake.   
Similarly, Keren et al. (2013) detected no correlation between the probability of a cell to survive 
antibiotic treatment and its level of ROS [215]. They only observed a protective effect of thiourea at 
low concentrations and similarly to the previous study also under anaerobic conditions. Overall, they 
did not notice a difference in survival after treatment with various antibiotics under aerobic and 
anaerobic conditions. They also questioned the efficiency of HPF as a specific ROS stain. 
Renggli et al. (2013) recently observed that E. coli cells treated with different bactericidal agents 
exhibited an increased autofluorescence when analyzed by flow cytometry [91]. This increase in 
fluorescence was reportedly caused by an altered cell morphology after antibiotic treatment. 
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Autofluorescence was dependent on the incubation time and the antibiotic concentration. While 
high concentrations of norfloxacin were needed to induce a pronounced increase in cell length, high 
concentrations of ampicillin completely lysed cells and elongated cells were only seen after 
treatment with low concentrations of ampicillin.   
According to Keren et al. (2013) a reason for the discrepancy between their results and the previous 
study by Kohanski et al. (2007) lies in the different antibiotic concentrations tested [213,215]. Keren 
et al. (2013) further stated that the effects seen with thiourea may be due to inhibition of cell growth 
and a slower metabolism, which leads to an increased tolerance to killing. Increased tolerance due to 
inhibition of metabolism could also explain the effects seen with the TCA cycle mutants [215]. Cell 
elongation is also less evident during slower growth, which may explain the results seen in the flow 
cytometry experiments [91]. Besides putting the observations on antibiotic-mediated induction of 
ROS in a different light, Keren et al. (2013) pointed to the absence of mutants lacking ROS production 
among drug resistant clinical isolates and the high antibiotic susceptibility of S. pneumoniae, which 
lacks an electron transport chain [215]. 
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OBJECTIVES 
 
B. cenocepacia strain J2315 is a member of the Bcc, a group of 18 closely related microorganisms. 
These opportunistic pathogens can cause severe lung infections in CF patients. Due to the innate 
resistance of Bcc bacteria and their capacity to form biofilms, infections are often difficult to treat. 
Persister cells present in biofilms are thought to be responsible for chronic infections. Upon 
treatment of a biofilm with high doses of an antibiotic, most of the bacteria are killed, but some of 
them will survive. After removal of the antibiotics, these persisters will start to grow and this will lead 
to a chronic infection. Despite the important role of persisters in treatment failure, the actual 
mechanisms responsible for the formation and maintenance of these cells are still largely unknown. 
Various studies have already indicated the involvement of TA-modules. Type II TA-modules consist of 
a toxin, which can inhibit an important cellular target and an antitoxin which can form a complex 
with the toxin, thereby inactivating it.  
 
The main aim of this dissertation was to investigate whether persister cells are present in Bcc 
biofilms, what the molecular basis of antimicrobial tolerance in Bcc persisters is, and how persisters 
can be eradicated from Bcc biofilms. 
 
In a first study (chapter III, paper 1), we wanted to quantify the number of surviving cells in B. 
cenocepacia J2315 biofilms treated with increasing concentrations of antibiotics (tobramycin and 
ciprofloxacin) and investigate the molecular mechanisms of tolerance in cells surviving a treatment 
that killed the majority of the population. In order to elucidate the molecular mechanisms involved in 
antibiotic tolerance, a transcriptome analysis was performed on B. cenocepacia biofilms treated with 
tobramycin. Based on recent publications that suggest that bactericidal antibiotics kill cells by a 
common mechanism comprising the generation of ROS, we focussed on the expression of genes 
encoding proteins involved in ROS production or in the protection against ROS. Flow cytometry of 
cells stained with a ROS-specific dye, catalase mutants and a SOD inhibitor were used to study the 
involvement of ROS in tobramycin mediated killing. 
 
Since TA-modules are thought to be involved in persistence, a second goal was to investigate 
whether TA-modules are present in B. cenocepacia J2315 and whether they contribute to the 
tolerance of B. cenocepacia biofilms towards different antibiotics (chapter III, paper 2). A first 
objective was to determine the relative expression levels of putative TA-modules, identified using 
RASTA-bacteria software, in tobramycin or ciprofloxacin treated, and untreated planktonic and 
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sessile cultures. Secondly, we aimed at constructing toxin overexpression mutants and evaluated 
their phenotype, with focus on  growth, biofilm formation and persistence.  
 
Moreover, we aimed to study a putative novel TA-module more in detail (chapter III, paper 3). A first 
objective was to construct overexpression mutants and perform a transcriptome analysis of the 
BCAM0258 overexpression mutant. Additionally, we wanted to determine transcription start sites 
using differential RNA sequencing and investigate the influence of overexpression of BCAM0257 and 
BCAM0258 on growth, biofilm formation, resistance, persistence, iron acquisition, AHL production 
and virulence in a Galleria mellonella infection model. 
 
A final goal was to evaluate the bacteriostatic and bactericidal effects of temocillin on planktonic and 
sessile Bcc cells (chapter III, paper 4). Due to resistance, the number of antibiotics that can be used to 
treat Bcc infections is limited. Temocillin is a semisynthetic 6-α-methoxy-penicillin, which is not 
degraded by most classical and extended-spectrum β-lactamases and AmpC enzymes. In 2004, it was 
granted orphan drug status for treatment of Bcc infected patients by the European Medicines 
Agency. However, to date, only few in vitro susceptibility data are available. We wanted to evaluate 
the bacteriostatic and bactericidal effects of temocillin on planktonic Bcc cells and examine its 
growth-inhibitory effect on freshly adhered Bcc sessile cells (= 4 h old biofilms) and its bactericidal 
effect on mature biofilms (24 h old biofilms). 
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ABSTRACT 
The presence of persister cells has been proposed as a factor in biofilm resilience. In the present 
study we investigated whether persister cells are present in Bcc biofilms, what the molecular basis of 
antimicrobial tolerance in Bcc persisters is, and how persisters can be eradicated from Bcc biofilms. 
After treatment of Bcc biofilms with high concentrations of various antibiotics often a small 
subpopulation survived. To investigate the molecular mechanism of tolerance in this subpopulation, 
B. cenocepacia biofilms were treated with 1024 μg/ml of tobramycin. Using ROS-specific staining and 
flow cytometry, we showed that tobramycin increased ROS production in treated sessile cells. 
However, approximately 0.1% of all sessile cells survived the treatment. A transcriptome analysis 
showed that several genes from the TCA cycle and genes involved in the electron transport chain 
were downregulated. In contrast, genes from the glyoxylate shunt were upregulated. These data 
indicate that protection against ROS is important for the survival of persisters. To confirm this, we 
determined the number of persisters in biofilms formed by catalase mutants. The persister fraction 
in ΔkatA and ΔkatB biofilms was significantly reduced, confirming the role of ROS detoxification in 
persister survival. Pretreatment of B. cenocepacia biofilms with itaconate, an inhibitor of isocitrate 
lyase (ICL), the first enzyme in the glyoxylate shunt, reduced the persister fraction approx. 10-fold 
when the biofilms were subsequently treated with tobramycin. In conclusion, most Bcc biofilms 
contain a significant fraction of persisters that survive treatment with high doses of tobramycin. The 
surviving persister cells downregulate the TCA cycle to avoid production of ROS and at the same time 
activate an alternative pathway, the glyoxylate shunt. This pathway may present a novel target for 
combination therapy. 
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INTRODUCTION 
B. cenocepacia is a member of the Bcc, a group of 18 closely related and phenotypically similar 
species [2]. These bacteria are opportunistic pathogens that can cause severe lung infections in 
immunocompromised people, including CF patients [237]. The prevalence and outcome of infections 
appear to be species dependent and infections with B. multivorans and B. cenocepacia are associated 
with high rates of transmission and high mortality [238]. B. cenocepacia J2315 belongs to the highly 
transmissible ET-12 lineage which has infected many CF patients in Canada, the UK and various 
European countries [239]. Unfortunately, Bcc organisms are difficult to eradicate because of their 
innate resistance to a wide range of antibiotics and their capacity to form biofilms [5]. Mechanisms 
of resistance include changes in lipopolysaccharide structure, the presence of several multidrug 
efflux pumps, inducible chromosomal β-lactamases and altered penicillin-binding proteins [39]. In 
addition, biofilm-associated cells are often more tolerant to antimicrobials than planktonic cells [240] 
due to reduced drug penetration in the biofilm, the lower growth rate of sessile cells and/or the 
expression of specific resistance genes [43,47]. Even when patients are treated with high doses of 
antibiotics known to be effective against Bcc species in vitro, it is often impossible to clear the 
infection [241].   
 
Persister cells, cells that have entered a dormant multidrug-tolerant state, are thought to be involved 
in the recalcitrance of biofilm related infections [51]. These persisters are not mutants but 
phenotypic variants of the wild type [51]. Upon treatment of a biofilm with high doses of an 
antibiotic most of the bacteria are killed, but some of them neither grow nor die. After removal of 
the antibiotic, these surviving cells will start to grow and will give rise to a new infection. The 
resulting biofilm will again only contain a very small fraction of persister cells [68]. The mechanisms 
leading to persistence are not well understood. Screening knockout mutant libraries has not led to 
the identification of mutants completely lacking persister cell formation, suggesting that dormancy 
mechanisms are redundant [51]. Currently, it is assumed that TA-modules are involved in persister 
formation [68]. Toxins are proteins that inhibit important cellular functions such as translation or 
replication. This condition can be reversed by the expression of the corresponding antitoxin which 
can form an inactive complex with the toxin. By causing a reversible dormant state, toxins protect 
bacteria against antibiotics which require active targets in order to be effective [51]. The 
phenomenon of persister formation in exponentially growing planktonic cultures has been 
demonstrated for several micro-organisms (including E. coli, P. aeruginosa, S. aureus and M. 
tuberculosis) [51], but has so far not been investigated in the Bcc.  
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Recently, Kohanski et al. demonstrated that the production of ROS contributes to the antimicrobial 
activity of bactericidal antibiotics. The primary drug-target interactions stimulate the oxidation of 
NADH via the electron transport chain, which itself is dependent on the TCA. A hyperactivation of the 
electron transport chain results in increased superoxide formation, leading to damage to iron-sulfur 
clusters in proteins with the release of ferrous iron. This ferrous iron can be oxidised in the Fenton 
reaction with the production of hydroxyl radicals capable of damaging proteins, DNA and lipids and 
ultimately leading to cell death [213].  
The glyoxylate cycle is an anaplerotic pathway of the TCA cycle, which bypasses the decarboxylation 
steps in which NADH is produced. This pathway allows microorganisms to utilize simple carbon 
compounds as a carbon source [242]. The glyoxylate cycle is absent in humans, making it an 
interesting drug target [243]. For example, Van Schaik et al. (2009) found that inhibition of ICL (the 
first enzyme of this shunt), by itaconate during experimental chronic B. pseudomallei lung infections 
forces the infection into an acute state, which can then be treated with antibiotics [244].  
In the present study we wanted to investigate whether persister cells are present in Bcc biofilms, 
what the molecular basis of antimicrobial tolerance in Bcc persisters is, and how persisters can be 
eradicated from Bcc biofilms.  
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MATERIAL AND METHODS 
Strains and culture conditions 
The strains used in the present study are shown in Tables 1 and 2 [19,245]. All strains were cultured 
at 37°C on Luria-Bertani agar (LBA, Oxoid, Hampshire, UK) or on MHA (Oxoid). Overnight cultures 
were diluted in Luria-Bertani broth (LBB, Oxoid) and incubated aerobically at 37°C. The succinate 
dehydrogenase (SDH) antisense overexpression mutants were grown on LBA supplemented with 800 
μg/ml Tp (Ludeco, Brussels, Belgium) or in LBB supplemented with 800 μg/ml Tp and 0.2% rhamnose 
(Sigma Aldrich, Bornem, Belgium). 
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Table 2. The MIC and fraction of persisters for early and late Bcc clonal isolates obtained from 
infected CF patients 
 
Species Strain  Time 
interval 
(years) 
 MIC Average % 
persisters (n = 3) 
SD 
Clonal isolates from Canada     
B. multivorans C8298 8 Early 64 0.1551 0.2352 
 D2156  Late 64 0.0068 0.0076 
B. multivorans C8814 5 Early 32 0.3411 0.3080 
 D0999  Late 128 0.0012 0.0008 
B. multivorans C6396 9 Early 64 0.0031 0.0004 
 D0913  Late 128 0.0005 0.0003 
B. cenocepacia C4053 6 Early 128 0.0004 0.0004 
 C6121  Late 64 0.0019 0.0009 
B. cenocepacia C3921 10 Early 1024 0.0249 0.0270 
 C9343  Late 1024 0.0051 0.0044 
B. cenocepacia C6483 4 Early 256 0.0019 0.0031 
 C8474  Late 256 0.0214 0.0363 
B. cenocepacia C4629 7 Early 128 0.0226 0.0326 
 C8482  Late 128 0.0036 0.0007 
B. cenocepacia C5876 8 Early 128 0.0020 0.0004 
 D0465  Late 256 0.0000 0.0001 
B. cenocepacia C5424 3 Early 256 0.0527 0.0753 
 C7376  Late 128 0.0114 0.0152 
Clonal isolates from the US 
   
B. cenocepacia AU0326 11 Early 256 0.0066 0.0095 
 AU18962  Late 512 0.0276 0.0441 
B. cenocepacia AU0734 13 Early 256 0.0010 0.0007 
 AU21801  Late 256 0.0001 0.0001 
B. vietnamiensis AU0808 12 Early 16 0.0019 0.0025 
 AU21645  Late 8 0.0092 0.0116 
B. dolosa AU3503 10 Early 32 0.0040 0.0044 
 AU21993  Late 32 0.0821 0.0702 
B. dolosa AU0265 14 Early 128 0.9246 0.7618 
 AU21961  Late 128 0.1230 0.1847 
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Minimal Inhibitory Concentration (MIC) 
MICs were determined in duplicate according to the EUCAST broth microdilution protocol using flat-
bottom 96-well microtiter plates (TPP, Trasadingen, Switzerland) [46]. Tobramycin and ciprofloxacin 
(Sigma Aldrich) concentrations tested ranged from 0.25 to 1024 μg/ml and from 0.25 to 128 μg/ml, 
respectively. Itaconate and 3-nitropropionate (3-NP) (Sigma Aldrich) concentrations ranged from 
0.20 to 100 mM. 2-Thenoyltrifluoroacetone (Sigma Aldrich) concentrations ranged from 5 to 625 nM. 
The MIC was defined as the lowest concentration for which no significant difference in optical 
density (λ = 590 nm) was observed between the inoculated and blank wells after 24 h incubation. 
Differences in absorbance were considered significant when the 95 %-confidence interval (calculated 
using Microsoft Excel) did not contain zero. All MIC determinations were performed in duplicate and 
replicates never differed more than two fold. When a two fold difference was observed between 
replicates, the lowest concentration was recorded as the MIC. 
 
Quantification of persister cells in biofilms and planktonic cultures 
To determine the number of surviving cells, 24 h old biofilms or planktonic cultures were exposed to 
tobramycin, an aminoglycoside antibiotic, or ciprofloxacin, a fluoroquinolone, in concentrations 
ranging from 0.5 to 64 x the MIC for 24 h. Biofilms were grown in the wells of a round-bottom 96-
well microtiter plate (TPP), as described previously [246]. After 24 h of growth, the supernatant was 
removed and 120 μl of an antibiotic solution in physiological saline (PS) or 120 μl PS (= control) was 
added and the plates were further incubated at 37°C. Twelve wells were used for each condition. 
After 24 h of treatment, cells were harvested by vortexing and sonication (2 x 5 min) (Branson 3510, 
Branson Ultrasonics Corp, Danbury, CT) and quantified by plating on LB (n ≥ 2 for all experiments). 
For the planktonic experiments an overnight culture was diluted to an optical density of 0.1 
(approximately 108 cells/ml). After an additional 24 h growth in a shaking warm water bath, cell 
suspensions with an optical density of 1 (approximately 109 cells/ml) were transferred to falcon tubes 
and centrifuged for 9 min at 5000 rpm. Cells were resuspended in an antibiotic solution in PS, or in PS 
and further incubated at 37°C. After 24 h of treatment the tubes were centrifuged, resuspended in 
PS and quantified by plating on LB (n ≥2 for all experiments). 
 
RNA extraction and microarray analysis 
Biofilms were grown as described above and exposed to an antibiotic (concentration of 4 x MIC) or a 
0.9 % NaCl solution (untreated controls) for 24 h. Treated and untreated B. cenocepacia J2315 sessile 
cells were harvested by vortexing (5 min) and sonication (5 min) and transferred to sterile tubes. RNA 
was extracted immediately following harvesting of the cells, using the Ambion RiboPure Bacteria Kit 
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(Ambion, Austin, TX) according to the manufacturer’s instructions and the procedure included a 
DNase I treatment for 1 h at 37°C. After extraction, RNA of both treated and untreated samples was 
concentrated using Microcon YM-50 filter devices (Milipore, Billerica, MA) and linearly amplified 
using the MessageAmp II-Bacteria Kit (Ambion) prior to the microarray analysis. The method was first 
optimised with the use of standard E. coli RNA. Assessment of RNA yield and quality, cDNA synthesis 
and the hybridization and washing of the custom made 4 x 44K arrays (Agilent, Santa Clara, CA) was 
performed as described previously [247]. The gene expression analysis was performed using 
GeneSpring GX 7.3 (Agilent) and data were normalized using the procedure recommended for two-
colour Agilent microarrays. Only features dedicated to B. cenocepacia J2315 that were labelled 
“present” or “marginal” were included in the analysis. After this initial filtering, a student’s T-test 
analysis was performed (p<0.05). The experimental protocols and the raw microarray data can be 
found in ArrayExpress under the accession number E-MEXP-3532. 
 
Quantitative RT-qPCR 
In order to validate the microarray results, the expression of 11 selected genes was examined using 
RT-qPCR. Biofilms were treated and RNA was extracted as described above. cDNA was synthesized 
using the iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). Forward and reverse primers were 
developed using tools available on the NCBI website and they were compared with the B. 
cenocepacia J2315 genome sequence using BLAST to determine their specificity (Table 3). The primer 
concentration used was 600 nM (300 nM for BCAM1588). All qPCR experiments were performed on a 
Bio-Rad CFX96 Real-Time System C1000 Thermal Cycler as described previously [247]. Each sample 
was spotted in duplicate and control samples without added cDNA were included in each 
experiment. The initial 3 min denaturation step at 95°C was followed by 40 amplification cycles, 
consisting of 15 s at 95°C and 60 s at 60°C. A melting curve analysis was included at the end of each 
run. To allow accurate normalization of our data, we also included three reference genes (BCAL2694, 
BCAS0175, BCAM2784) for which we confirmed expression stability using GeNorm [248] prior to the 
actual analyses (Figure S1). 
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Flow cytometry 
The induction of ROS by tobramycin was confirmed by staining of treated (4 x MIC tobramycin, 24 h) 
and untreated biofilms with the ROS-specific fluorescent dye 2',7'-dichlorodihydro-fluorescein 
diacetate (DCFHDA, Sigma Aldrich), followed by quantification of labeled cells by flow cytometry. 
After 24 h of treatment, as described above, 22 μl DCFHDA (0.1 mM) was added to each well. After a 
30 min incubation at 37°C in the dark, the wells were rinsed and 100 μl PS was added. Tobramycin-
treated and untreated sessile cells were harvested by scraping and then transferred to sterile tubes. 
The tubes were centrifuged (for 6 min, at 9000 rpm), the cells were resuspended and 100 fold diluted 
in PS. All solutions were prepared using MQ water (Millipore, Billerica, MA) and were filter-sterilized 
before use (Puradisk FP30; Whatman, Middlesex, UK). Labeled cells were quantified using a Cyan 
ADP flow cytometer (Beckman Coulter, Suarlée, Belgium) with a 488 nm argon laser and a 530-540 
nm emission filter. Data of at least 50000 cells were collected for each sample. 
 
Effect of superoxide dismutase, isocitrate lyase or succinate dehydrogenase inhibition on survival 
of Bcc persisters 
To confirm the importance of protection against ROS for the survival of persister cells, the number of 
surviving cells was quantified in biofilms treated with tobramycin (4 x MIC, 24 h) in combination with 
the SOD inhibitor diethyldithiocarbamate (0.05 mM) (Sigma Aldrich). To confirm the importance of 
ICL for persistence, the number of surviving cells was quantified in treated (4 x MIC, 24 h) and 
untreated biofilms grown in LBB supplemented with 50 mM itaconate or 10 mM 3-NP, two ICL 
inhibitors. These concentrations were below the MIC of these inhibitors for the strains tested (data 
not shown). Itaconate and 3-NP solutions were neutralised with NaOH in LBB and sterilized by 
filtration. To evaluate the role of SDH in persistence, the number of surviving cells was determined in 
biofilms grown in LBB supplemented with 250 nM 2-thenoyltrifluoroacetone, a concentration well 
below the MIC (data not shown).  
 
Construction of ICL mutant 
The genome of B. cenocepacia J2315 contains two ICL encoding genes, BCAL2118 and BCAM1588. To 
confirm their importance, we constructed a double ICL mutant. All B. cenocepacia mutant strains 
were constructed following the protocol described by Hamad et al., which allows for the creation of 
unmarked nonpolar gene deletions [249]. Briefly, this mutagenesis procedure requires the upstream 
and downstream regions flanking the target gene to be cloned into pGPI-SceI-XCm plasmid. The PCR 
amplifications of these regions (about 500 bp each) were performed with the HotStar HiFidelity 
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polymerase kit (QIAGEN, Milan, Italy) according to the manufacturer's instructions.  
The following primer pairs were used for the deletion of BCAL2118 (aceA):  
• KOaceXL (5’-TTTCTAGAATTTCACGATACGGGA-3’ XbaI site is underlined)  
• KOaceBL (5’-TTGGATCCCGGACAGGTAGATGGC-3’ BamHI site is underlined)  
• KOaceBR (5’-TTGGATCCACAAGGGCTTCACGGC-3’ BamHI site is underlined) 
• KOaceKR (5’-TTGGTACCCTATCTCGGCATCATC-3’ KpnI site is underlined) 
The following primer pairs were used for the deletion of BCAM1588:  
• KO1588XL (5’-TTTCTAGATGACCGATCCGCACGC-3’ XbaI site is underlined) 
• KO1588BL (5’-TTGGATCCCGACCGACAACCTGGC-3’ BamHI site is underlined) 
• KO1588BR (5’-TTGGATCCCTTGTTCTGGGCACGC-3’ BamHI site is underlined) 
• KO1588KR (5’-TTGGTACCATCAAAGAATTGTCC-3’ KpnI site is underlined) 
The mutagenesis plasmids were conjugated into B. cenocepacia J2315 and also into the ΔBCAL2118 
mutant strain, in order to create the ΔBCAL2118ΔBCAM1588 double mutant (designated as D2). 
Exconjugants were selected in the presence of Tp (200 μg/ml), chloramphenicol (400 μg/ml) and 
ampicillin (200 μg/ml). The insertion of the mutagenesis plasmid into B. cenocepacia genome was 
confirmed by spraying catechol on the cells, which turn yellow in the presence of this compound and 
2,3-catechol-dioxygenase, encoded by xylE (located in pGPI-SceI-XCm plasmid). Subsequently, pDAI-
SceI-SacB plasmid (encoding the I-SceI endonuclease), was mobilized by conjugation. Site-specific 
double-strand breaks take place in the chromosome at the I-SceI recognition site, which is present in 
pGPI-SceI-XCm plasmid, resulting in tetracycline-resistant (due to the presence of pDAI-SceI-SacB) 
and Tp-susceptible (indicating the loss of the integrated plasmid) exconjugants. The gene deletions 
were confirmed by PCR reaction and sequencing of the amplification products. The isolation of 
deletion mutants cured from pDAI-SceI-SacB was achieved by growing B. cenocepacia cells on LB 
medium without antibiotics and then screening the resulting colonies for loss of tetracycline 
resistance. 
 
Construction of SDH antisense overexpression mutants 
To confirm the importance of SDH we constructed an antisense overexpression mutant. SDH contains 
4 subunits. Genes encoding the two hydrophobic subunits sdhC and sdhD (BCAM0967 and 
BCAM0968) were amplified by PCR using a PhusionR high Fidelity PCR Kit (Bioké NEB, Leiden, the 
Nederlands).  
The following primers were used for amplifying BCAM0967:  
• forward primer 5’-GTACAAGCATATGTTAGAATGCTCCGAACA-3’ (NdeI restriction site is 
underlined)  
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• reverse primer 5’-ATTCTAGAATGACTGACGCAGTAAGAAAGC-3’ (XbaI restriction site is 
underlined) 
The following primers were used for amplifying BCAM0968:  
• forward primer 5’-GTACAAGCATATGTTACACTCTCCAGAGAA-3’ (NdeI restriction site is 
underlined)   
• reverse primer 5’-AATCTAGAATGGCAGCCAACAACCGAATC-3’ (XbaI restrictions site is 
underlined) 
Cycling conditions were 30s 98°C, 30 cycli of 10s 98°C, 30s 60°C, and 24s 72°C, and 10 min 72°C. PCR 
products were purified with a High Pure PCR product purification kit (Roche, Vilvoorde, Belgium), 
digested and subsequently ligated into a plasmid described by Cardona et al. (2006), with a 
rhamnose-inducible promotor and a Tp selection marker [250]. DNA ligations, restriction 
endonuclease digestions, and agarose gel electrophoresis were performed according to standard 
techniques [251]. Restriction enzymes and T4 DNA ligase were purchased from Bioké NEB. Plasmid 
transformation experiments with E. coli DH5α were carried out by the calcium chloride method 
[252]. Resistant colonies were isolated and screened for the presence of the construct. Plasmids 
were transferred into B. cenocepacia by triparental mating [253] using pRK2013 as a helper plasmid 
[254]. Exconjugants were selected on LB agar plates supplemented with 800 μg/ml Tp and 50 μg/ml 
gentamicin. 
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RESULTS AND DISCUSSION 
Presence of persister cells 
The presence of persister cells has been proposed as an important factor in biofilm resilience [43]. To 
investigate the presence of these dormant, multidrug-tolerant phenotypic variants in Bcc biofilms, 
mature biofilms were treated with tobramycin, an aminoglycoside antibiotic, frequently used in the 
treatment of infected CF patients. The experiments were carried out using B. cenocepacia J2315, a 
member of the epidemic ET-12 lineage of which the genome has been sequenced. The MIC was 
previously determined to be 256 μg/ml [46]. Biofilms were treated with various concentrations of 
tobramycin, ranging from 0.5 to 64 x MIC for 24 h.  
We found that most cells were killed when J2315 biofilms were treated with tobramycin in 
concentrations ranging from 1 to 4 x MIC, but even at higher concentrations (up to 64 x MIC), some 
of the cells survived, indicating the presence of persisters (Fig. 1). Similar results were obtained for 
other Bcc strains (Table 4). Treatment with ciprofloxacin, a fluoroquinolone, resulted in an even 
higher fraction of surviving cells (Fig. 1). The presence of persisters is not unique to biofilms as we 
found similarly-shaped survival curves in planktonic cultures, although the fraction of surviving cells 
was considerably lower (Fig. 1).   
 
Table 4. The average percentage surviving cells for different Bcc strains after treatment of biofilms 
with high concentration of tobramycin or ciprofloxacin (n ≥ 3) 
 
 Tobramycin (4 x MIC) Ciprofloxacin (4 x MIC) 
Strain % surviving cells SD % surviving cells SD 
B. cenocepacia J2315 0.3409 0.1877 10.2425 1.4721 
B. cenocepacia K56-2 0.0064 0.0072 3.7081 3.5486 
B. cenocepacia C5424 0.0319 0.0038 37.9861 15.6789 
B. cenocepacia HI2424 0.0007 0.0007 3.6601 0.6902 
B. ambifaria AMMD 0.0096 0.01424 14.6604 11.3466 
B. lata ATCC 17769 0.8581 1.5047 4.6846 2.3581 
B. multivorans ATCC17616 0.0011 0.0012 26.1484 21.8644 
B. ubonensis LMG 20358 0.0548 0.0867 0.6486 1.1232 
B. contaminans LMG 16227 0.0183 0.0268 10.5396 9.1080 
B. dolosa LMG 18943 0.1165 0.0839 18.6143 6.3400 
B. cepacia LMG 1222 0.2369 0.4611 4.3806 5.0242 
B. vietnamiensis LMG 22486 0.8721 1.1513 1.8217 1.8081 
B. pyrrocinia LMG 14191 2.4287 3.4043 6.7670 6.6825 
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Figure 1. The percentage surviving cells after treatment of B. cenocepacia J2315 with tobramycin or ciprofloxacin. The 
results from the biofilm experiments are indicated with open circles and those from the planktonic cultures with triangles. 
Error bars represent min-max (n ≥ 2).  
 
Mulcahy et al. (2010) analyzed clonal pairs of early and late P. aeruginosa isolates from single CF 
patients and found that in the majority of these patients, cultures of late isolates contained increased 
numbers of drug-tolerant persister cells [62]. We analyzed clonal pairs of early and late Bcc isolates, 
obtained from 14 CF patients. The MICs and the fraction of persister cells are shown in Table 2. In 
general, the MICs were very similar (i.e. within a two-fold dilution), indicating that the strains did not 
acquire resistance during the course of the infection. Only in four patients the persister fraction was 
higher in the late isolates. In three patients there was no difference between the early and the late 
isolates and in eight patients the number of surviving cells was lower in the late than in the early 
isolate. Our observations suggest that, unlike in P. aeruginosa, the fraction of persisters does not 
increase with the duration of colonisation. 
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Induction of ROS by tobramycin 
Recently, it was shown that bactericidal antibiotics induce the production of ROS [213]. Tobramycin 
is known to corrupt protein synthesis and by using ROS-specific staining and flow cytometry, we 
confirmed that tobramycin also drastically increased ROS production in treated sessile cells. Most of 
the cells in treated, unlike untreated biofilms showed a high fluorescent signal (Fig. 2). 
 
Figure 2. The number of cells in function of the DCHFDA-derived fluorescent signal for untreated and treated biofilms. 
Treated biofilms were exposed to tobramycin in a concentration of 4 x MIC (1024 μg/ml) (24 h). The mean percentage of 
cells with a high fluorescent signal (>30) is indicated (n = 7). Differences between treated and untreated biofilms are 
statistically significant (p < 0.05).  
 
Gene expression in cells treated with high doses of tobramycin  
A transcriptome analysis showed a considerable change in gene expression in sessile cells treated 
with high doses of tobramycin relative to untreated sessile cells. Of the 8729 B. cenocepacia J2315 
sequences represented on the array, 2688 (30.8 %) were significantly (p < 0.05) upregulated, while 
the expression of 2413 sequences (27.6 %) was significantly (p < 0.05) downregulated. 669 (9.4 %) 
protein-coding genes were significantly (p < 0.05) upregulated by a factor of at least two, while the 
expression of 651 protein-coding genes (9.1 %) was significantly (p<0.05) downregulated by a factor 
of at least two. In addition, a significant differential expression of two or more was noted for 270 
intergenic regions (161 upregulated and 109 downregulated) and for 37 rRNA genes (all 
downregulated). Only a single tRNA gene was upregulated, but 31 tRNA genes were downregulated. 
A breakdown of differentially expressed protein-encoding genes by functional category is presented 
in supplementary data (Fig. S2) [255,256]. 
In this study we focused on genes involved in the production of ROS and we found that the major 
pathways were all downregulated in cells surviving high doses of tobramycin treatment (Table 5). We 
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observed that genes from the TCA cycle, including the majority of genes resulting in the production 
of NADH or FADH2, genes involved in the electron transport chain and the gene coding for ferredoxin 
reductase were downregulated in persister cells. On the other hand genes involved in production of 
NADPH, which plays a pivotal role in maintaining the proper cellular redox balance, were upregulated 
[257]. For example BCAL3276, the gene coding for NAD-kinase, an enzyme that mediates the 
formation of NADP (a key coenzym known to tilt cellular metabolism towards the synthesis of NADPH 
and away from the formation of NADH) was upregulated. Similarly, BCAL3395, the gene coding for 
malic enzyme, which is one of the NADPH producing enzymes, was also upregulated. Isocitrate 
dehydrogenase kinase-phosphatase, a bifunctional enzyme that can inactivate isocitrate 
dehydrogenase, thereby directing isocitrate to the glyoxylate shunt, as well as both ICL encodig genes 
were also found to be upregulated. In line with these findings, BCAL0813, encoding a RNA 
polymerase factor sigma 54 which represses the glyoxylate pathway was downregulated [258]. 
Glutamate dehydrogenase (BCAL3359) was upregulated and α-ketoglutarate dehydrogenase 
(BCAL1515) was downregulated indicating an increased production of α-ketoglutarate, a ROS 
scavenger. Other proteins involved in response to oxidative stress which were significantly 
upregulated include proteins involved in glutathione biosynthesis, thioredoxin, peroxiredoxin and 
glutathione peroxidase. The expression levels of selected genes were confirmed by qPCR (Table 5).  
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Table 5. Differences in gene expression expressed as fold changes in treated vs untreated biofilms 
Gene number Annotation Microarray qPCR 
Glyoxylate shunt   
BCAL2122 Malate synthase 1.4* -3.3* 
BCAL2118 Isocitrate lyase AceA 2.3* 1.9  
BCAM1588 Isocitrate lyase 3.1* 1.6 
BCAL0813 RNA polymerase factor sigma 54 -1.5* - 
BCAL1949 Glyoxylate carboligase -1.5 - 
Tricarboxylic acid cycle   
BCAM0961 Aconitate hydratase -1.1 - 
BCAM2701 Aconitate hydratase -1.3* -1.3 
BCAM1833 Aconitate hydratase/methylisocitrate 
dehydratase 
1.5* 1.1  
BCAL2735 Isocitrate dehydrogenase 1.3* -2.5* 
BCAL2736 Isocitrate dehydrogenase 1.4 1.5  
BCAL1515 α-ketoglutarate dehydrogenase E1  -2.0* - 
BCAL1516 Dihydrolipoamide succinyltransferase  -3.3* - 
BCAL1517 Dihydrolipoamide dehydrogenase -2.5* - 
BCAL2207 Putative dihydrolipoamide dehydrogenase -1.3* - 
BCAL1215 Dihydrolipoamide dehydrogenase -1.4* - 
BCAL0956 Succinyl-CoA synthetase beta chain -2.0* - 
BCAL0957 Succinyl-CoA synthetase subunit alpha -3.3* -10.0* 
BCAM0967 Putative succinate dehydrogenase -1.7* - 
BCAM0968 Putative succinate dehydrogenase  -2.5* - 
BCAM0969 Succinate dehydrogenase flavoprotein  -2.5* - 
BCAM0970 Succinate dehydrogenase iron-sulfur subunit -5.0* -25.0* 
BCAL2908 Fumarate hydratase -1.3* 1.9* 
BCAL2287 Putative fumarate dehydrogenase 1.0 - 
BCAM0965 Malate dehydrogenase 1.0 -2.0* 
BCAL2746 Putative citrate synthase -1.3 - 
BCAM0964 Putative lyase -1.4* - 
BCAS0023 HpcH/HpaI aldolase/citrate lyase family  -2.5* - 
BCAM0972 Type II citrate synthase -5.0* - 
Oxidative phosphorylation   
BCAL2142 Cytochrome o ubiquinol oxidase subunit III -2.0* - 
BCAL2143 Ubiquinol oxidase polypeptide I -2.0* - 
BCAL0750 Cytochrome c oxidase polypeptide I -1.7* - 
BCAL0752 Cytochrome c oxidase assembly protein -2.5* - 
BCAL0753 Hypothetical protein -2.5* - 
BCAL0754 Putative cytochrome c oxidase subunit III -2.0* - 
BCAL0030-0037 F0F1 ATP synthase subunit A-ε -1.7*- -2.5*° - 
BCAL2331-2343 NADH dehydrogenase subunit B-N -2.5- -10.0*° - 
NAD(P)H production   
BCAL3276 NAD-kinase 1.4* - 
BCAL0672 Isocitrate dehydrogenase kinase/phosphatase 1.3* - 
BCAL3359 Glutamate dehydrogenase 4.2* - 
BCAL3395 Malic enzyme 1.7* - 
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Response to oxidative stress   
BCAL1250 Putative glutathione S-transferase 1.6* - 
BCAL3331 Putative glutathione S-transferase 3.4* - 
BCAL0463 Putative thioredoxin 1.6* - 
BCAL2013 AhpC/TSA family protein 1.9* - 
BCAL2106 Glutathion peroxidase 1.6* - 
BCAM2318 Putative ferredoxin oxidoreductase -10.0* -33.3* 
Fe-storage    
BCAM2627 Putative hemin ABC transporter protein 5.2* - 
BCAM2630 Hemin importer ATP binding subunit 2.8* - 
BCAM2224 Putative pyochelin receptor protein FptA 2.7* - 
BCAL1790 Putative iron-transport protein 2.5* - 
BCAL1347 Putative Fe uptake system extracellular binding 
protein 
2.5* - 
BCAM2228 Putative pyochelin synthetase PchF 2.1* - 
BCAL1789 Putative iron-transport protein 2.0* - 
BCAL1371 Putative TonB-dependent siderophore receptor 2.0* - 
BCAL1702 Putative ornibactin biosynthesis protein -2.2* - 
 
-: no qPCR experiments were performed. *: significant change in expression between the treated and the 
untreated biofilms (n = 3, p < 0.05). °: range of fold changes for the various subunits. 
 
Eradication of persister cells 
Our transcriptome analysis suggested that protection against ROS is important in survival of persister 
cells. To confirm this we determined the number of persisters in biofilms formed by catalase 
mutants. B. cenocepacia contains two catalases of which one (KatA) is a specialized 
catalase/peroxidase which helps maintaining the normal activity of the TCA cycle, while KatB is a 
classical catalase/peroxidase which plays a global role in cellular protection against oxidative stress 
by converting toxic H2O2 into H2O and O2 [247]. We found the persister fraction to be slightly reduced 
in biofilms formed by the ΔkatA mutant but almost 40-fold reduced in biofilms formed by the ΔkatB 
mutant (Fig. 3). Furthermore, the number of surviving cells was almost 100 times lower after addition 
of the SOD inhibitor diethyldithiocarbamate (DETC) (Fig. 4). SODs are antioxidant enzymes that 
detoxify O2-. by a dismutation reaction generating H2O2 and O2 [245]. The inhibitor had no effect on 
untreated biofilms in the concentrations tested, but reduced the number of surviving cells in a 
concentration dependent manner when combined with tobramycin. Together, these results indicate 
that protection against ROS is indeed important for the survival of persister cells.  
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Figure 3. Effect of knocking out catalase function on survival of peristers. The number of surviving cells in biofilms formed 
by B. cenocepacia C5424 and two catalase mutants after treatment with tobramycin in a concentration of 4 x MIC (512 
μg/ml). Error bars represent standard deviation (n = 3).   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Effect of superoxide dismutase inhibition on survival of persisters. The number of surviving cells in B. cenocepacia 
J2315 biofilms after treatment with tobramycin alone (4 x MIC, 24 h) or in combination with diethyldithiocarbamate (DETC 
0.05 mM). Error bars represent standard deviation (n = 3, p < 0.05). 
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Persister cells are typically considered as “dormant” (i.e. metabolically inactive) cells [51] but our 
data challenge that paradigm. While it is true that some pathways (i.e. TCA cycle) were found to be 
downregulated, other pathways were upregulated, and these may be a novel therapeutic target for 
combination therapy. The importance of the upregulation of the glyoxylate shunt for the survival of 
persister cells was confirmed by inhibition of ICL, the first enzyme in the shunt. Because persisters 
are thought to be pre-existent, biofilms were grown in the presence of these inhibitors. During 
treatment the inhibitors were removed because of pH incompatibility with the antibiotics used. 
Pretreatment of B. cenocepacia biofilms with the ICL inhibitor itaconate in a concentration of 50 mM 
reduced the persister fraction approximately 10 fold when the biofilms were subsequently treated 
with tobramycin. Pretreatment with 10 mM 3-NP, a more potent ICL inhibitor resulted in similar 
reductions (Fig. 5). The concentrations of the ICL inhibitor used were below the MIC and they did not 
affect growth in the untreated biofilms. In addition, we did not observe an effect of either inhibitor 
on ROS production (data not shown). The additional killing observed after combined treatment with 
tobramycin and an ICL inhibitor was not observed with ciprofloxacin (Fig. 5). This may suggest that 
this effect is related to the type of antibiotic and/or the magnitude of its effect on biofilms. However, 
this remains to be investigated. Similar results were obtained in other Bcc bacteria (Fig. 6).  
Figure 5. Effect of isocitrate lyase inhibition on B. cenocepacia J2315. The number of surviving cells in B. cenocepacia J2315 
biofilms after treatment with tobramycin (4 x MIC, 24 h) or ciprofloxacin (4 x MIC, 24 h) for biofilms grown in LB or LB 
supplemented with 50 mM itaconate (ita) or 10 mM 3-nitropropionate (3-NP). Error bars represent standard deviation. 
Statistically significant differences are indicated by an asterisk (p < 0.05, n ≥ 3). 
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Figure 6. Effect of iocitrate lyase inhibition on different Bcc strains. The number of surviving cells in different Bcc biofilms 
after treatment with tobramycin (4 x MIC, 24 h) for biofilms grown in LB or LB supplemented with 50 mM itaconate. 
Statistically significant differences are indicated by an asterisk (p < 0.05) (n≥3). 
 
To confirm the results obtained by chemically inhibiting ICL, we constructed a B. cenocepacia J2315 
mutant in which both ICL genes were inactivated. Surprisingly, there was no significant decrease in 
the number of surviving cells after treatment with tobramycin in the D2 mutant compared to wild 
type (Fig. 7A), but we did find an additional effect after adding 3-NP to the mutant. Itaconate and 3-
NP are succinate analogues and besides inhibiting ICL, they also inhibit SDH [259].  
We hypothesised that an upregulation of ICL in persisters not only limits the production of NADH 
(and thus limits ROS production) but also leads to an increased intracellular succinate concentration. 
Succinate can be oxidised by SDH, thereby generating FADH2 which can lead to basal production of 
ATP in persister cells in which other energy-generating systems are downregulated. Itaconate and 3-
NP likely kill persisters by shutting down the remaining ATP production by inhibiting both ICL and 
SDH. To test this hypothesis we constructed a SDH antisense overexpression mutant in the D2 
background, in which SDH is inactivated if rhamnose is present. However, we noticed that Tp 
(required to maintain the plasmid) and/or rhamnose (required to induce antisense RNA expression) 
had a mild influence on biofilm formation as such, and on the number of persisters in biofilms (data 
not shown), which made interpretation of these data impossible. However, addition of an 
ubiquinone type SDH inhibitor, 2-thenoyltrifluoroacetone, to B. cenocepacia D2 biofilms significantly 
(p < 0.05) reduced the number of surviving persisters (Fig. 7B), while not affecting the MIC for 
tobramycin (data not shown).   
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Figure 7A. The number of surviving cells in a double ICL mutant (D2) compared to wild type (WT). The number of surviving 
cells in a double ICL mutant (D2) and in a wild type B. cenocepacia J2315 (WT) biofilm after treatment with tobramycin (4 
MIC, 24h) for biofilms grown in LB or LB supplemented with 10 mM 3-NP. Error bars represent standard deviation (n ≥ 3). 
For both strains, treatment with 3-NP resulted in significantly (p < 0.05) less surviving cells compared to the untreated 
control.  
Figure 7B. Effect of succinate dehydrogenase inhibition on B. cenocepacia D2. The number of surviving cells in B. 
cenocepacia D2 biofilms after treatment with tobramycin (4 x MIC, 24 h) for biofilms grown in LB or LB supplemented with 
250 nM 2-thenoyltrifluoroacetone (Then). Error bars represent standard deviation (n = 4). Statistically significant differences 
are indicated by an asterisk (p < 0.05). 
 
The reaction catalysed by ICL also leads to the production of glyoxylate. In B. cenocepacia glyoxylate 
can be used to form malate (through the activity of malate synthase) or tartronate semialdehyde 
(through the activity of glyoxylate carboligase). There are two malate synthases of which only one 
(BCAL2122) was slightly upregulated and glyoxylate carboligase (BCAL1949) was slightly 
downregulated (Table 5).    
 
Conclusion 
Our results contribute to a better understanding of the molecular mechanisms responsible for the 
antimicrobial tolerance of Bcc biofilms by demonstrating that these biofilms contain tolerant 
persister cells. In these surviving persister cells, the TCA cycle was downregulated and the expression 
of genes involved in the electron transport chain was also downregulated. This way the cells avoid 
the production of ROS. At the same time, persister cells activate an alternative pathway, i.e. the 
glyoxylate shunt. When biofilms were grown in the presence of an inhibitor of ICL and SDH, less 
persisters survived. Similar results were obtained in different species, indicating that this mechanism 
is widespread within the Bcc. So far, most anti-persister strategies focussed on “reawaking” 
* * 
* 
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persisters for efficient killing [115], but we found that inhibiting a cellular target can also reduce the 
number of surviving persisters. This finding may provide novel approaches for treatment of persister-
related infections. 
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Figure S1. Average expression stability values (M) of remaining control genes during stepwise exclusion of the least stable 
control gene (between brackets). Genes are ranked from left to right in order of increasing expression stability (decreasing 
M value). Genes labeled with an asterisk were used for normalization. 
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Table  S2. Differentially expressed protein-coding genes ordered by functional category [255,256] 
 
Functional category  Code Probes Up Down  % up % down 
Hypothetical protein 0.0.0 145 16 19 11% 13% 
Conserved hypothetical protein 0.0.2 871 108 82 12% 9% 
Chemotaxis and mobility 1.1.1 72 3 0 4% 0% 
Chromosome replication 1.2.1 11 4 1 36% 9% 
Chaperones 1.3.1 24 3 3 13% 13% 
Protection responses        
Cell killing 1.4.1.  5 2 0 40% 0% 
Detoxification 1.4.2 42 3 1 7% 2% 
Drug-analog sensitivity 1.4.3 89 6 4 7% 5% 
Transport/ binding proteins       
Transport/binding proteins 1.5.0 478 35 19 7% 4% 
Amino acids and amines 1.5.1 101 12 7 12% 7% 
Cations 1.5.2 44 9 6 21% 14% 
Carbohydrates, organic acids and alcohols 1.5.3 63 3 7 5% 11% 
Anions 1.5.4 15 2 1 13% 7% 
Other 1.5.5 97 4 6 4% 6% 
Adaptation        
Adaptation, atypical conditions 1.6.1 32 4 6 13% 19% 
Osmotic adaptation 1.6.2 11 1 3 9% 27% 
Fe storage 1.6.3 38 7 1 18% 3% 
Cell division       
Cell division 1.7.1 23 2 2 9% 9% 
Macromolecule metabolism       
Macromolecule degradation 2.1.0 1 0 0 0% 0% 
Degradation of DNA 2.1.1 9 0 0 0% 0% 
Degradation of RNA 2.1.2 11 1 0 9% 0% 
Degradation of polysaccharides 2.1.3 8 0 1 0% 13% 
Degradation of proteins, peptides 
glycoproteins 2.1.4 38 2 2 5% 5% 
Macromolecules synthesis- modification       
Macromolecules synthesis-modification 2.2.0 3 1 3 33% 27% 
Amino acyl tRNA synthesis, tRNA 
modification 2.2.1 42 0 8 0% 19% 
Basic protein- synthesis, modification 2.2.2 5 0 0 0% 0% 
DNA-replication, repair, restriction, 
modification 2.2.3 67 7 12 11% 18% 
Lipopolysaccharide 2.2.5 55 4 12 7% 22% 
Lipoprotein 2.2.6 3 0 1 0% 33% 
Phospholipids 2.2.7 9 0 0 0% 0% 
Polysaccharides 2.2.8 3 0 2 0% 67% 
Protein modification 2.2.9 20 0 2 0% 10% 
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Proteins - translation and modification 2.2.10 28 0 5 0% 18% 
RNA synthesis, modification, DNA 
transcription 2.2.11 36 1 7 3% 19% 
tRNA 2.2.12 47 0 0 0% 0% 
Metabolism of small molecules       
Metabolism of small molecules 3.0.0 2 1 0 50.% 0% 
Amino acid biosynthesis 3.1.0 9 1 1 11% 11% 
Arginine 3.1.2 9 0 2 0% 22% 
Asparagine 3.1.3 1 0 1 0% 100% 
Aspartate 3.1.4 1 0 0 0% 0% 
Chorismate 3.1.5 1 0 0 0% 0% 
Cysteine 3.1.6 4 0 0 0% 0% 
Glutamate 3.1.7 3 1 0 33% 0% 
Glutamine 3.1.8 3 0 1 0% 33% 
Glycine 3.1.9 5 0 0 0% 0% 
Histidine 3.1.10 11 0 0 0% 0% 
Isoleucine 3.1.11 3 0 0 0% 0% 
Leucine 3.1.12 7 2 0 29% 0% 
Lysine 3.1.13 7 0 0 0% 0% 
Methionine 3.1.14 10 0 1 0% 10% 
Phenylalanine 3.1.15 2 2 0 100% 0% 
Proline 3.1.16 3 0 0 0% 0% 
Serine 3.1.17 2 0 1 0% 50% 
Threonine 3.1.18 3 0 2 0% 67% 
Tryptophan 3.1.19 11 0 1 0% 9% 
Tyrosine 3.1.20 1 0 1 0% 100% 
Valine 3.1.21 3 0 2 0% 67% 
Biosynthesis of cofactors, carriers       
Biosynthesis of cofactors, carriers 3.2.0 5 0 1 0% 20% 
ACP 3.2.1 9 4 0 44% 0% 
Biotin 3.2.2 5 0 0 0% 0% 
Cobalamin 3.2.3 13 2 0 15% 0% 
Folic acid 3.2.5 10 0 04 0% 40% 
Heme, porphyrin 3.2.6 26 0 0 0% 0% 
Lipoate 3.2.7 3 0 0 0% 0% 
Menaquinone, ubiquinone 3.2.8 10 1 4 10% 40% 
Molybdopterin 3.2.9 10 0 0 0% 0% 
Pantothenate 3.2.10 8 0 1 0% 13% 
Pyridine nucleotide 3.2.11 6 1 1 17% 17% 
Pyridoxine 3.2.12 8 1 1 13% 13% 
Riboflavin 3.2.13 9 1 2 11% 22% 
Thiamin 3.2.14 10 0 1 0% 10% 
Thioredoxin, glutaredoxin, glutathione 3.2.15 11 1 2 9% 18% 
BCCP 3.2.16 3 0 0 0% 0% 
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Central intermediary metabolism       
Entner-Douderoff 3.3.3 2 0 0 0% 0% 
Gluconeogenesis 3.3.4 7 0 2 0% 29% 
Glyoxylate 3.3.5 13 1 1 8% 8% 
Misc. glucose metabolism 3.3.7 1 1 0 100% 0% 
Misc. glycerol metabolism 3.3.8 1 1 0 100% 0% 
Non-oxidative branch, pentose pathway 3.3.9 4 0 0 0% 0% 
Nucleotide hydrolysis 3.3.10 4 0 0 0% 0% 
Nucleotide interconversions 3.3.11 13 0 1 0% 8% 
Phosphorus compounds 3.3.13 7 0 1 0% 14% 
Polyamine biosynthesis 3.3.14 14 2 1 14% 7% 
Pool, multipurpose conversions of 
intermed. metabolism 3.3.15 72 7 8 10% 11% 
S-adenosyl methionine 3.3.16 1 0 0 0% 0% 
Salvage of nucleosides and nucleotides 3.3.17 13 1 1 8% 8% 
Sugar-nucleotide biosynthesis, conversions 3.3.18 3 0 1 0% 33% 
Sulfur metabolism 3.3.19 18 4 0 22% 0% 
Amino acids 3.3.20 15 0 0 0% 0% 
Amino acids: other 3.3.21 36 0 6 0% 17% 
Degradation       
Degradation 3.4.0  19 3 0 16% 0% 
Amines 3.4.1 22 1 2 5% 9% 
Amino acids 3.4.2 58 7 5 12% 9% 
Carbon compounds 3.4.3 117 5 13 4% 11% 
Fatty acids 3.4.4 34 6 3 18% 9% 
Other 3.4.5 75 5 6 7% 8% 
ATP-proton motive force 3.4.6 0 0 0   
Energy metabolism, carbon       
Aerobic respiration 3.5.1 28 3 15 11% 54% 
Anaerobic respiration 3.5.2 10 0 2 0% 20% 
Electron transport 3.5.3 72 3 10 4% 14% 
Fermentation 3.5.4 3 0 0 0% 0% 
Glycolysis 3.5.5 12 0 1 0% 8% 
Oxidative branch, pentose pathway 3.5.6 4 0 0 0% 0% 
Pyruvate dehydrogenase 3.5.7 2 0 0 0% 0% 
TCA cycle 3.5.8 22 0 9 0% 41% 
ATP 3.5.9 12 0 5 0% 42% 
Fatty acid biosynthesis       
Fatty acid and phoshatic acid biosythesis 3.6.1 22 4 1 18% 5% 
Nucleotide biosynthesis      
Purine ribonucleotide biosynthesis 3.7.1 16 0 2 0% 13% 
Pyrimidine ribonucleotide biosynthesis 3.7.2 12 0 2 0% 17% 
Cell envelop          
Periplasmatic/exported/lipoproteins 4.1.0 465 57 38 12% 8% 
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Inner membrane 4.1.1 392 29 32 7% 8% 
Murein sacculus, peptidoglycan 4.1.2 38 5 6 13% 16% 
Outer membrane constituents 4.1.3 63 8 3 13% 5% 
Surface polysaccharides and antigens 4.1.4 66 1 20 2% 30% 
Surface structures 4.1.5 38 1 3 3% 8% 
Ribosome constituents      
Ribosomal and stable RNAs 4.2.1 1 0 0 0% 0% 
Ribosomal proteins-synthesis, modification 4.2.2 57 0 34 0% 60% 
Ribosomes-maturation and modification 4.2.3 4 0 3 0% 75% 
Extrachromosomal       
Colicin-related functions 5.1.1 2 0 1 0% 50% 
Phage-related functions and prophages 5.1.2 276 38 8 14% 3% 
Plasmid-related functions 5.1.3 26 3 2 12% 8% 
Transposon-related functions 5.1.4 71 6 1 9% 1% 
Rest 5.1.5 33 2 3 6% 9% 
Global functions       
Global functions 6.0.0 14 3 1 21% 7% 
Global regulatory functions 6.1-6.5 768 88 39 11% 5% 
Not classified 7.0.0 1281 112 105 
 
9% 8% 
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ABSTRACT 
Biofilms are involved in the recalcitrance of infections due to the presence of persister cells. Although 
the molecular basis of persistence is still largely unknown, TA-modules are thought to play a role. In 
this study, we investigated whether TA-modules contribute to persistence towards antibiotics in B. 
cenocepacia J2315. 16 pairs of genes were identified as TA-modules. Overexpression of the different 
toxins had various effects on growth, persistence and biofilm formation. Toxins of which the 
overexpression resulted in growth inhibition, had a positive influence on the number of surviving 
persisters, while toxins of which the overexpression did not have influence on growth, had no or a 
negative influence on the number of surviving persisters. Furthermore, the expression of the TA-
modules was compared between treated and untreated sessile and planktonic WT cultures. For 10 
toxin encoding genes, the expression was higher in untreated sessile cells than in untreated 
planktonic cells. Nine toxin encoding genes were upregulated after treatment with tobramycin, but 
none after treatment with ciprofloxacin. These results indicate that most, but not all TA-modules 
contribute to persistence in B. cenocepacia J2315 and that this contribution depends on the mode of 
growth and the antibiotic used.   
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INTRODUCTION 
Biofilms are microbial communities of sessile cells which are embedded in a self-produced matrix of 
extracellular polymeric substances, including DNA, polysaccharides and proteins [37]. They play an 
important role in the recalcitrance of infections due to the presence of persister cells [62]. 
Persistence is the ability of a small subpopulation of bacteria to survive antibiotic treatment without 
expressing a specific resistance mechanism [49]. Although the molecular basis of persistence is still 
largely unknown, TA-modules are thought to play a role in it [84]. They were first identified on 
plasmids and they contribute to their maintenance [136]. Chromosomal TA-modules have an 
influence on biofilm formation, gene and growth regulation, programmed cell death, stabilization of 
mobile genetic elements and persistence [84,260]. 
Five types of TA-modules have been described [137]. While toxins are always proteins, the antitoxins 
can either be proteins (types II, IV, V) or RNA-molecules (types I and III) [137]. Type II TA-modules are 
the best characterized ones and they usually consist of two genes organized in an operon, encoding a 
stable toxin and an unstable antitoxin [84]. Under normal conditions, the antitoxin forms a complex 
with the toxin, thereby inactivating it. Both the antitoxin and the toxin-antitoxin complex can act as 
repressors of toxin transcription. However, in stress conditions the antitoxin is degraded, toxin 
molecules are released and can inhibit important cellular functions [84]. Based on their structural 
features and modes of action, type II TA loci have been divided into different families [149]. The most 
abundant one of the TA gene families is the VapBC family and the corresponding toxins are site-
specific riboendonucleases that cleave initiator tRNA [84]. Toxins belonging to the RelE family, are 
riboendonucleases that cleave mRNA positioned at the ribosomal A-site, while ribosome 
independent mRNAses, e.g. toxins belonging to the MazF family, cleave mRNA specifically at ACA 
motifs in a ribosome-independent manner. Toxins of the HipA family are serine kinases previously 
thought to inhibit the translation factor EF-Tu [84], but recently found to actually inhibit a glutamyl-
tRNA synthetase (GltX) [104]. Other prototypes of toxin super-families are the Zeta, Doc, YafO, VapD, 
GinA, GinB, GinC and GinD toxin families. Toxins target various cellular processes including 
replication, cell wall assembly and protein translation [135]. As bactericidal antibiotics kill cells by 
corrupting these cellular functions, their inhibition by toxins prevents bacterial killing and gives rise 
to persister cells [49].  
MqsRA was found to be involved in E. coli biofilm formation through regulation of RpoS [186]. Kim et 
al. found that deletion of five TA-modules (mazEF, relBE, chpB, yoeB/yefM, yafQ/dinJ) in E. coli 
reduced biofilm formation after 8 h, but increased it after 24 h [201]. Deletion of only the toxins on 
the other hand increased biofilm formation after 8 h [201]. In contrast deletion of relE or mazF had 
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no influence on biofilm formation in Streptococcus mutans [199]. These studies indicate that at least 
some TA-modules are also involved in biofilm formation. 
B. cenocepacia is a member of the Bcc, a group of 18 closely related bacterial species which can 
cause severe lung infections in immunocompromised people, e.g. cystic fibrosis patients [2]. These 
metabolically versatile microorganisms are often very difficult to eradicate due to their innate 
resistance, the capacity to form biofilms and the presence of persister cells [25,41,44,261]. In the 
present study we investigated whether TA-modules play a role in the tolerance of B. cenocepacia 
J2315 towards different antibiotics.  
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MATERIAL AND METHODS 
Strains and culture conditions 
B. cenocepacia J2315 (LMG 16656) was cultured at 37°C on Luria-Bertani agar (LBA, Oxoid, 
Hampshire, UK). Overnight cultures were diluted in Luria-Bertani broth (LBB, Oxoid) and incubated 
aerobically at 37°C. Overexpression mutants and the vector control (i.e. the WT strain with an empty 
vector) were grown on LBA supplemented with 800 μg/ml Tp (Ludeco, Brussels, Belgium) or in LBB 
supplemented with 800 μg/ml Tp, with or without 0.2 % rhamnose (Sigma Aldrich, Bornem, Belgium). 
E. coli DH5α was grown at 37°C on LBA and E. coli DH5α overexpression mutants on LBA 
supplemented with 50 μg/ml Tp. E. coli pRK2013 was grown at 37°C on LBA supplemented with 40 
μg/ml kanamycin (Sigma).  
Identification of TA-modules 
The RASTA bacteria software tool was used to identify possible TA-modules [164]. This tool uses a 
search method relying on the size of the genes, their genomic organization, and the presence of 
conserved functional domains. Using BLASTP we searched for sequences homologous to toxins and 
antitoxins of known TA-families and searched for conservation in other Burkholderia species. The cut-
off E-value and the identity threshold used in this analysis were 10−5 and 40 %, respectively. 
Construction of toxin overexpression mutants 
To study the role of the different toxins, overexpression mutants were constructed as described 
previously [261]. The primers and specific cycling conditions are listed in Table S1. Generally cycling 
conditions were 30s at 98°C, 30 cycles of 10s at 98°C, 30s at 60°C, 24s at 72°C and finally 10 min at 
72°C. PCR-constructs were digested and ligated into a plasmid pSCrhaB2 [262], containing a 
rhamnose-inducible promotor and a Tp selection marker. The CaCl2 method was used to transform 
the plasmid into E. coli DH5α [252]. Resistant colonies were isolated and screened for the presence 
of the construct. Plasmids were transferred into B. cenocepacia J2315 by triparental mating [253] 
using pRK2013 as a helper plasmid [254]. Exconjugants were selected on LB agar plates 
supplemented with 800 μg/ml Tp and 50 μg/ml gentamicin and screened. Plasmid extraction, PCR 
and agarose gel electrophoresis were performed to determine the presence of the right insert. 
Determination of growth characteristics 
To study the influence of toxin overexpression on growth, overnight cultures were diluted to an 
optical density (λ = 590 nm) of 0.05 (approximately 5 x 107 CFU/ml) in LBB supplemented with 800 
μg/ml Tp and 0.2 % rhamnose. 50 μl of this suspension was added to the wells of a 24 well microtiter 
plate (TPP, Trasadingen, Switzerland) and mixed with 950 μl medium. Plates were incubated at 37°C 
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and the absorbance was measured every 30 minutes for 3 days at 590 nm. Three wells were included 
per strain and the experiment was repeated once.  
Sequencing of the inserts 
To investigate whether selection against the plasmid carrying the toxin gene takes place after 
prolonged induction, planktonic cultures were grown in the presence of 0.2 % rhamnose and 800 
μg/ml Tp as described above. After approximately 50 h of growth, plasmids were extracted and PCR 
was performed using primers that anneal up- and downstream of the insert (Table S1). Products 
were analysed by agarose gel electrophoresis and sequenced. The resulting sequences were analysed 
using Finch TV.   
Biofilm formation 
To measure differences in biofilm biomass between the vector control and the overexpression 
mutants, an inoculum suspension containing approximately 5 x 107 CFU/ml was added to the wells of 
a round-bottomed 96-well microtiter plate (TPP). Ten wells were included per strain and the 
experiment was repeated at least twice. Biofilms were grown in LBB supplemented with Tp and 0.2 % 
rhamnose to induce toxin expression. Following 4h of adhesion, the supernatant was removed and 
the plates were rinsed with physiological saline (0.9 % w/v NaCl) (PS). Subsequently, 100 μl of fresh 
LBB supplemented with 800 μg/ml Tp and 0.2 % rhamnose was added and the plates were further 
incubated at 37°C. After 24 h the supernatant was removed, wells were rinsed with 100 μl PS and 
100 μl of 99 % methanol (Sigma) was added and left in contact for 15 minutes. Methanol was 
removed and plates were dried at 37°C. When all residual methanol was evaporated, 100 μl of a 0.1 
% crystal violet staining (Prolab diagnostics, UK) was added for 20 minutes. Plates were rinsed with 
water and 150 μl of a 33 % acetic acid solution was added for 5 minutes. After shaking, absorption 
was measured at 590 nm. Only mutants for which there were no differences in growth, when grown 
planktonically were included in this experiment. 
Quantification of persister cells 
To determine the number of surviving persisters, 24 h old biofilms were exposed for 24 h to 
tobramycin or ciprofloxacin in a concentration of 4 x MIC (1024 or 32 μg/ml, respectively) [261]. 
Biofilms were grown as described above, but toxin expression was induced only shortly before 
treatment. Biofilms were grown in LBB supplemented with 800 μg/ml Tp and without rhamnose. 
After 24 h of growth, the supernatant was removed and 100 μl of LBB supplemented with 800 μg/ml 
Tp and 0.2 % rhamnose was added to induce toxin expression. After 2 h of induction, 120 μl of an 
antibiotic solution in PS or 120 μl PS (= control) was added and the plates were incubated for an 
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additional 24 h at 37°C. Twelve wells were included per condition. Cells were harvested by vortexing 
and sonication (2 x 5 min) (Branson 3510, Branson Ultrasonics Corp, Danbury, CT) and quantified by 
plating on LB (n ≥ 3 for all experiments). 
RNA extraction and quantitative RT-qPCR  
To compare the expression of the TA-modules between treated and untreated biofilms the wild type 
(WT) strain was grown as a biofilm, as described above using unsupplemented LBB as growth 
medium. Biofilms were subsequently treated with tobramycin or ciprofloxacin in a concentration of 4 
x MIC or PS (= control). After 24 h of treatment, cells were harvested by vortexing and sonication (2 x 
5 min) and transferred to sterile tubes (n = 3 for all experiments). To determine the expression in WT 
planktonic cultures, an overnight culture in LBB without supplementation was diluted to an optical 
density of 0.1 (approximately 108 CFU/ml). After an additional 24 h growth, cell suspensions with an 
optical density of 1 (approximately 109 CFU/ml) were similarly treated with tobramycin, ciprofloxacin 
or PS. After 24 h cells were washed with PS and harvested.  
RNA was extracted immediately following harvesting of the cells, using the Ambion RiboPure Bacteria 
Kit (Ambion, Austin, TX), according to the manufacturer’s instructions. The absorbance was 
measured using a Biodrop (Isogen Life Science, Temse, Belgium) to calculate RNA concentration and 
to evaluate RNA quality. cDNA was synthesized using the iScript cDNA Synthesis Kit (Bio-Rad, 
Hercules, CA). Forward and reverse primers were developed using tools available on the NCBI 
website and they were compared with the B. cenocepacia J2315 genome sequence (accession 
numbers AM747720, AM747721, AM747722 and AM747723) using BLAST to determine their 
specificity (Table S2). The primer concentration used was 300 nM. All qPCR experiments were 
performed on a Bio-Rad CFX96 Real-Time System C1000 Thermal Cycler as described previously 
[261]. Each sample was spotted in duplicate and control samples without added cDNA were included 
in each experiment. The initial 3 min denaturation step at 95°C was followed by 40 amplification 
cycles, consisting of 15 s at 95°C and 60 s at 60°C. A melting curve analysis was included at the end of 
each run. Three reference genes (BCAL2694, BCAS0175, BCAM2784) were included to allow accurate 
normalization. These reference genes were previously found to be stably expressed [261].  
Differential RNA sequencing 
To determine transcription start sites for the identified TA-modules, the WT strain was grown as a 
biofilm and after 24 h of growth RNA was extracted, as described above. Differential RNA sequencing 
was performed as described in Kröger et al. [263]. In brief, two biological replicates of total RNA 
samples were each divided into two aliquots and one aliquot was treated with terminator 
exonuclease (TEX). Per sample two cDNA libraries were constructed, one from TEX-treated and one 
Chapter III: Experimental work    Paper 2 
 
 100 
from untreated RNA. TEX selectively degrades processed RNAs which carry a monophosphate at the 
5’ end. Primary transcripts carrying a triphosphate, are not degraded by TEX and thus enriched in the 
TEX treated library. Prior to sequencing, RNA was polyadenylated and reverse transcriptase primed 
with poly-T primers in order to only generate cDNA based on one priming event per RNA molecule. 
Both libraries were then sequenced from the 5’ end only, using Illumina technology. Sequencing 
adapters, poly-A tails and sequences with a phred score < 20 were clipped from the sequencing reads 
and reads < 12 bp were discarded. Remaining reads were mapped to the B. cenocepacia J2315 
genome using Segemehl [264] with an accuracy setting of 95% and a seed difference threshold of 
one. Resulting mapping data were normalized to total reads. Sites with a local maximum in mapped 
read starts and enrichment in the TEX-treated library were defined as transcription start sites, with a 
threshold of minimal 10 reads in both biofilm replicates. 
Transcriptome analysis  
To confirm that the identified TA-modules were expressed and to compare the expression of the 
toxins and the antitoxins, a transcriptome analysis of untreated sessile cells was performed. The WT 
strain was grown as a biofilm and after 24 h of growth, RNA was extracted as described above (n = 3). 
RNA quantifications were performed using picogreen fluorescence measurement on a FLUOstar 
galaxy plate reader (BMG Labtech, Ortenberg, Germany). Two micrograms total RNA of each sample 
were depleted for ribosomal RNA using the Ribo-zero Magnetic Gram-Negative Bacteria kit 
(Epicentre, Madison, WI, U.S.A.). Approximately 30 ng of rRNA depleted RNA was used to create 
barcoded strand specific cDNA sequencing libraries with the Truseq stranded Total RNA library 
preparation kit (Illumina, San Diego, USA). The libraries were equimolarly pooled and sequenced in 
one lane of an Illumina HiSeq 1500 flowcell, generating 2x100 bp paired end reads. After sequencing, 
the data were demultiplexed using the sample specific nucleotide barcode. 
Three independent samples were analyzed and CLC bio (Qiagen, Venlo, The Nederlands) was used to 
analyze the data. For each sample at least 40000000 paired-end reads were analyzed. Reads were 
mapped to B. cenocepacia J2315 genome; in order to be included in the analysis, a minimum of 90 % 
of the read had to map with minimal 80 % similarity to a gene or the flanking region 150 bp up- or 
downstream of a gene. For each sample, more than 70 % of the reads was mapped to a gene and 
more than 60 % was uniquely mapped. The number of reads assigned to a transcript were divided by 
the transcript length and normalized to the number of mapped reads to obtain reads per kb per 
million (RPKM) expression values. The raw sequencing data can be found in ArrayExpress under the 
accession number E-MTAB-2079. 
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Statistical data analysis 
Unless otherwise mentioned, statistical data analysis was performed using SPSS software, version 21 
(SPSS, Chicago, IL, USA). The Shapiro-Wilk test was used to verify the normal distribution of the data. 
Normally distributed data were analyzed using a one-sample T-test or an independent sample T-test, 
whereas non-normally distributed data were analyzed using a Wilcoxon signed-rank test or a Mann-
Whitney test. P-values < 0.05 were considered significant. For the qPCR experiments an arbitrary cut-
off value of 1.5 fold was applied to identify differentially expressed genes. Genes were considered 
significantly up-or downregulated if p-value < 0.05 and fold change > 1.5. 
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RESULTS AND DISCUSSION 
In silico identification of TA-modules in B. cenocepacia J2315  
Using RASTA bacteria software, 15 pairs of genes were identified as possible TA-modules (Fig. 1). 
Only pairs of which both genes had RASTA scores higher than or equal to 60 % were included. In 
addition, we looked for sequence similarities with known TA-modules. For two putative TA-modules 
the corresponding protein sequences did not show sequence similarities with reported TA-modules 
(BCAM0257-8-9, BCAL0175-6-7) and those were not further investigated in the present study. 
However, based on sequence similarity with known TA-modules, three other putative pairs were 
identified and included in the present study: BCAM0626-7 (resembling the RelBE module in 
Burkholderia pseudomallei), BCAM1766-7 (resembling hipAB) and BCAS0433-4 (annotated as hipAB - 
like).  
 
Figure 1. Overview of the location of TA-modules identified in B. cenocepacia J2315. Similarities with known toxin families 
based on Protein BLAST analysis are indicated. Toxins and antitoxins are shown as colored and transparent arrows, 
respectively. (note that the chromosomes and plasmid pBCJ2315 are not drawn to scale). 
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Of the 16 TA-modules included in the present study, one was found on the plasmid (pBCA093-4) and 
three others on genomic islands (BCAL1127-8-9, BCAM0271-2, BCAM1051-2). Among the toxins (Fig. 
1) are proteins similar to ribosome independent mRNA interferases (MazF), ribosome dependent 
mRNA interferases (RelE), tRNA interferases (VapC) and kinases [135]. As described for other 
bacteria, several homologues of the same type of toxin are present at different locations in the 
genome [191]. Transcriptome analysis and differential RNA sequencing revealed that all TA-modules 
were transcribed as one operon. Transcription start sites were located at or maximum 30 bp 
upstream of the startcodon, as determined by differential RNA sequencing [178,265,266]. Although 
type II TA-modules usually consist of two genes, with an antitoxin located upstream of a toxin one 
operon consisting of three genes was identified (BCAS0579-81). BCAL1129 also had a RASTA score of 
more than 60 %, but does not form an operon with BCAL1127-8. In three operons the toxin was 
located upstream of the antitoxin, as previously described for HigBA, HicAB and MqsRA [149]. 
Identification of TA-modules in other Burkholderia species 
Twelve of the sixteen toxins found in B. cenocepacia J2315 were also present in other B. cenocepacia 
strains (Table 1). BCAL3209 was only found in B. cenocepacia strains and not in other Burkholderia 
species, while BCAL0070, BCAM0816, BCAM0627 and BCAM1766 were conserved in both Bcc and 
non-Bcc strains, as well as in B. pseudomallei. Among the Bcc strains, most of the toxins identified in 
the present study were also found in B. ambifaria, B. multivorans and B. vietnamiensis strains (10, 7 
and 6 toxins respectively), whereas only 3 and 2 toxins were conserved in B. dolosa and B. cepacia, 
respectively. Only five of the toxins identified in the present study were also found in B. 
pseudomallei. One of them (BCAL1127), was exclusively found in B. pseudomallei. BCAM1051 was 
the only toxin which was not found in any of the other Burkholderia strains investigated. Hence TA-
modules are reasonably conserved within the Burkholderia genus, which suggests they have a 
physiological function. 
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Table 1. Conservation of toxins, identified in B. cenocepacia J2315, in other Burkholderia species 
Gene 
number 
B. cenocepacia* other Bcc species* non-Bcc Burkholderia 
species* 
B. 
pseudomallei * 
BCAL3284 + + + - 
BCAL0070 + + + + 
BCAL3209 + - - - 
BCAL1127 - - - + 
BCAL0610 + + - - 
BCAL1109 + - + - 
BCAM1194 - + + - 
BCAM0347 + + + - 
BCAM0816 + + + + 
BCAM1051 - - - - 
BCAM0272 + + + - 
pBCA093 + + + - 
BCAS0580 - + + - 
BCAM0627 + + + + 
BCAS0434 + + + - 
BCAM1766 + + + + 
*B. cenocepacia, strains AU1054, HI2424, MC0-3, PC184; Bcc: strains B. ambifaria AMMD, MC40-6; B. cepacia GG4, B. 
dolosa AU0158, B. multivorans ATCC17616, B. vietnamiensis G4, non-Bcc: strains B. gladioli BSR3, B. glumae BGR1, B. 
phenoliruptrix BR3459a, B. phymatum STM815, B. phytofirmans PsJN, B. rhizoxinica HK454, B. thailandensis; B. 
pseudomallei, strains 1106a, 1026b, 1710b, 668, BPC006, K96243, MSHR346  
Overexpression of some, but not all toxins negatively impacts growth 
To study the TA-modules found in B. cenocepacia J2315 more in detail, toxin overexpression mutants 
(in which expression of the toxin is controlled by a rhamnose inducible promoter) were constructed. 
Mutants were constructed for most TA-modules with exception of BCAM1051, BCAM1766 or 
BCAS0434, which could not be PCR-amplified. In more than half of the mutants growth inhibition was 
observed compared to the vector control, while there was no difference between the vector control 
and the other mutants under the conditions tested (Fig. 2). Growth was delayed most when 
BCAM3209 or BCAL0070 (similar to MazF and RelE respectively) were overexpressed. Although 
BCAL0070, BCAL0610, BCAM0816 and BCAM0627 all show sequence similarities to RelE, 
overexpression of BCAM0816 had no influence on growth, while overexpression of one of the other 
toxins resulted in growth inhibition. Similarly, BCAL3284, BCAM1194, BCAS0580 and pBCA093 all 
resemble VapC, but growth was only delayed in the latter two.  
As previously observed, the intrinsic activity of particular toxins can be less than that of other toxins 
and some toxins may even be non-functional, which would explain the lack of a detectable 
phenotype. Moreover, the activity of a toxin will also be influenced by (i) its interaction with the 
cognate antitoxin, and/or (ii) interactions with other TA-modules. Examples of this have been 
described in various organisms. In V. cholerae it was shown that overexpression of higB only 
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inhibited growth in a higAB deletion mutant (Budde et al., 2007), whereas overexpression of a B. 
pseudomallei hipA homolog only inhibited growth in an E. coli hipA deletion mutant (Butt et al., 
2012). Finally, the observed differences might also be due to differences in protein production 
between the toxins. For example, in M. tuberculosis differences in protein expression were 
responsible for the different phenotypes observed between mutants overexpressing VapC homologs 
[184].       
Figure 2. Effect of overexpression of toxins on the growth of B. cenocepacia J2315. Strains were grown in LBB supplemented 
with 800 μg/ml Tp and 0.2 % rhamnose. 
 
After a prolonged lag phase all mutants started growing again at more or less the same growth rate 
as the WT, suggesting selection against the plasmid carrying the toxin gene has taken place. Plasmid 
extraction and subsequent PCR analysis and agarose gel electrophoresis confirmed that the plasmid 
and the insert were still present. However, after reinoculation of exponentially growing mutants 
which previously displayed a prolonged lag phase, this prolonged lag phase was no longer observed, 
suggesting either a mutation in the toxin and/or (an) adaptive mutation(s) somewhere else in the 
genome had taken place. We therefore sequenced the inserts, but no mutations were found in the 
toxin encoding sequences. Further research will be required to determine whether adaptive 
mutations actually do occur in the genome. 
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Toxins are involved in B. cenocepacia persistence  
To study the involvement of TA-modules in persistence, biofilms were treated with tobramycin or 
ciprofloxacin in concentrations of 4 x MIC and toxin expression was induced 2 h before treatment by 
adding 0.2 % rhamnose to the medium. In 7/13 toxin-overexpressing mutants investigated the 
number of persisters was higher than in the vector control following treatment (with tobramcyin or 
ciprofloxacin) (Fig. 3). Although those toxins are homologous to toxins known to inhibit translation, in 
6 of these toxin overexpression mutants more persisters survived treatment with ciprofloxacin, 
whereas in two of them also significantly more persisters survived after treatment with tobramycin. 
BCAL0610 was the only toxin which upon overexpression increased the number of persisters after 
treatment with tobramycin, but not after treatment with ciprofloxacin. Overexpression of 
BCAM0347, BCAL3284, BCAL1109 or BCAM1194 had no influence on the number of surviving 
persisters, whereas overexpression of BCAM0816 and BCAL1127 resulted in less persisters compared 
to the vector control. Overall, toxins of which the overexpression resulted in growth inhibition, had a 
positive influence on the number of persisters, while toxins of which the overexpression did not have 
influence on growth, had no or a negative influence on the number of persisters. 
Since several toxins had an influence on the persister fraction when overexpressed, we were 
interested in their expression under physiological conditions in the WT strain. Transcriptome analysis 
indicated that all TA-modules were expressed in untreated biofilms and the expression levels of the 
toxin encoding genes correlated well with those of the antitoxin encoding genes (Fig. S3). While most 
TA-modules had mean expression values between 5 and 100 RPKM, five TA-modules had values 
higher than 200 RPKM, indicating they are quite highly expressed, since less than 10 % of the 
expressed genes had values higher than 200 RPKM.   
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To investigate the expression of these TA-modules in the WT strain further, we compared the 
expression of the toxin coding genes in treated and untreated biofilms and planktonic cultures using 
qPCR. The expression in untreated cells was for 10 toxin encoding genes higher in sessile than 
planktonic cells (Fig. 4). Rotem et al. (2010) suggested that bacterial cells become dormant when the 
toxin level is higher than a threshold and that the amount by which the threshold is exceeded 
determines the duration of dormancy [98]. Since we found that the expression was higher in 
untreated biofilms compared to planktonic cultures, this threshold may be exceeded more frequently 
in biofilms and may play a role in the higher frequency of persisters found in biofilms compared to in 
planktonic cultures [261]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Fold change in toxin gene expression between stationary phase sessile (BF) and planktonic (PL) cells, based on 
qPCR data. Error bars represent SEM (n ≥ 3). Statistically significant differences (p < 0.05) are indicated by an asterisk. 
 
In Table 2 the fold changes in toxin gene expression after treatment with tobramycin or ciprofloxacin 
in high concentrations (= 4 x MIC) are shown. When grown in a biofilm, 9 toxin encoding genes were 
significantly upregulated (p < 0.05, fold change ≥ 1.5) after treatment with tobramycin, while none 
were significantly upregulated after treatment with ciprofloxacin. This indicates that only treatment 
with tobramycin, which targets translation, induces expression of these toxin encoding genes under 
the conditions tested, although the influence of ectopic toxin overexpression was more pronounced 
after treatment with ciprofloxacin. The toxin encoding genes upregulated in sessile cells were also 
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upregulated in planktonic cells and the single toxin encoding gene found on the plasmid was among 
the most highly upregulated genes. Overexpression of BCAM0347, BCAL3284 and BCAM1194 did not 
have an influence on the number of surviving persisters and, similarly those toxin encoding genes 
were not differentially expressed in biofilms after treatment. While the antitoxin BCAM0346 was 
almost two fold downregulated (p-value < 0.05, fold change = 1.7) in sessile cells after tobramycin 
treatment, the toxin BCAM0347 was 11.3 times upregulated after treatment with tobramycin in the 
planktonic cultures. Although the latter difference was not statistically significant, this suggests that 
planktonic and sessile cells not always have the same mechanisms to regulate the relative amounts 
of T and AT. BCAM0272 was only downregulated after treatment with ciprofloxacin in the planktonic 
mode of growth, whereas BCAM1051 was significantly downregulated after treatment with 
tobramycin in sessile cells. 
 
Table 2. Fold changes in expression for different toxin encoding genes in sessile and planktonic 
cells after treatment with tobramycin (Tob) or ciprofloxacin (Cip), compared to untreated cells, 
based on qPCR experiments 
                                Fold changes in expression 
 Sessile cells Planktonic cells 
Toxin Tob Cip Tob Cip 
BCAL0070 5.1* (0.002) 1.3 (0.023) 6.6* (0.000) -1.5 (0.052) 
BCAL0610 3.6* (0.014) -1.3 (0.175) 5.7 (0.186) 1.5 (0.180) 
BCAL1109 7.9* (0.015) -1.2 (0.020) 18.9 (0.122) 1.1 (0.788) 
BCAL1127 -1.1 (0.772) -1.1 (0.453) 1.6 (0.558) 1.1 (0.905) 
BCAL3209 1.6 (0.059) -1.4 (0.029) 3.0 (0.302) -1.0 (0.852) 
BCAL3284 -1.5 (0.420) -1.2 (0.771) 1.3 (0.537) 3.0 (0.402) 
BCAM0272 5.1* (0.000) -1.1 (0.759) 2.4 (0.323) -9.1* (0.009) 
BCAM0347 1.2 (0.122) -1.4 (0.003) 11.3 (0.136) 1.4 (0.357) 
BCAM0816 2.0* (0.008) 1.7 (0.187) 1.8* (0.025) 3.0 (0.51) 
BCAM1051  -9.1* (0.017) -2.1 (0.127) -9.3 (0.053) -2.1 (0.092) 
BCAM1194 1.1 (0.623) 1.1 (0.427) 1.6 (0.432) -1.2 (0.761) 
BCAM1766 6.9 * (0.001) 2.0 (0.256) 5.9 (0.087) 3.0 (0.063) 
BCAS0434 3.0* (0.004) 1.1 (0.790) 3.2 (0.114) 1.1 (0.769) 
BCAS0580 5.8* (0.001) -1.1 (0.359) 6.4 (0.131) 1.6 (0.446) 
pBCA093 9.7* (0.014) 1.1 (0.737) 13.9 (0.108) 1.0 (0.873) 
Statistically significant differences (n = 3, fold change > 1.5, p < 0.05) are indicated with an asterisk. The p-value is indicated 
between parentheses. 
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Role of TA-modules in biofilm formation 
The expression of the toxin genes differed between biofilms and planktonic cultures. To determine 
whether toxins also play a role in biofilm formation, the amount of biomass formed in the vector 
control and overexpression mutants was quantified using crystal violet staining. Only mutants for 
which there were no differences in growth compared to the vector control, when grown 
planktonically were included in this experiment. We found that the results were toxin-dependent 
(Fig. 5). Overexpression of BCAM0816, BCAM0347, (resembling RelE and VapC) resulted in 
significantly more biofilm formation compared to the vector control, whereas overexpression of 
BCAL1109 or BCAL1127 resulted in less biofilm formation compared to the vector control. 
Overexpression of the 2 other toxins had no significant influence on biomass. Overall these results 
indicate that the influence on biomass does not (solely) dependent on a toxin’s capacity to inhibit 
growth.  
 
Figure 5. Influence of toxin overexpression on biofilm formation. The fraction (%) absorbance after crystal violet staining 
compared to the vector control for different toxin overexpression mutants. Error bars represent SEM (n ≥ 3). Statistically 
significant differences (p < 0.05) are indicated by an asterisk. 
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Conclusion 
Type II TA-modules are present in B. cenocepacia J2315. We found and analysed 16 TA-modules with 
sequence similarities to known TA-modules (Table 3). Twelve of these TA-modules were conserved in 
other B. cenocepacia strains and 9 of them also in other Bcc and non-Bcc strains. As described for 
other species overexpression of those toxins contributed to persistence [147]. However, differences 
in toxin induction were observed between different treatments and toxin induction also depended 
on the mode of growth. Interestingly only toxins of which the overexpression resulted in growth 
inhibition, had a positive influence on the number of surviving persisters. For 10 toxin encoding 
genes, the expression in untreated cells was higher in biofilm cells compared to planktonic cells. Out 
of the 5 toxin-overexpressing mutants that did not differ from the vector control when grown 
planktonically, two showed an increase in biofilm formation. TA-modules form an attractive target 
for treating persistent infections, but redundancy may be a challenge. Our results moreover indicate 
that there may not be an overall effect on persistence and biofilm biomass. 
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Table S2. Primers used in qPCR experiments 
 
Gene Forward primer Reverse primer 
BCAL0069 tgcgggtgtttcgccgatttg gccgacgcatccacatcgaac 
BCAL0070 ccgaaggcgctggaggatcg gtagcgccaccgccctttct 
BCAL0609 cgcgtccggcctttatcgtg gcgaacacgctctggctgac 
BCAL0610 gggatcgtgctgggcaaggt tcgatgttctcgcggtcgca 
BCAL1109 gggaaattcgcctgcgcgat tgttcgtgcgcgtcgattgc 
BCAL1127 attgaacgcgaagccgattt gtgtttgcccttcacttggt
BCAL1128 acgcttgatcagctggccctt acgggcgtgccttttccttg 
BCAL3208A ggccgggctacgtccaattca gcgattgccgagcgcattcat 
BCAL3209 cgctcgtggtgcagtcgga tcggcgcggcgtaaggaa 
BCAL3283 aattggggcgggagtccgaa tcggcgcggcgtaaggaa 
BCAL3284 gcgccgcgtcaatttgggaa acgccttcgacgtgatcgct 
BCAM0271 aggcccgcatcgaaacggatg ggccgagacgacgaaatcgga 
BCAM0272 atgagcggtgcgcagttggt cgtgccgcatgcgaatcgag 
BCAM0346 aaccaggacgtgaccaaggca gcctgccgcgatcggtaatg 
BCAM0347 tggagacgggcgtcttgcag cgtcgagccatgccctgaga 
BCAM0815 ggccgagcgccttgatgact ctgtcgcgcgaagggctgta 
BCAM0816 atgtcgaggtgcgcgagcatt tgctctgcggcggcgataaa 
BCAM1051 gaggaactcggcggcctacc ttctacccgcgcgagagctg 
BCAM1193 ttcaagcatggcggctcgca tgcgaacctcggccgtatcg 
BCAM1194 actggcccgtttgcatgcct gctcgctggctcttgtacgc 
BCAM1766 aatggcgtgcgggtcggaat tttccagccggcgtcgtaca 
BCAM1767 tcaggccaaggggctgacg gcgtttccagcgacgacagg 
pBCA093 cgccacccggatcggagaaa agcgtcgaagagccacgctt 
BCAS0434 acgctgatcgcgtccgctaa atacgcggtgggtgacgcaa 
BCAS0580 gaccgcgctgatggagtcgt gcaacgtcccagcacccaga 
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Figure S3. Comparison of the expression of toxin and antitoxin encoding genes in untreated sessile B. cenocepacia J2315 
cells, based on RNA sequencing data. 
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ABSTRACT 
 
Aims 
In this study we investigated the function of BCAM0257-8-9 located in the BCESM region of the 
Burkholderia cenocepacia J2315 genome.  
 
Methods 
Differential RNAseq was used to determine transcription start sites. The phenotype of 
overexpression mutants was studied and a transcriptome analysis of the BCAM0258 overexpression 
mutant was performed.  
 
Results  
BCAM0257 and BCAM0258 were identified as belonging to an operon, positively regulated by 
BCAM0259. We found that this operon is involved in persistence and that BCAM0258 functions as a 
regulator influencing quorum sensing and activating pathways related to iron acquisition and biofilm 
formation. Overexpression of BCAM0257 increased virulence. 
 
Conclusion 
The BCESM genomic region contains an operon that contributes to quorum sensing and is involved in 
persistence, biofilm formation and virulence. BCAM0257-8-9 is found in all sequenced B. cenocepacia 
ET-12 genomes and these results may help explain why infections with strains of the B. cenocepacia 
ET-12 lineage are difficult to treat. 
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INTRODUCTION 
Burkholderia cenocepacia is a member of the Burkholderia cepacia complex (Bcc), a group of 18 
closely related and phenotypically similar species [2]. Bcc species cause respiratory tract infections in 
immunocompromised people, including cystic fibrosis patients [237]. Their capability to form 
biofilms, and their intrinsic resistance and persistence contribute to the frequent failure of 
antimicrobial therapy directed against these infections [25,41,44,261]. Persistence is defined as the 
ability of bacterial cells to survive antibiotic treatment without expressing a specific resistance 
mechanism [49,51]. Although the exact molecular basis of this phenomenon is still unknown, toxin 
antitoxin (TA)-modules are thought to be involved [68]. TA-modules consist of a toxin, which can 
inhibit an important cellular function and an antitoxin which can form a complex with the toxin, 
thereby inactivating it [135]. B. cenocepacia J2315 belongs to the highly transmissible ET-12 lineage 
which has infected patients in Canada, the UK and other European countries [12]. Isolates belonging 
to this clone are characterized by the presence of the cblA gene (encoding the cable pilus) [13] and 
the “B. cepacia epidemic strain marker” (BCESM) [14]. This genetic marker is located on a genomic 
island (GI), BcenGI11, also containing genes involved in metabolism and virulence. The function of 
several other genes located on BcenGI11 remains unknown. Genes with known function found in this 
GI include genes involved in fatty acid biosynthesis, amino acid metabolism and quorum sensing 
(CciI, CciR) [15].  
Quorum sensing is a density-dependent bacterial cell-to-cell communication system [22]. When a 
bacterial population reaches a critical density, signal molecules are released which can modulate 
gene expression in neighboring cells. B. cenocepacia J2315 contains 3 different acyl-homoserine 
lactone (AHL)-based quorum sensing systems (CepIR, CciR, CepR2) [5,23]. The majority of genes 
controlled by quorum sensing are regulated by CepR [24]. While CepR primarily functions as a 
positive regulator, CciR mainly inhibits gene expression and approximately 200 genes are reciprocally 
co-regulated by both systems. CepR2, an orphan LuxR analogue influences the expression of several 
CepR or CciR regulated genes, but does not require AHLs for its activity [23]. In addition to this AHL 
based quorum sensing system, other quorum sensing systems found in Bcc bacteria employ 4-
hydroxy-2-alkylquinolines or cis-2-dodecenoic acids (= the Burkholderia diffusible signal factor 
(BDSF)) [25]. Quorum sensing regulated genes include genes encoding proteins involved in 
siderophore synthesis, protease production, motility, biofilm formation and a type III secretion 
system [24]. Several regulators (CepS, ShvR, YciR, SuhB, YciL, BCAM1871, AtsR) have been shown to 
influence quorum sensing regulation [26-29]. 
In the present study we investigated the function of three B. cenocepacia J2315 genes (BCAM0257, 
BCAM0258, BCAM0259) located on BcenGI11 in the BCESM region.   
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MATERIAL AND METHODS 
Strains and culture conditions 
B. cenocepacia J2315 (LMG 16656) was cultured at 37°C on Luria-Bertani agar (LBA, Oxoid, 
Hampshire, UK). Overnight cultures were diluted in Luria-Bertani broth (LBB, Oxoid) and incubated 
aerobically at 37°C. Overexpression mutants and the WT strain with an empty vector were grown on 
LBA supplemented with 800 μg/ml Tp (Ludeco, Brussels, Belgium) or in LBB supplemented with 800 
μg/ml Tp with or without 0.2 % rhamnose (Sigma Aldrich, Bornem, Belgium). E. coli DH5α was grown 
at 37°C on LBA and E. coli DH5α overexpression mutants on LBA supplemented with 50 μg/ml Tp. E. 
coli pRK2013 was grown at 37°C on LBA supplemented with 40 μg/ml kanamycin (Sigma) and E. coli 
JB523 was grown at 30°C in LB medium containing 4 % NaCl, 10 mg/ml thymidine (Sigma) and 100 
μg/ml tetracycline (Sigma). 
Identification of BCAM0257-8-9 as a putative TA-module  
The RASTA bacteria software tool was used to search for TA-modules in the genome of B. 
cenocepacia J2315 [164]. This tool uses a search method relying on the size of the genes, their 
genomic organization, and the presence of conserved functional domains. Using BLASTP we searched 
the protein sequences of putative TA-modules for homology to toxins and antitoxins belonging to 
known TA families. The cut-off E-value and the identity threshold used in this analysis were 10−5 and 
40 %, respectively.  
BLASTN was used to study conservation of the nucleotide sequences of BCAM0257, BCAM0258 and 
BCAM0259 in other Burkholderia species. Both sequenced and partially sequenced genomes were 
included in the analysis.   
Determination of operon structure 
To determine whether BCAM0257-8-9 form an operon, PCR was performed on genomic DNA, RNA 
and cDNA. Genomic DNA was extracted using an alkaline lysis method [267]. For the RNA extraction 
the Ambion RiboPure Bacteria Kit (Life Technologies, Renfrewshire, UK) was used. cDNA was 
synthesized using the iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). Primers were designed to 
span the intergenic region between BCAM0259 and BCAM0258, and the region between BCAM0258 
and BCAM0257 (Table 1). Cycling conditions were 30s 98°C, 30 cycli of 10s 98°C, 30s 60°C, 24s 72°C 
and finally 10 min 72°C. Products were analyzed with agarose gel electrophoresis. 
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Table 1. Primers used in the present study 
Gene Forward primer Reverse primer 
Primers used for the construction of overexpression mutants* 
BCAM0257 gtacaacatatgaatagcccaaccactgc cgtctagatcatggttgttgtttgtgtgag 
BCAM0258 tccggttcatatggtgttttcaaaacgcct cgtctagactattcttgcgcgagcgattct 
BCAM0259 gtacaacatatgcgtcggaccttatcgaca attctagatcaggaggcggcggttcg 
BCAM0257-8 tccggttcatatggtgttttcaaaacgcct cgtctagatcatggttgttgtttgtgtgag 
 
Primers used for qPCR 
BCAM0257 agcccaaccactgcgcacttt gtcgcgaggcctacttgggt 
BCAM0258 ggttgcgtaccgacctcacc agcgctggcggaaaattcgtc 
BCAM0259 tcgatctttcccaagcgtct ttgccggtctcgtactgatt 
BCAM2761 (cblA) tgctgctctgatgtcgatgt acccggcagatattgcatct 
BCAM2231 (pchR) agatcgacctccttcgcttc ctcgtaccagtcacggctat 
BCAM0199 cgtcgattacggcaagcac acttcccacgacaacgagaa 
BCAM1870 (cepI) [268] tcccgtcggcgaacgaaagt cggcgaacagcgacttcagc 
BCAM1868 (cepR) [268] acggctggatggcgcactac acgcccaccgacaatccgaa 
BCAM0239a (cciI) [268] tcgacgacatgccaaccacga ccgctccgggtaactgccaa 
BCAM0240 (cciR) [268] gctggccaccgcctttctca agcggacacgtcaccgaaca 
BCAM0188 (cepR2) [268] cgcgcccggtcgtatggaat gcgaccagccgtaacgcatc 
   
Primers used for elucidation of the operon structure 
IG BCAM0257-8 ctcctaattgctgggcgact atcgtgttcggatggacgtt 
IG BCAM0258-9 agtacgagaccggcaaacac cgtacaggaagcttgtcgga 
*NdeI and XbaI restriction sites are underlined. 
Construction of overexpression mutants 
To study the role of BCAM0257, BCAM0258 and BCAM0259 we constructed overexpression mutants, 
as described previously [261]. The primers used are listed in Table 1. Cycling conditions were 30s 
98°C, 30 cycli 10s 98°C, 30s 60°C, 24s 72°C and 10 min 72°C. PCR products were digested and ligated 
into plasmid pSCrhaB2 containing a rhamnose-inducible promotor and a Tp selection marker [262]. 
The CaCl2 method was used to transform the plasmid into E. coli DH5α [252]. Tp resistant colonies 
were isolated and screened for the presence of the construct. Plasmids were transferred into B. 
cenocepacia J2315 by triparental mating [253] using pRK2013 as a helper plasmid [254]. Exconjugants 
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were selected on LBA plates supplemented with 800 μg/ml Tp and 50 μg/ml gentamicin. Resistant 
colonies were screened for the correct insert by plasmid extraction, PCR and gel electrophoresis. 
Determination of growth characteristics  
To study the influence on growth when BCAM0257, BCAM0258, BCAM0259, or BCAM0257 and 
BCAM0258 was expressed in E. coli DH5α, overnight cultures of the different E. coli mutants were 
diluted to an optical density (λ = 590) of 0.05 (approximately 5 x 107 CFU/ml) in LB supplemented 
with Tp and 0.2% rhamnose. 20 μl was added to the wells of a 24 well microtiter plate and mixed 
with 980 μl medium. Plates were incubated at 37°C and the absorbance was measured at 590 nm 
every 30 minutes for 24 h. Three wells were included per condition and the experiment was repeated 
once (n = 2 x 3). To evaluate growth on solid media, 10 μl of the overnight dilution was streaked on 
LBA with or without 0.2 % rhamnose and plates were incubated at 37°C for 16 h. To study the 
influence of expression of BCAM0258 or BCAM0257-8 in E. coli more in detail, overnight cultures 
were further diluted up to 10-5 and 10 μl of each dilution was streaked on LBA with or without 0.2 % 
rhamnose and plates were incubated at 37°C. 
Antimicrobial susceptibility testing 
MICs were determined in duplicate according to the EUCAST broth microdilution protocol using flat-
bottom 96-well microtiter plates (TPP, Trasadingen, Switzerland) [246]. Tobramycin (TCI Europe, 
Zwijndrecht, Belgium), ciprofloxacin (Sigma Aldrich) and Tp concentrations tested ranged from 0.25 
to 1024 μg/ml, from 0.25 to 128 μg/ml and from 0.78 to 400 μg/ml, respectively. The MIC was 
defined as the lowest concentration for which no difference in optical density (λ = 590 nm) was 
observed between the inoculated and blank wells after 24 h incubation. All MIC determinations were 
performed in duplicate.  
Biofilm formation 
To determine differences in biofilm formation between the B. cenocepacia J2315 WT strain and 
BCAM0257 or BCAM0258 overexpression mutants, an inoculum suspension containing 
approximately 5 x 107 CFU/ml was added to the wells of a round-bottomed 96-well microtiter plate 
(TPP). Ten wells were included per strain and the experiment was repeated twice (n = 3 x 10). 
Biofilms were grown in LBB supplemented with Tp and 0.2 % rhamnose to induce toxin expression. 
Following 4h of adhesion, the supernatant was removed and the plates were rinsed with 
physiological saline (PS). Subsequently, 100 μl of fresh LBB supplemented with Tp and 0.2 % 
rhamnose was added and the plates were further incubated at 37°C. After 24 h the supernatant was 
removed, wells were rinsed with 100 μl PS. 
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To measure biomass 100 μl of a 99 % methanol solution (Sigma) was added and left in contact for 15 
minutes. Methanol was removed and plates were dried at 37°C. When all residual methanol was 
evaporated, 100 μl of a 0.1 % crystal violet solution (Prolab diagnostics, UK) was added. After 20 
minutes, plates were rinsed with water and 150 μl of a 33 % acetic acid solution was added. 
Absorption was measured at 590 nm.  
To determine the number of viable cells, biofilms were grown as described above. After rinsing, 120 
μl of a commercially available resazurin solution (CellTiter-Blue, Promega, Madison, WI, USA) was 
added to the wells. Fluorescence (λex 560 nm, λem 590 nm) was measured after 2 h of incubation.  
To determine the number of colony forming units in the supernatant, biofilms were grown as 
described above. After 24 h cells present in the supernatant were quantified by plating (n = 3).  
RNA extraction and transcriptome analysis  
Biofilms were grown as described above. After 24 h of growth, the supernant was removed and 100 
μl of PS was added to the wells. The microtiter plates were subsequently vortexed (5 min, 900 rpm) 
and sonicated (5 min, 40 kHz) to harvest the cells. This procedure was once repeated and cells were 
transferred to sterile tubes. RNA was extracted immediately following harvesting of the cells using 
the Ambion RiboPure Bacteria Kit (Life Technologies, Renfrewshire, UK), according to the 
manufacturer’s instructions. This procedure included a DNase I treatment for 1 h at 37°C. RNA 
quantifications were performed using picogreen fluorescence measurement on a FLUOstar galaxy 
plate reader (BMG Labtech, Ortenberg, Germany). Two microgram total RNA of each sample was 
depleted for ribosomal RNA using the Ribo-zero Magnetic Gram-Negative Bacteria kit (Epicentre, 
Madison, WI, U.S.A.). Approximately 30 ng of rRNA depleted RNA was used to create barcoded 
strand specific cDNA sequencing libraries with the Truseq stranded Total RNA library preparation kit 
(Illumina, San Diego, USA). These 6 libraries were equimolarly pooled and sequenced in one lane of 
an Illumina HiSeq 1500 flowcell, generating 2x100 bp paired end reads. After sequencing, the data 
was demultiplex using the sample specific nucleotide barcode. 
Three independent samples were analyzed per strain and CLC bio (Qiagen, Venlo, The Nederlands) 
was used to analyze the data. For each sample at least 40000000 paired-end reads were analyzed. 
Reads were mapped to B. cenocepacia J2315 genome; in order to be included in the analysis a 
minimum of 90 % of the read had to map with minimal 80 % similarity to a gene or the flanking 
region 150 bp up- or downstream of a gene. For each sample more than 70 % of the reads was 
mapped to a gene and more than 60 % was uniquely mapped. The number of reads assigned to a 
transcript was divided by the transcript length and normalized to the number of mapped reads to 
obtain reads per kb per million (RPKM) expression values. A T-test on proportions (Baggerly’s test) 
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was used to detect significant fold changes between the WT and the BCAM0258 overexpression 
mutant. Differences in normalized expression values were considered significant if p-value < 0.01. 
The experimental protocols and the raw sequencing data can be found in ArrayExpress under the 
accession number E-MTAB-2079. 
Differential RNA sequencing 
The WT strain was grown in a biofilm in LBB and after 24 h of growth RNA was extracted as described 
above (two biological replicates). Differential RNA sequencing was performed as described by Kröger 
et al. [263]. In brief, each RNA sample was divided in two aliquots and one aliquot was treated with 
terminator exonuclease (TEX). For each sample two cDNA libraries were constructed, one from TEX-
treated and one from untreated RNA. TEX selectively degrades processed RNAs carrying a 
monophosphate at the 5’ end. Primary transcripts carrying a triphosphate, are not degraded by TEX 
and thus enriched in the TEX treated library. Prior to sequencing, RNA was polyadenylated and 
reverse transcriptase primed with poly-T primers to only generate cDNA based on one priming event 
per RNA molecule. Both libraries were then sequenced from the 5’ end, using Illumina technology. 
Sequencing adapters, poly-A tails and sequences with a phred score < 20 were clipped from the 
sequencing reads and reads < 12 bp were discarded. The remaining reads were mapped to the B. 
cenocepacia J2315 genome with Segemehl [264] with an accuracy setting of 95 % and a seed 
difference threshold of one. Resulting mapping data was normalized to total reads. Sites with a local 
maximum in mapped read starts and enrichment in the TEX-treated library were defined as 
transcription start sites, with a threshold of minimal 10 reads in both biofilm replicates. 
Quantification of persister cells in biofilms  
To determine the number of surviving persisters, 24 h old biofilms were exposed to tobramycin or 
ciprofloxacin concentrations of 4 x the MIC (1024 or 32 μg/ml, respectively) for 24 h [261]. Biofilms 
were grown as described above, but expression of BCAM0257, BCAM0258, BCAM0259 or 
BCAM0257-8 was induced only shortly before treatment. To this end, biofilms were grown in LBB 
supplemented with Tp and without rhamnose. After 24 h of growth, the supernatant was removed 
and 100 μl of LBB supplemented with Tp and 0.2 % rhamnose was added to induce toxin expression. 
After 2h of induction, 120 μl of an antibiotic solution in PS or 120 μl PS (= control) was added and the 
plates were further incubated at 37°C. Twelve wells were used for each condition. After 24 h of 
treatment, cells were harvested by vortexing and sonication (2 x 5 min) (Branson 3510, Branson 
Ultrasonics Corp, Danbury, CT) (a procedure demonstrated not to affect cell viability [data not 
shown]) and quantified by plating on LBA (n ≥ 3 for all experiments).   
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Quantitative RT-PCR (qPCR) 
The expression of various genes was measured by qPRC in sessile and planktonic cultures of the WT, 
and BCAM0257, BCAM0258 or BCAM0259 overexpression mutants. Biofilms were grown as 
described above (n = 3). For the experiments with planktonic cells an overnight culture in LBB was 
diluted to an optical density of 0.1 (approximately 108 CFU/ml). After an additional 24 h growth, cell 
suspensions with an optical density of 1 (approximately 109 CFU/ml) were transferred to falcon tubes 
and centrifuged for 9 min at 5000 rpm (n = 3). RNA was extracted as described above and cDNA was 
synthesized using the iScript cDNA Synthesis Kit (Bio-Rad). Forward and reverse primers were 
designed using tools available on the NCBI website and they were compared to the B. cenocepacia 
J2315 genome sequence using BLAST to determine their specificity (Table 1). For five genes primers 
previously described were used [268]. The primer concentration was 300 nM. All qPCR experiments 
were performed on a Bio-Rad CFX96 Real-Time System C1000 Thermal Cycler as described previously 
[261]. Each sample was run in duplicate and control samples without cDNA were included in each 
experiment. The initial 3 min denaturation step at 95°C was followed by 40 amplification cycles, 
consisting of 15s at 95°C and 60s at 60°C. We included three reference genes (BCAL2694, BCAS0175, 
BCAM2784) to normalize our data. These reference genes were previously found to be stably 
expressed [261]. 
Quantification of acyl-homoserine-lactones (AHL) 
Biofilms were grown in LBB supplemented with 800 μg/ml Tp and 0.2 % rhamnose as described 
above. After 24 h the supernatant was removed and filtered (diameter: 0.22 μm). AHL production 
was quantified using the E. coli JB523 assay as described previously, with minor modifications [269]. 
As the high concentration of Tp present in the supernatant inhibited growth of E. coli JB523, 
thymidine (100 μg/ml) (which increased the MIC for Tp) was added to the growth media and 
fluorescence was measured after 48 h instead of 24 h. Five wells were included per strain and the 
experiment was repeated twice (n = 3 x 5). 
Quantification of siderophores 
Siderophore production was measured using the chrome azurol S (CAS) assay [270]. Biofilms were 
grown in minimal medium (containing 0.3 % KH2PO4, 0.5 % NaCl, 1 % NH4Cl, 0.2 % glucose, 0.3 % 
casamino acids) supplemented with 800 μg/ml Tp and 0.2 % rhamnose as described above. After 48 
h the supernatant was removed and filtered (diameter: 0.22 μm). 0.5 ml of the supernatant was 
added to the wells of a 24 well microtiter plate and mixed with 0.5 ml CAS solution (0.15 mM). After 
3 h the absorbance was measured at 630 nm. Three wells were included per condition and the 
experiment was repeated twice (n = 3 x 3). 
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Virulence in the Galleria mellonella infection model 
Infection of G. mellonella larvae was performed as described previously [57]. Overnight cultures were 
centrifuged and diluted to an OD of 0.05 or 0.005 corresponding to approximately 5 x 107 CFU/ml or 
5 x 106 CFU/ml in PS supplemented with Tp and rhamnose. A 3 ml syringe (BD Plastipak, 
Erembodegem, Belgium) was used to inject 10 μl in G. mellonella via the left lower leg. 10 healthy, 
randomly chosen larvae were injected per strain and incubated at 37°C (n = 5 x 10). A control group 
was injected with PS supplemented with Tp and 0.2 % rhamnose. The number of dead larvae was 
scored 24, 48 and 72 hours after infection.  
Confocal laser scanning microscopy 
Biofilms were grown in wells of a black 96-well plate with glass bottom (Greiner Bio-one, Wemmel) in 
LBB supplemented with Tp and rhamnose as described above. After 24 h of growth, the wells were 
rinsed with PS and filled with 100 μl staining solution (containing 1 ml PS, 3 μl SYTO9 and 3 μl 
propidium iodide). The plates were incubated in the dark for 15 min at room temperature and the 
biofilm was visualized with a Nikon C1 confocal laser scanning module attached to a motorized Nikon 
TE2000-E inverted microscope (Nikon Benelux, Brussels, Belgium) equipped with a Plan Apo 
VC60×1.4 NA oil immersion objective and suitable optical elements to obtain fluorescent and 
differential interference contrast transmission images. Excitation wavelength was 488 nm, emission 
wavelength 500-530 nm for SYTO9 and 660 nm for propidium iodide and Z-stacks were recorded. 
Images were obtained from at least two biofilms for each strain and representative images are 
shown. 
Statistical data analysis 
Unless otherwise mentioned, statistical data analysis was performed using SPSS software, version 21 
(SPSS, Chicago, IL, USA). The Shapiro-Wilk test was used to verify the normal distribution of the data. 
Normally distributed data were analyzed using a one-sample T-test or an independent sample T-test, 
while non-normally distributed data were analyzed using a Wilcoxon signed-rank test or a Mann-
Whitney test. P-values < 0.05 were considered significant.  
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RESULTS AND DISCUSSION 
Identification of BCAM0257-8-9 as a putative TA-module  
In a search for TA-modules using RASTA bacteria software, BCAM0257-8-9 was identified as a 
putative novel TA-module in B. cenocepacia J2315. This module consists of three genes located in GI 
BcenGI11 (chromosome 2), also encoding the BCESM [14,15]. Two of them (BCAM0257 and 
BCAM0258) have high RASTA scores (86 % and 87 %, respectively), whereas the other gene, 
BCAM0259 has a lower score (61 %). The DNA sequences of BCAM0257-8-9 contain a conserved 
domain belonging to the HTH-XRE superfamily and these genes were provisionally annotated as 
putative regulators [15].  
Their organization, with 16 bp between BCAM0257 and BCAM0258, and 94 bp between BCAM0258 
and BCAM0259 suggests they could be transcribed as a single operon. PCR with cDNA as template 
using primers spanning the intergenic region between BCAM0257 and BCAM0258, and the region 
between BCAM0258 and BCAM0259, confirmed that BCAM0257 and BCAM0258 form an operon. 
However, analysis of the PCR-product of the intergenic region between BCAM0259 and BCAM0258, 
suggested that the product was only caused by read through (data not shown). Results obtained with 
differential RNA sequencing confirmed that BCAM0258 and BCAM0259 indeed both have their own 
transcription start site (TSS) (Fig. 1).  
 
 
 
 
 
 
 
Figure 1. Transcriptome analysis of BCAM0257-8-9 located on Bcen GI11 on chromosome 2 in B. cenocepacia J2315. Panel 
A: Location of transcription start sites as revealed by local maxima in mapped reads starts. Data are obtained by differential 
sequencing, TEX-treated. Panel B: Coverage in differential sequencing data, TEX-treated. Panel C: Coverage in whole 
transcriptome sequencing data. All data are from reads only mapping to the reverse strand. 
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As the TSS for BCAM0259, at position 313702, coincides with the annotated gene start, this transcript 
is leaderless. For BCAM0258 the TSS is located 27 bp upstream of the annotated gene start, at 
position 313299, while BCAM0257 does not have a TSS. These data, as well as coverage data from 
whole transcriptome sequencing confirmed the presence of two operons: one operon consisting of 
BCAM0257 and BCAM0258 which is relatively strongly transcribed compared to adjacent genes, and 
one consisting of BCAM0259 whose expression is at least ten times lower compared to BCAM0257-8.  
Genes similar to BCAM0257-8-9 are only found in sequenced genomes of representatives of B. 
cenocepacia ET-12 (J2315, K56-2 and BC7) and in two non-ET-12 B. cenocepacia strains (MC03 and 
PC184). Using BLASTP no similarities between BCAM0257-8-9 and toxins or antitoxins of known TA 
families were found. Although type II TA-modules usually consist of two genes, systems with a toxin, 
an antitoxin and an additional gene have previously been described [165-168]. For example, in E. coli 
PaaA and ParE form an operon together with a transcriptional regulator (PaaR) [165]. Similarly, in 
Bacillus subtilis ζε TA-modules are organized in an operon together with the ω gene, coding for a 
global transcriptional regulator [167]. Finally, the Mycobacterium smegmatis Phd/Doc TA-module is 
found in a larger operon with two additional genes [168]. 
BCAM0259 regulates the expression of BCAM0257 and BCAM0258 
To investigate the relation between BCAM0257-8 and BCAM0259, the three genes BCAM0257-8-9 
were separately cloned into a plasmid with a rhamnose inducible promoter and plasmids were 
transferred into B. cenocepacia J2315. The influence of overexpression of BCAM0257, BCAM0258 or 
BCAM0259 on the expression of the other genes was measured by qPCR (Fig. 2). BCAM0259 was 
found to regulate the expression of the BCAM0257-8 operon as its overexpression induced 
expression of both genes. Overexpression of BCAM0258 significantly reduced the expression of 
BCAM0259, suggesting a negative feedback mechanism, while overexpression of BCAM0257 did not 
have an influence on the expression of the other genes. This latter observation is in contrast with 
what is generally accepted for type II TA-modules, which are thought to regulate their own 
transcription through conditional cooperativity, in which the relative ratio of toxin and antitoxin 
dictates the repression state of the operon [170].  
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Figure 2. Influence of BCAM0257, BCAM0258 or BCAM0259 overexpression on the expression of the other genes. Error bars 
represent standard error mean (n = 3), statistically significant differences compared to the WT (p < 0.05) are indicated with 
an asterisk.   
 
BCAM0258 encodes a protein with toxin-like activity 
To investigated whether this module, as suggested by its RASTA score, encodes a TA-module, 
plasmids containing BCAM0257, BCAM0258, BCAM0259, or BCAM0257 and BCAM0258 were 
transformed into E. coli DH5α and growth was evaluated. In liquid medium a prolonged lag phase 
and a significant reduction in growth (p < 0.05, at time = 972 min) was observed compared to the WT 
when BCAM0258 or BCAM0259 was expressed, while only a slightly prolonged lag phase and no 
reduction in growth was observed when BCAM0257 was expressed (Fig. 3).  Similarly, cells grew 
more slowly on LBA plates compared to the WT when BCAM0258 or BCAM0259 was expressed, 
whereas there was no difference in growth in the absence of rhamnose or when BCAM0257 was 
expressed (Fig. S1). While these results suggest that BCAM0258 encodes a toxin, growth of the 
BCAM0258 overexpression mutant could not be restored by co-expression of the putative antitoxin 
BCAM0257 (Fig. 3, Fig. S1). Together these results indicate that although overexpression of 
BCAM0258 is toxic to the cell, BCAM0257-8 is not a classical TA-module.  
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Figure 3. Effect of overexpression of BCAM0257, BCAM0258, BCAM0259 or BCAM0257-8 on growth of E. coli DH5α grown 
in LBB supplemented with 0.2% rhamnose and 50 μg/ml Tp. 
Influence on persistence 
Since the overexpression of type II toxins and other toxic molecules has been shown to increase the 
number of persisters [84,85], the number of persisters was determined in BCAM0257, BCAM0258 or 
BCAM0259 overexpression mutants in B. cenocepacia J2315. Overexpression of BCAM0257, 
BCAM0258 or BCAM0259 did not have an influence on the antimicrobial susceptibility of B. 
cenocepacia J2315, as MICs for tobramycin and ciprofloxacin remained unaltered (MIC for 
tobramycin = 256 μg/ml, MIC for ciprofloxacin = 8 μg/ml). However, induction of BCAM0257, 
BCAM0258 or BCAM0259 2h before treatment with an antibiotic markedly influenced survival of 
persister cells in biofilms. The number of surviving persisters was approx. 10-fold lower in the 
BCAM0257 overexpressing mutant than in the WT (Fig. 4 A and B). In contrast, up to 3 times more 
persister cells survived when BCM0258 was overexpressed. The number of surviving persisters in a 
mutant that overexpressed both BCAM0258 and BCAM0257 was similar to the levels in the WT after 
treatment with ciprofloxacin and approx. 100-fold lower than in the WT after treatment with 
tobramycin. While expression of BCAM0259 or BCAM0258 in E. coli resulted in growth inhibition, 
overexpression of BCAM0259 in B. cenocepacia did not lead to an increase in the number of 
persisters, probably because BCAM0259 positively regulates the expression of BCAM0257-8.  
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Figure 4. The fraction of surviving persisters in B. cenocepacia J2315 biofilms after treatment with a high concentration (4 x 
MIC) of tobramycin (A) or ciprofloxacin (B) in the WT and BCAM0257, BCAM0258, BCAM0259 or BCAM0257-8 
overexpression mutants. Error bars represent standard error mean (n ≥ 3), statistically significant differences compared to 
the WT (p < 0.05) are indicated with an asterisk.  
 
BCAM0258 functions as a transcriptional regulator affecting quorum sensing 
To further investigate the role of BCAM0257-8-9, a transcriptomic analysis of the B. cenocepacia 
J2315 BCAM0258 overexpression mutant was performed after growth in a biofilm. 616 genes were 
significantly upregulated, while 108 genes were downregulated compared to the WT (p < 0.01, fold 
change ≥ 2) (Table S2). BCAM0259 and 6 genes located closely together on chromosome 1 
(BCAL3148-53) were more than 25-fold downregulated. A group of genes encoding hypothetical 
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proteins (BCAM0190-96) and an efflux pump (BCAM0199-0202) were more than 90-fold upregulated. 
Important functional classes among the upregulated genes were Fe storage, transport-binding 
proteins, drug-analog sensitivity, stress adaptation, sulphur metabolism, phage related functions and 
prophages. Genes involved in oligopeptide transport, glycerol metabolism and motility were 
downregulated. Many of these genes are quorum sensing regulated [29] and overexpression of 
BCAM0258 also increased the expression of the B. cenocepacia J2315 quorum sensing systems (CciIR, 
CepIR, CepR2) (Table 2). Several regulators (CepS, ShvR, YciR, SuhB, YciL, BCAM1871, AtsR) have 
already been shown to influence quorum sensing regulation [26-29] and two of them CepS and 
BCAM1871 were also found to be significantly upregulated in the BCAM0258 overexpression mutant.  
Table 2. Differences in expression of quorum sensing related genes between the BCAM0258 
overexpression mutant and WT, as determined by RNA sequencing 
Gene Fold change P-value 
BCAM0188 (cepR2) 11.1 0.00005 
BCAM0189 (cepS) 6.9 0.0000003 
BCAM1870 (cepI) 1.6 0.02 
BCAM1868 (cepR) 1.7 0.03 
BCAM0239a (cciI) 1.7 0.14 
BCAM0240 (cciR) 1.7 0.02 
BCAM0227 (BDSF sensor kinase) 1.9 0.002 
BCAM0581 (BDSF synthase) 1.2 0.5 
BCAM1871 1.4 0.0002 
 
The upregulation of these quorum sensing systems was confirmed by qPCR and expression levels of 
cciI, cciR, cepI, cepR and cepR2 were also determined when BCAM0257 or BCAM0259 was 
overexpressed (Fig. 5). When BCAM0259 was overexpressed cepR and cciI were significantly 
upregulated. When BCAM0257 was overexpressed, cciI, cciR and cepR2 were upregulated compared 
to the WT. However, due to variability between samples those differences were not statistically 
significant.  
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Figure 5. Influence of BCAM0257, BCAM0258 or BCAM0259 overexpression on the expression of the other genes. Error bars 
represent standard error mean (n = 3), statistically significant differences compared to the WT (p < 0.05) are indicated with 
an asterisk.   
 
BCAM0190-6 and BCAM0199-0202 were more than 90 times upregulated in the BCAM0258 
overexpression mutant compared to the WT and BCAM0199 was also upregulated in the BCAM0257 
and BCAM0259 overexpression mutant (Fig. 6). These genes are under negative CepR2 control and 
CepR2, an orphan LuxR analog [23] was upregulated in the BCAM0258 overexpression mutant. At 
first sight this seems contradictory, but Ryan et al. (2013) found that CepR2 is antagonized by OHL 
when CepS is coexpressed [28]. This may explain the simultaneous upregulation of cepR2 and cepS 
and operons under negative CepR2 regulation. Several genes under positive CepR2 control, including 
pchR were upregulated when BCAM0258 was overexpressed (Fig. 6). 
 
 
 
 
 
 
 
Figure 6. Gene expression in BCAM0257, BCAM0258 and BCAM0259 overexpression mutants. Error bars represent standard 
error mean (n = 3), statistically significant differences compared to the WT (p < 0.05) are indicated with an asterisk.   
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To confirm the influence on quorum sensing, the relative amount of AHL produced were compared 
between the WT and BCAM0257 and BCAM0258 overexpression mutants, using the E. coli JB523 
biosensor. When BCAM0258 or BCAM0257 were overexpressed significantly more AHLs were 
produced than in the WT (fold change = 1.9 and 3.5, respectively, p < 0.05). The BCAM0259 
overexpression mutant was not included in this experiment because of differences in growth 
compared to the B. cenocepacia J2315 WT strain (data not shown), which preclude a comparison of 
the amount of AHL produced. 
BCAM0257 and BCAM0258 are involved in virulence  
To study the effects on virulence, Galleria mellonella larvae were infected with the WT, the 
BCAM0257 or BCAM0258 overexpression mutant, and followed for at least 48 h (Fig. 7). Two 
different inocula were used. When infected with a low inoculum there was no difference in the 
number of surviving larvae between infection with the WT or one of the mutants after 24 h. 
However, after 48 h and 72 h significantly fewer larvae survived when infected with the BCAM0257 
overexpression mutant compared to the WT, while there were no significant differences between 
infection with the BCAM0258 overexpression mutant or the WT. When infected with a higher 
inoculum of the BCAM0257 overexpression mutant significantly fewer larvae survived after 24 h, but 
there was again no difference compared to the WT when larvae were infected with the BCAM0258 
overexpression mutant. After 48 h there was no significant difference in survival following infection 
with the WT or any of the overexpression mutants. 
The increased virulence observed in the BCAM0257 overexpression mutant could be related to the 
increased production of AHLs in this mutant. 
Figure 7. The fraction (%) surviving G. mellonella larvae after infection with B. cenocepacia J2315 WT or BCAM0257 or 
BCAM0258 overexpression mutants. Larvae were injected with 5 x 104 CFUs and evaluated after 24, 48 and 72 h (left) or 
injected with 5 x 105 CFUs and evaluated after 24 and 48 h (right). Error bars represent standard error mean (n ≥ 5),  
statistically significant differences compared to the WT (p < 0.05) are indicated with an asterisk.  
*
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Genes involved in pyochelin and ornibactin biosynthesis or encoding iron uptake regulators and tonB 
dependent receptors, were significantly upregulated in the BCAM0258 overexpression mutant 
compared to the WT (Table 3). The expression levels of pchR (pyochelin biosynthesis gene) were 
determined in the other mutants as well, and this gene was also significantly upregulated in the 
BCAM0259 overexpression mutant, but not in the BCAM0257 overexpression mutant (Fig. 6). In line 
with these observations the siderophore concentration was significantly higher in 48 h old biofilms 
when BCAM0258 was overexpressed (fold change = 2.0, p < 0.05), but there were no differences 
when BCAM0257 was overexpressed.            
Table 3. Differences in expression of genes involved in iron acquisition and biofilm formation 
between the BCAM0258 overexpression mutant and the WT , as determined by RNA sequencing (p 
< 0.01) 
Gene Fold change Function 
Genes involved in iron acquisition 
BCAM2439 14.9 TonB-dependent receptor 
BCAM2007 14.2 TonB-dependent receptor 
BCAM1187 10.9 TonB-dependent receptor 
BCAM2230-32 (pchDER) 5.9-8.4 Pyochelin biosynthesis 
BCAL1688-1700 (orbABCDEFGHIS) 3.4-28.2 Ornibactin biosynthesis 
BCAM2626 (huvA) 8.0 Putative heme receptor protein 
BCAL1370 (fecR) 4.3 Iron uptake regulatory protein 
Genes involved in biofilm formation 
BCAM2759-62 (cblA-D) -11.0-1.3 Cable pili 
BCAL0813 (rpoN) -1.75 Regulator flagellar motility 
BCAL0124-25 (flhDC) -3.44-3.7 Master regulator of motility 
BCAM0854-65 (bceA-L) 19.0-81.0 Production of cepacian 
BCAM0184-86 (bclABC) 39.4-55.7 Lectins, structural development 
BCAM2140-41 3.0 Type I secretion system 
BCAL1677 (fimA)- 80 2.6-4.8 Type I pilus 
BCAM1349 2.0 Transcriptional regulator of biofilm 
formation 
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BCAM0257 and BCAM0258 play a role in biofilm formation 
Using qPCR, BCAM0257 and BCAM0258 were both found to be significantly upregulated in biofilms 
compared to planktonic cultures (2.7 and 1.8 times, respectively). To investigate their role in biofilm 
formation, biomass was measured using a crystal violet staining and the number of cells present in 
the supernatant was determined using plate counting. The number of viable cells in the biofilms was 
measured using the conversion of resazurin to resorufin, a surrogate marker for the number of viable 
cells present in the biofilm. When BCAM0258 was overexpressed, biofilm mass and the number of 
viable cells per biofilm were significantly lower than in WT biofilms, while the fraction of cells in the 
supernatant was higher than in WT biofilms (Fig. 8). These results suggest that when BCAM0258 is 
overexpressed, cells are less firmly attached to the surface and/or each other and that there is more 
dispersion than in WT biofilms (Fig. 8). In contrast, when BCAM0257 was overexpressed, biomass 
was higher than in WT biofilms and less cells were found in the supernatant. It should be noted that 
overexpression of BCAM0257 or BCAM0258 did not have an influence on growth of B. cenocepacia 
J2315 when grown planktonically (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Influence on cell viability and biomass. The fraction (%) absorbance after crystal violet staining, fluorescence after 
resazurin staining and colony forming units (CFUs) in the supernatant per biofilm compared to the WT for BCAM0257 and 
BCAM0258 overexpression mutants. Error bars represent standard error mean (n = 3), statistically significant differences 
compared to the WT (p < 0.05) are indicated with an asterisk. 
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A confocal image of the BCAM0258 overexpression mutant biofilm demonstrated the presence of 
more dead cells than in WT biofilms, likely due to a toxic effect of BCAM0258 overexpression (Fig. 9). 
Biofilms formed by the BCAM0257 overexpression mutant were more similar in structure to WT 
biofilms.  
 
Figure 9. Confocal laser scanning microscopy image of 24 h old biofilms of B. cenocepacia J2315 WT and the BCAM0257 and 
BCAM0258 overexpression mutants. Biofilms were stained with a solution containing 3 μl of SYTO9, 3 μl propidium iodide 
and 1 ml PS. 
 
To further investigate the difference in biofilm phenotype between the BCAM0258 overexpression 
mutant and the WT, we looked for genes involved in biofilm formation that were differentially 
expressed in the BCAM0258 overexpression mutant, as determined by RNA sequencing (Table 3). 
Genes encoding the cable pilus (cblA-D), thought to be important for adhesion were downregulated, 
as were rpoN, a regulator involved in flagellar motility, and flhDC, the master regulator of motility 
[25]. Lectins which are important in structural development of the biofilm and a type I pilus were 
upregulated. Striking is a high upregulation (up to 80 x) of genes involved in the production of the 
exopolysacharide cepacian (bceA-L), as B. cenocepacia J2315 does not produce cepacian due to a 
frameshift mutation in bceB [25]. The expression of some selected genes was confirmed by qPCR and 
also analyzed in the other mutants (Fig. 6). One of the genes involved in the production of lectins 
(bclA) was also upregulated when BCAM0257 or BCAM0259 was overexpressed. cblA was 
downregulated when BCAM0258 or BCAM0257 was overexpressed (17-fold and 3-fold 
downregulated, respectively) and bapA was upregulated only when BCAM0258 was overexpressed. 
According to Inhülsen et al. (2012) BapA plays a major role in B. cenocepacia H111 biofilm formation 
[33]. Proteins like BapA are transported to the cell surface via a type I secretion system and this 
system was also upregulated when BCAM0258 was overexpressed. 
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These results indicate that the BCAM0257-8 operon, plays a role in biofilm formation, but more 
research is needed to elucidate the exact mechanisms involved. 
Conclusion 
The B. cenocepacia J2315 BCESM genomic region contains an operon (BCAM0257-8) which is 
positively regulated by an adjacent gene (BCAM0259). This operon consists of a regulator influencing 
quorum sensing and activating cellular pathways involved in iron acquisition, virulence and biofilm 
formation. BCAM0257 and BCAM0258 are small genes, separated by only a few base pairs, located 
on a genomic island BcenGI11. Overexpression of BCAM0258 inhibits cell growth and overexpression 
of BCAM0257 or BCAM028 affects persistence and biofilm formation in opposite ways. These 
characteristics are reminiscent of TA-modules. However, while co-over expression of BCAM0258 with 
BCAM0257 abolished the increase in number of persister cells observed when BCAM0258 is 
overexpressed alone, co-expression of BCAM0258 with BCAM0257 did not restore growth to WT 
levels in E. coli. BcenGI11 is only present in B. cenocepacia strains belonging to the ET-12 lineage 
which has caused major outbreaks in CF patients worldwide and genes similar to BCAM0257-8-9 are 
found in all sequenced B. cenocepacia ET-12 genomes. Although more research is needed to further 
characterize the function of BCAM0257-8-9, our results may help explaining why infections with 
strains of the B. cenocepacia ET-12 lineage are so difficult to treat.  
 
EXECUTIVE SUMMARY 
Determination of the operon structure: 
• BCAM0258 forms an operon with BCAM0257 and is located in the BCESM region of the 
Burkholderia cenocepacia J2315 genome. 
• BCAM0259 positively regulates expression of this operon. 
Functional characterization of BCAM0257-8: 
• BCAM0258 is a novel  transcriptional regulator influencing quorum sensing . 
• BCAM0257-8 is involved in persistence, iron acquisition, virulence and biofilm formation. 
Significance: 
• Genes similar to BCAM0257-8-9 are found in all sequenced B. cenocepacia ET-12 genomes. 
• The presence of this operon could help explaining why infections with B. cenocepacia ET-12 
strains are so difficult to treat. 
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Figure S1. A. First screening: Growth of E. coli BCAM0257, BCAM0258 or BCAM0259 overexpression mutants on LBA with or 
without rhamnose supplementation. Overnight cultures were diluted to an optical density (λ = 590) of 0.05 (approximately 
5 x 107 CFU/ml) in LB supplemented with Tp and 0.2% rhamnose. 10 μl of the overnight dilution was streaked on LBA with 
or without 0.2 % rhamnose and plates were incubated at 37°C for 16 h.  
B. More in detail: Growth of E. coli BCAM0258 and BCAM0257-8 overexpression mutants on LBA with or without rhamnose 
supplementation. Overnight cultures were diluted to an optical density (λ = 590) of 0.05 (approximately 5 x 107 CFU/ml) in 
LB supplemented with Tp and 0.2% rhamnose. Serial dilutions were spotted on LB plates with or without rhamnose 
supplementation. Plates were incubated overnight at 37°C. 
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Table S2. Results from the transcriptomic analysis of the BCAM0258 overexpression mutant (p < 0.01, 
fold change ≥ 2) 
Downregulated 
Gene number Fold Change P-value  Annotation 
BCAM0259 -76.33 0.000   putative repressor protein 
BCAL3152 -37.25 0.000   putative RNA polymerase sigma factor 
BCAL3148 -34.35 0.000   hypothetical protein 
BCAL3153 -32.50 0.000   putative lipoprotein 
BCAL3151 -31.74 0.000   hypothetical protein 
BCAL3150 -29.69 0.000   hypothetical protein 
BCAL3149 -27.33 0.000   hypothetical protein 
BCAM0765 -12.00 0.000   aldose epimerase family protein 
BCAM2761 -11.72 0.000 cblA giant cable pilus 
BCAM2762 -10.54 0.000 cblB giant cable pilus chaperone protein 
BCAM2728 -9.81 0.008 oppA 
putative periplasmic oligopeptide-binding 
protein precursor 
BCAM2730 -9.48 0.000   putative tripeptide permease 
BCAL1454 -8.44 0.000   hypothetical protein 
BCAL1519 -7.79 0.000   putative transposase 
BCAM2727 -7.33 0.001 oppB putative oligopeptide transporter permease 
BCAM0047 -7.10 0.000   putative transporter-LysE family 
BCAM2760 -6.93 0.000 cblC putative outer membrane usher 
BCAL2998 -6.87 0.002   transglycosylase associated protein 
BCAL0925 -5.92 0.001 glpK glycerol kinase 
BCAM2624 -5.11 0.003   hypothetical protein 
BCAM2623 -4.75 0.000   hypothetical protein 
BCAL0440 -4.69 0.000   hypothetical protein 
BCAL0924 -4.49 0.000 glpF putative glycerol uptake facilitator protein 
BCAL2675 -3.97 0.000   DNA polymerase III subunit chi 
BCAL0124 -3.73 0.002 flhD transcriptional activator FlhD 
BCAL2586 -3.60 0.000   AraC family regulatory protein 
BCAL0121 -3.54 0.005 aqpZ aquaporin Z 
BCAL0125 -3.44 0.001 flhC transcriptional activator FlhC 
BCAS0191 -3.44 0.000   putative endoribonuclease 
BCAL2674 -3.37 0.000   hypothetical protein 
BCAL1453 -3.37 0.000   fusaric acid resistance transport protein 
BCAL0603 -3.26 0.000 puuC 
γ-glutamyl- γ -aminobutyraldehyde 
dehydrogenase 
BCAM2201 -3.22 0.007   hypothetical protein 
BCAL2676 -3.22 0.000 pepA leucyl aminopeptidase 
BCAL0606 -3.09 0.000   
putative transport related, membrane 
protein 
BCAL0940 -3.04 0.001   putative transglycosylase 
BCAL0560 -3.03 0.000   subfamily M24B peptidase 
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BCAM1672 -3.02 0.003 uxuA mannonate dehydratase 
BCAL0151 -3.00 0.007   extracellular ligand binding protein 
BCAS0221 -2.93 0.000 afcB pseudogene 
BCAS0224 -2.93 0.002 afcD hypothetical protein 
BCAL2737 -2.92 0.002   putative pseudouridine synthase 
BCAL0368 -2.90 0.000 cspD cold shock-like protein CspD 
BCAL2251 -2.87 0.001   major facilitator superfamily protein 
BCAL3323 -2.86 0.001   nitrilase 
BCAL1162a -2.81 0.000   putative transposase 
BCAL2537 -2.74 0.003   LysR family regulatory protein 
BCAL0369 -2.72 0.000   putative amino acid permease 
BCAL0169 -2.72 0.000   hypothetical protein 
BCAL3357 -2.70 0.000 gltJ 
glutamate/aspartate transport system 
permease 
BCAS0220 -2.66 0.006   putative permease 
BCAL0441 -2.65 0.000   putative L-lactate permease 
BCAM0020 -2.64 0.003   hypothetical protein 
BCAL2154 -2.61 0.000 ppiA  UDP-2,3-diacylglucosamine hydrolase  
BCAL0018 -2.58 0.000   
putative branched-chain amino acid ABC 
transporter permease 
BCAL2153 -2.58 0.000 ppiB peptidyl-prolyl cis-trans isomerase B 
BCAL2994 -2.55 0.000 fbp  fructose-1,6-bisphosphatase 
BCAL2526a -2.51 0.000   MerR family regulatory protein 
BCAL0049 -2.50 0.008   putative aminotransferase 
BCAL0824 -2.47 0.000   hypothetical protein 
BCAL1806 -2.43 0.005   hypothetical protein 
BCAS0222 -2.40 0.000 afcA putative AMP-dependent synthetase 
BCAL3526 -2.40 0.002 gspE type II secretion system protein E 
BCAL2585 -2.35 0.000   putative nitrilase 
BCAL1498 -2.29 0.000   hypothetical protein 
BCAL0602 -2.25 0.000   MerR family regulatory protein 
BCAL0014 -2.24 0.000   putative GMC oxidoreductase 
BCAL0518 -2.23 0.000 calB putative coniferyl aldehyde dehydrogenase 
BCAL2943 -2.23 0.000   hypothetical protein 
BCAL0545 -2.22 0.000 dppB 
putative dipeptide transport system 
permease 
BCAL0541 -2.20 0.000   putative FAD dependent oxidoreductase 
BCAL2944 -2.20 0.000 hldD 
ADP-l-glycero-D-manno-heptose-6-
epimerase 
BCAL2517 -2.19 0.000   hypothetical protein 
BCAL0605 -2.18 0.000   hypothetical protein 
BCAL0042 -2.17 0.003 putA 
proline dehydrogenase/pyrroline-5-
carboxylate dehydrogenase 
BCAL2151 -2.15 0.000   hypothetical protein 
BCAL1820 -2.15 0.000   hypothetical protein 
BCAL1315 -2.15 0.001   hypothetical protein 
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BCAL3356 -2.14 0.000 gltK 
glutamate/aspartate transport system 
permease 
BCAL1456 -2.14 0.001   
putative fusaric acid resistance outer 
membrane efflux protein 
BCAL2581 -2.14 0.000   pseudogene 
BCAL2707 -2.13 0.000   putative transport system permease 
BCAL0857 -2.13 0.000   hypothetical protein 
BCAL0534 -2.13 0.002   
two-component regulatory system, response 
regulator protein 
BCAM2316 -2.13 0.000   putative amino acid permease 
BCAL0019 -2.13 0.006   
putative branched-chain amino acid ABC 
transporter permease 
BCAL0546 -2.12 0.004 dppC 
putative dipeptide transport system 
permease 
BCAL2125 -2.11 0.006   putative acetyltransferase 
BCAL2552 -2.10 0.000   hypothetical protein 
BCAM2358 -2.10 0.004   putative esterase 
BCAL2708 -2.09 0.000   putative amino-acid transport permease 
BCAL2148 -2.09 0.000 accA 
acetyl-CoA carboxylase carboxyltransferase 
subunit alpha 
BCAL1316 -2.09 0.000   hypothetical protein 
BCAL0436 -2.08 0.000   
glyoxalase/bleomycin resistance 
protein/dioxygenase superfamily protein 
BCAL0177 -2.08 0.002   putative plasmid conjugal transfer protein 
BCAL2945 -2.07 0.000 hldA D-beta-D-heptose 7-phosphate kinase 
BCAL2583 -2.06 0.000   transposase 
BCAL1618 -2.04 0.007   hypothetical protein 
BCAM1932 -2.04 0.009   HxlR-family transcriptional regulator 
BCAL1264 -2.04 0.000   hypothetical protein 
BCAL1518 -2.03 0.000   AFG1-like ATPase 
BCAL1557 -2.03 0.001   GntR family regulatory protein 
BCAL2434 -2.03 0.000   
glyoxalase/bleomycin resistance 
protein/dioxygenase superfamily protein 
BCAL3523 -2.02 0.000 gspG type II secretion system protein G 
BCAL0680 -2.02 0.002   hypothetical protein 
BCAL2145 -2.02 0.001   NADH-ubiquinone oxidoreductase subunit 
BCAL0017 -2.02 0.001   
putative branched-chain amino acid ABC 
transporter periplasmic protein 
BCAL0175 -2.01 0.006   hypothetical protein 
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Upregulated 
Gene number Fold Change P-value  Annotation 
BCAM0200 787.75 0.000  efflux system transport protein 
BCAM0201 540.31 0.000  major facilitator superfamily protein 
BCAM0199 472.50 0.000  outer membrane efflux protein 
BCAM0193 130.91 0.000  hypothetical protein 
BCAM0192 126.30 0.000  hypothetical protein 
BCAM0194 119.00 0.000  hypothetical protein 
BCAM0195 117.48 0.000  putative non-ribosomal peptide synthetase 
BCAM0196 99.53 0.000  hypothetical protein 
BCAM0202 89.96 0.000  hypothetical protein 
BCAM0857 81.16 0.005 bceD 
low molecular weight protein-tyrosine-
phosphatase 
BCAM0855 77.56 0.008 bceC UDP-glucose dehydrogenase 
BCAM0856 70.55 0.008 bceB pseudogene 
BCAM0858 69.63 0.003 bceE 
putative polysaccharide biosynthesis/export 
lipoprotein 
BCAM0258 60.36 0.000 repressor protein 
BCAM0860 60.19 0.005 bceG glycosyltransferase 
BCAM0190 59.95 0.001  hypothetical protein 
BCAM1414 59.64 0.000  hypothetical protein 
BCAM0861 56.81 0.007 bceH putative glycosyltransferase 
BCAM0859 56.61 0.004 bceF tyrosine-protein kinase 
BCAM0185 55.73 0.000 bclC lectin 
BCAM0191 47.62 0.000 putative non-ribosomal peptide synthetase 
BCAM0863 45.57 0.001 bceJ putative glycosyltransferase 
BCAM0184 42.71 0.000 bclB lectin 
BCAM1004 41.98 0.006 gca GCP-mannose 4,6-dehydratase 
BCAM0862 41.79 0.004 bceI putative polymerase 
BCAM1010 39.86 0.006 gtaB 
putative UTP-glucose-1-phosphate 
uridylyltransferase 
BCAM0186 39.36 0.001 bclA lectin 
BCAM1876A 38.27 0.000 hypothetical protein 
BCAM0864 31.81 0.000 bceK glycosyltransferase 
BCAM0197 29.14 0.000 LysR family regulatory protein 
BCAL1688 28.18 0.000 orbS extracytoplasmic-function sigma-70 factor 
BCAM0084 24.16 0.002 putative glycosyl transferase 
BCAL1700 23.18 0.000 orbA ornibactin receptor 
BCAL3123 21.76 0.000 wbxC acetyltransferase 
BCAM1878A 21.69 0.000  hypothetical protein 
BCAM2044 21.66 0.003  putative asparagine synthetase 
BCAM0082 21.39 0.005  putative polysaccharide deacetylase 
BCAM0854 19.81 0.008 bceA 
bifunctional exopolysaccharide biosynthesis 
protein (phosphomannose isomerase and 
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GDP-D-mannose pyrophosphorylase) 
BCAL1585 18.53 0.002 hupB histone-like DNA-binding phage protein 
BCAM1877 17.93 0.000  hypothetical protein 
BCAM0083 17.26 0.001  hypothetical protein 
BCAL1587 16.35 0.001  hypothetical protein 
BCAL1588 16.17 0.004  hypothetical protein 
BCAM0065 15.24 0.000  putative transporter-LysE family 
BCAL1592 15.15 0.001  putative phage transposition protein 
BCAM2439 14.91 0.000  TonB-dependent receptor 
BCAL1586 14.57 0.003  hypothetical protein 
BCAM0835 14.49 0.000  AraC family regulatory protein 
BCAM2007 14.21 0.000  TonB-dependent siderophore receptor 
BCAS0355 12.41 0.000 xylA xylose isomerase 
BCAM0107 12.26 0.000 LysR family regulatory protein 
BCAL1591 12.22 0.004  putative phage DNA transposition protein 
BCAL3311 12.08 0.000  hypothetical protein 
BCAM0188 11.12 0.000 cepR2 CepR2 
BCAM1187 10.92 0.005  TonB-dependent siderophore receptor 
BCAL3310 10.91 0.000  hypothetical protein 
BCAL1589 10.82 0.003  hypothetical protein 
BCAM2008 10.58 0.000  hypothetical protein 
BCAM2647 10.29 0.006  hypothetical protein 
BCAM2231 10.23 0.000 pchR transcriptional regulator PchR 
BCAM2648 10.19 0.000 
NAD dependent epimerase/dehydratase 
family protein 
BCAL1689 9.52 0.000 orbH MbtH-like protein 
BCAS0601 9.49 0.000  hypothetical protein 
BCAL2746A 9.34 0.000  hypothetical protein 
BCAM1003 9.04 0.000  putative epimerase 
BCAM1364 9.02 0.000  
putative NAD dependent 
epimerase/dehydratase 
BCAM2530 8.97 0.001  putative monooxygenase 
BCAM0740 8.90 0.000  hypothetical protein 
BCAM2009 8.78 0.002  putative hydroxylase 
BCAM1878 8.66 0.000  putative phage repressor protein 
BCAM0496 8.51 0.000  putative transporter-LysE family 
BCAM0239 8.38 0.000 hypothetical protein 
BCAM2230 8.35 0.000 pchE dihydroaeruginoic acid synthetase PchE 
BCAM2006b 8.34 0.005  pseudogene 
BCAM0151 8.29 0.000  pseudogene 
BCAS0340 8.19 0.008  ABC transporter ATP-binding protein 
BCAL1593 8.16 0.000  hypothetical protein 
BCAS0356 8.05 0.000 xylF 
D-xylose-binding periplasmic protein 
precursor 
BCAM2626 7.95 0.000 huvA putative heme receptor protein 
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BCAM1880 7.91 0.000  hypothetical protein 
BCAM1971 7.90 0.002  putative ABC transporter permease 
BCAL1690 7.88 0.000 orbG putative dioxygenase 
BCAM1973 7.87 0.000  
putative ABC transporter substrate-binding 
protein 
BCAM2169 7.79 0.000  putative outer membrane autotransporter 
BCAL1686 7.76 0.000  hypothetical protein 
BCAM2338 7.69 0.000  putative glycosyltransferase 
BCAS0602 7.58 0.000  hypothetical protein 
BCAS0066 7.54 0.000  putative porin 
BCAS0350 7.53 0.009  hypothetical protein 
BCAM1972 7.48 0.000  putative ABC transporter permease 
BCAS0416 7.47 0.002  putative oxidoreductase 
BCAM0741 7.47 0.000  LysR family regulatory protein 
BCAS0341 7.41 0.007  
putative binding-protein-dependent 
transport system protein 
BCAL1687 7.32 0.000  hypothetical protein 
BCAM2336 7.19 0.000  putative sugar transferase 
groL2 7.13 0.000  
BCAL1974 7.13 0.000  putative lipoprotein 
BCAM0552 7.10 0.000  
putative sigma-54 dependent transcriptional 
regulator 
BCAM2232 7.09 0.006 pchD putative pyochelin biosynthetic protein PchD 
BCAM0720 7.07 0.000  hypothetical protein 
BCAM1560 6.98 0.007  putative solute-binding protein 
BCAL0055 6.98 0.000  
putative heavy metal resistance membrane 
ATPase 
BCAS0425 6.95 0.001  hypothetical protein 
BCAM2031 6.90 0.009  hypothetical protein 
BCAM0189 6.89 0.000 cepS CepS 
BCAS0351 6.86 0.001  
carboxymuconolactone decarboxylase family 
protein 
BCAM2531 6.81 0.001  
putative ABC transporter solute-binding 
protein 
BCAM2027a 6.74 0.004  hypothetical protein 
BCAM2335 6.72 0.000  outer membrane efflux protein 
BCAM1316b 6.72 0.000  hypothetical protein 
BCAL1092 6.72 0.000  
ABC transporter extracellular solute-binding 
protein 
BCAS0418 6.65 0.006  putative luciferase-like monooxygenase 
BCAS0342 6.61 0.000  hypothetical protein 
BCAM1118 6.55 0.000  hypothetical protein 
BCAL0358 6.55 0.000  family M1 metalopeptidase 
BCAL2281 6.43 0.000  putative ferrichrome receptor 
BCAM1124 6.39 0.005  putative ABC transporter system permease 
BCAS0417 6.38 0.002  putative cytochrome c 
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BCAM0633 6.37 0.000  hypothetical protein 
BCAM2339 6.37 0.000  putative methyltransferase 
BCAM2234 6.31 0.001 pchB isochorismate-pyruvate lyase 
BCAS0293 6.27 0.000 aidA nematocidal protein AidA 
BCAM2771 6.17 0.000  putative dihydrodipicolinate synthetase 
BCAS0236 6.14 0.000  
putative haemagglutinin-related 
autotransporter protein 
BCAM0222 6.12 0.005  
two-component regulatory system response 
regulator protein 
BCAL1691 6.08 0.000 orbC 
putative iron transport-related ATP-binding 
protein 
BCAM1125 6.06 0.001  putative ABC transporter system permease 
BCAS0352 6.04 0.001  AraC family regulatory protein 
BCAL1693 6.03 0.000 orbF 
putative iron transport-related membrane 
protein 
BCAL1584 6.03 0.007  hypothetical protein 
BCAM2683 5.96 0.002  
putative cation-transporting ATPase 
membrane protein 
BCAM2770 5.94 0.000  putative sulfur-binding protein 
BCAM2337 5.92 0.006  
putative multidrug resistance transporter 
protein 
BCAM0634 5.89 0.000  hypothetical protein 
BCAM2228 5.85 0.009 pchF pseudogene 
BCAL1091 5.82 0.000  ABC transporter membrane protein 
BCAS0154 5.82 0.000  hypothetical protein 
BCAS0292 5.72 0.000  hypothetical protein 
BCAS0419 5.67 0.000  putative acyl-CoA dehydrogenase protein 
BCAM2224 5.66 0.004  putative pyochelin receptor protein FptA 
BCAM1559 5.64 0.001  putative acetyltransferase 
BCAL1090 5.64 0.002  ABC transporter ATP-binding protein 
BCAS0421 5.54 0.004  pseudogene 
BCAS0109 5.50 0.000  
succinylglutamate 
desuccinylase/aspartoacylase family protein 
BCAM2334 5.34 0.000  efflux system transport protein 
groS2 5.34 0.000  
BCAM1464 5.29 0.000  hypothetical protein 
BCAM2772 5.28 0.000  
class II aldolase/adducin domain-containing 
protein 
BCAS0288 5.26 0.000  
putative phosphoribosylglycinamide 
synthetase protein 
BCAL0413 5.26 0.000  hypothetical protein 
BCAM2340 5.24 0.000 phaG 
putative (R)-3-hydroxydecanoyl-ACP:CoA 
transacylase 
BCAS0155 5.20 0.000  hypothetical protein 
BCAM2649 5.19 0.000  hypothetical protein 
BCAM2527 5.14 0.004  hypothetical protein 
BCAM2416 5.14 0.000  hypothetical protein 
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BCAL1369 5.06 0.000 fecI putative RNA polymerase sigma factor FecI 
BCAL2290 5.01 0.000 putative bacterioferritin ferredoxin protein 
BCAL1692 5.00 0.000 orbD 
iron-hydroxamate transporter permease 
subunit 
BCAM1879 4.99 0.000  hypothetical protein 
BCAM1122 4.95 0.000  putative taurine dioxygenase 
BCAM1121 4.94 0.000  putative taurine dioxygenase 
BCAL1694 4.80 0.000 orbB 
putative iron transport-related exported 
protein 
BCAM1988 4.79 0.000 putative lipoprotein 
BCAS0514 4.79 0.005 
Bcep
Mu43 hypothetical protein 
BCAL1678 4.78 0.002  putative outer membrane usher protein 
BCAL0531 4.76 0.000  hypothetical protein 
BCAL1379 4.73 0.000  hypothetical protein 
BCAS0426 4.70 0.000  putative taurine dioxygenase 
BCAM0515 4.66 0.004  glutathione S-transferase 
BCAM0906 4.63 0.000  
putative dienelactone hydrolase family 
protein 
BCAL2231 4.62 0.000  N-acetylglutamate synthase 
BCAS0661B 4.61 0.000  hypothetical protein 
BCAM0152 4.61 0.000  putative lipoprotein 
BCAS0153 4.59 0.000  hypothetical protein 
BCAM1126 4.56 0.000  hypothetical protein 
BCAL1594 4.56 0.003  hypothetical protein 
BCAM0311 4.54 0.001  putative 6-phosphofructokinase 
BCAM0299 4.53 0.000  putative zinc-binding alcoholdehydrogenase 
BCAL2232 4.53 0.000  hypothetical protein 
BCAL1581 4.51 0.003  hypothetical protein 
BCAS0750 4.51 0.000  hypothetical protein 
BCAM1316a 4.50 0.000  hypothetical protein 
BCAS0345 4.49 0.001  putative acyl-CoA dehydrogenase protein 
BCAM2006a 4.47 0.000  pseudogene 
BCAM2563 4.47 0.000  methyl-accepting chemotaxis protein 
BCAM1391 4.39 0.001  putative sulfonate monooxygenase 
BCAL1378 4.38 0.001  hypothetical protein 
BCAM2781 4.37 0.003  hypothetical protein 
BCAS0547 4.36 0.005 
Bcep
Mu8 putative DNA-binding phage protein 
BCAM1565 4.34 0.004  putative monooxygenase 
BCAM1566 4.31 0.000  putative substrate-binding protein 
BCAS0334 4.31 0.000  
two-component regulatory system, response 
regulator protein 
BCAS0541 4.30 0.000  hypothetical protein 
BCAM0709 4.27 0.000  hypothetical protein 
BCAL1370 4.27 0.001 fecR iron uptake regulatory protein FecR 
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BCAM0280 4.26 0.000 putative phospholipid-binding protein 
BCAL1695 4.24 0.000 orbE 
ornibactin biosynthesis ABC transport 
protein 
BCAM1220 4.21 0.000  putative hydrolase 
BCAM2010 4.21 0.002  hypothetical protein 
BCAM0540 4.20 0.000  putative serine acetyltransferase 
BCAM0293 4.19 0.002  putative acetate kinase 
BCAM0797 4.18 0.000  hypothetical protein 
BCAM0298 4.17 0.002  
putative phosphate acetyl/butyryl 
transferase 
BCAM1389 4.17 0.003  hypothetical protein 
BCAM1390 4.17 0.003  hypothetical protein 
BCAM2349A 4.17 0.000  hypothetical protein 
BCAM1969 4.16 0.000  
putative phosphatidylinositol-specific 
phospholipase C 
BCAS0540 4.14 0.000 
Bcep
Mu16 hypothetical protein 
BCAL2607 4.13 0.000 hypothetical protein 
BCAS0520 4.12 0.005 
Bcep
Mu37 hypothetical protein 
BCAM1301 4.11 0.001  hypothetical protein 
BCAS0769 4.07 0.000  putative periplasmic solute-binding protein 
BCAL1582 4.06 0.001  hypothetical protein 
BCAL3177 4.06 0.000  putative aminotransferase 
BCAM1392 4.06 0.001  putative acyl-CoA dehydrogenase 
BCAS0545 4.05 0.003 
Bcep
Mu10 hypothetical protein 
BCAM0539 4.02 0.001  hypothetical protein 
BCAL2291 4.02 0.000  TonB family protein 
BCAL2445 4.00 0.000  hypothetical protein 
BCAM1827 4.00 0.000  hypothetical protein 
BCAM1308 3.99 0.002  hypothetical protein 
BCAS0543 3.99 0.000 
Bcep
Mu12 putative phage transcriptional regulator 
BCAS0282 3.97 0.004  hypothetical protein 
BCAM0308 3.97 0.000  hypothetical protein 
BCAM0497 3.96 0.000  putative lipoprotein 
BCAM0710 3.94 0.000  family M35 metallopeptidase 
BCAL2444 3.94 0.000  hypothetical protein 
BCAM0284 3.92 0.003  putative cytochrome c 
BCAL1377 3.89 0.002  citrate transporter 
BCAL2215 3.86 0.000  putative racemase 
BCAM2073 3.86 0.001  hypothetical protein 
BCAS0108 3.85 0.000  Major Facilitator Superfamily protein 
BCAS0516 3.82 0.000 
Bcep
Mu41 hypothetical protein 
BCAM0150 3.82 0.000  putative lipoprotein 
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BCAM0764 3.81 0.000  LacI family regulatory protein 
BCAM1881 3.80 0.000  hypothetical protein 
BCAM2640A 3.80 0.001  hypothetical protein 
BCAS0540a 3.80 0.000 
Bcep
Mu15 hypothetical protein 
BCAS0519 3.79 0.000 
Bcep
Mu38 hypothetical protein 
BCAM1696 3.78 0.000 putative lipoprotein 
BCAM1111 3.77 0.000 speF ornithine decarboxylase 
BCAM0853 3.76 0.000  hypothetical protein 
BCAM1697 3.76 0.000  
putative membrane-associated amino 
terminal protease 
BCAS0523 3.76 0.000 
Bcep
Mu34 hypothetical protein 
BCAM0622 3.74 0.000 
two-component regulatory system sensor 
kinase 
BCAS0512 3.70 0.003 
Bcep
Mu45 hypothetical protein 
BCAM1221 3.70 0.002  allantoate amidohydrolase 
BCAM0317 3.68 0.000  hypothetical protein 
BCAS0531 3.67 0.000 
Bcep
Mu25 putative phage membrane protein 
BCAM0307 3.66 0.000 hypothetical protein 
BCAS0524 3.65 0.001 
Bcep
Mu32 hypothetical protein 
BCAS0549 3.65 0.004 
Bcep
Mu6 hypothetical protein 
BCAS0546 3.63 0.000 
Bcep
Mu9 Tn552/IS1604 rve transposase 
BCAL2297 3.63 0.000  hypothetical protein 
BCAM1465 3.63 0.000  hypothetical protein 
BCAL1677 3.62 0.000  putative type-1 fimbrial protein 
BCAM1922 3.60 0.000  putative DNA-binding phage protein 
BCAM1551 3.59 0.000  
putative dehydrogenase, cytochrome C 
subunit 
BCAM1552 3.57 0.000  
putative dehydrogenase iron-sulfur binding 
subunit 
BCAM1488 3.56 0.000  putative proline racemase 
BCAS0542 3.56 0.001 
Bcep
Mu13 hypothetical protein 
BCAM0278 3.55 0.000  putative heat shock protein 
BCAM1780 3.53 0.000  
peptidoglycan-binding lysm:peptidase m23b 
precursor 
BCAM0305 3.53 0.002  outer membrane transport system protein 
BCAS0281 3.52 0.003  
putative 2-hydroxy-3-oxopropionate 
reductase 
BCAM1413a 3.50 0.000  hypothetical protein 
BCAL1539 3.50 0.000  hypothetical protein 
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BCAS0529 3.49 0.003 
Bcep
Mu27 hypothetical protein 
BCAS0506 3.48 0.003 
Bcep
Mu51 putative phage tail protein gpI 
BCAM2825 3.48 0.006  major facilitator superfamily protein 
BCAM2526 3.46 0.000  putative monooxygenase 
BCAM1876 3.46 0.003  hypothetical protein 
BCAM1882 3.45 0.000  hypothetical protein 
BCAL1103 3.44 0.000  putative OsmB-like lipoprotein 
BCAL1577 3.43 0.000  hypothetical protein 
BCAM1703 3.41 0.000  putative acetyltransferase 
BCAM1280 3.41 0.000 
putative GntR-family transcriptional 
regulator/aminotransferase 
BCAM2627 3.41 0.000 hmuS putative hemin ABC transporter protein 
BCAS0527 3.40 0.001 
Bcep
Mu29 hypothetical protein 
BCAS0518 3.39 0.003 
Bcep
Mu39 putative phage tail sheath protein 
BCAS0237 3.38 0.001  putative outer membrane protein 
BCAM2415 3.37 0.001  putative NADPH-dependent FMN reductase 
BCAS0689 3.37 0.000  metallo-beta-lactamase superfamily protein 
BCAS0344 3.36 0.004  hypothetical protein 
BCAS0360 3.36 0.001  TonB-dependent receptor 
BCAL1696 3.35 0.000 orbI 
ornibactin biosynthesis non-ribosomal 
peptide synthase 
BCAM0309 3.33 0.000  
putative cell division-related metallo 
peptidase 
BCAM0623 3.33 0.000  
two-component regulatory system response 
regulator protein 
BCAM0066 3.33 0.000  putative lipoprotein 
BCAL0914 3.32 0.006  putative DNA binding protein 
BCAM1652 3.29 0.002  putative lipoprotein 
BCAS0550 3.27 0.000 
Bcep
Mu5 hypothetical protein 
BCAL0117 3.27 0.000  hypothetical protein 
BCAL3491 3.26 0.000  hypothetical protein 
BCAM2143 3.26 0.000 adhA cable pilus associated adhesin protein 
BCAM0316 3.26 0.000 hypothetical protein 
BCAS0521 3.24 0.007 
Bcep
Mu36 hypothetical protein 
BCAS0528 3.24 0.005 
Bcep
Mu28 putative phage portal protein 
BCAM1921 3.24 0.007  putative phage membrane protein 
BCAM0698 3.24 0.000  FAD dependent oxidoreductase 
BCAM1570 3.23 0.003 adhA 
BCAM0285 3.23 0.001 hypothetical protein 
BCAS0530 3.23 0.000 Bcep hypothetical protein 
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Mu26 
BCAM2510 3.22 0.003  hypothetical protein 
BCAM0279 3.21 0.001  hypothetical protein 
BCAS0526 3.20 0.004 
Bcep
Mu30 phage Mu F virion morphogenesis protein 
BCAM1242A 3.18 0.000  hypothetical protein 
BCAM1430 3.18 0.000  metallo-beta-lactamase superfamily protein 
BCAM2380 3.17 0.000  
putative D-isomer specific 2-hydroxyacid 
dehydrogenase 
BCAM0828 3.15 0.000  hypothetical protein 
BCAM0187 3.14 0.003  2-isopropylmalate synthase 
BCAL1413A 3.08 0.000  putative lipoprotein 
BCAM0936 3.08 0.000  
putative MscS mechanosensitive ion channel 
precursor 
BCAM0542 3.08 0.003  hypothetical protein 
BCAS0067 3.07 0.000  AraC family regulatory protein 
BCAM1242 3.05 0.000  hypothetical protein 
BCAM1412 3.04 0.000  hypothetical protein 
BCAM2438 3.03 0.000  putative lipoprotein 
BCAS0525 3.03 0.005 
Bcep
Mu31 
putative phage Mu G virion morphogenesis 
protein 
BCAM0321 3.03 0.000 hypothetical protein 
BCAM1112 3.03 0.003 adiA biodegradative arginine decarboxylase 
BCAM0697 3.03 0.000  putative hydrolase 
BCAM0699 3.02 0.000  putative exported dehydrogenase 
BCAS0729 3.01 0.000 deoA thymidine phosphorylase 
BCAM2431 3.00 0.000  enoyl-CoA hydratase 
BCAM2836 3.00 0.003  putative diguanylate cyclase 
BCAM0315 3.00 0.004  hypothetical protein 
BCAM0319 2.99 0.000  putative universal stress protein 
BCAM2430 2.99 0.000  putative biotin carboxylase 
BCAS0280 2.99 0.005  Major Facilitator Superfamily protein 
BCAM0796 2.97 0.000  hypothetical protein 
BCAM0320 2.96 0.000  putative cytochrome b561 
BCAS0510 2.94 0.003 
Bcep
Mu47 hypothetical protein 
BCAS0513 2.94 0.005 
Bcep
Mu44 putative phage tail protein 
BCAM2642 2.93 0.000  hypothetical protein 
BCAM0313 2.93 0.001  hypothetical protein 
BCAM1162 2.92 0.000 cheB3 chemotaxis-specific methylesterase 
BCAS0183 2.92 0.000 hypothetical protein 
BCAL2293 2.90 0.000  putative biopolymer transport protein 
BCAM2252 2.89 0.000  pseudogene 
BCAM2140 2.88 0.001  transporter system transport protein 
BCAM0780 2.88 0.000  putative helicase 
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BCAS0617 2.88 0.003  hypothetical protein 
BCAM0303 2.88 0.004  
ABC transporter ATP-binding membrane 
protein 
BCAL0343 2.87 0.002 bcsL putative type VI secretion system protein  
BCAS0555 2.86 0.000  pseudogene 
BCAM2141 2.86 0.002  
ABC transporter ATP-binding membrane 
protein 
BCAM2015 2.84 0.000  putative zinc-binding dehydrogenase 
BCAM2154 2.84 0.000  hypothetical protein 
BCAS0336 2.84 0.000  putative glutathione transferase 
BCAM2614 2.84 0.000  hypothetical protein 
BCAS0517 2.83 0.002 
Bcep
Mu40 putative phage tail tube protein 
BCAM1553 2.83 0.000  
putative dehydrogenase molybdenum-
binding subunit 
BCAL2292 2.83 0.000  putative bipolymer transport protein 
BCAM2450 2.83 0.000  putative hydrolase 
BCAM1813 2.81 0.000  hypothetical protein 
BCAM0280A 2.81 0.000  hypothetical protein 
BCAM2769 2.81 0.000  short chain dehydrogenase 
BCAM1113 2.81 0.002 potE putrescine transporter 
BCAM0290 2.81 0.000  putative universal stress protein 
BCAM0282 2.80 0.000  hypothetical protein 
BCAM0378 2.80 0.000  hypothetical protein 
BCAL2049 2.79 0.001  putative oxidoreductase 
BCAM2037 2.77 0.000  putative [2Fe-2S]-binding protein 
BCAL2467 2.76 0.000  putative lipoprotein 
BCAS0751 2.76 0.000  
putative gamma-glutamyltransferase 
precursor 
BCAL2276 2.76 0.001  hypothetical protein 
BCAM2432 2.75 0.000  
putative biotin-dependent carboxyl 
transferase 
BCAM1802 2.73 0.000  putative regulatory protein 
BCAM0042 2.73 0.000  putative aldo/keto reductase 
BCAM0871 2.72 0.000  putative transcriptional regulator 
BCAM0150A 2.72 0.001  pseudogene 
BCAL3314 2.71 0.000  hypothetical protein 
BCAM1161 2.70 0.000  putative cyclic-di-GMP signaling protein 
BCAL2156 2.69 0.000  
putative tRNA/rRNA methyltransferase 
protein 
BCAL2986 2.69 0.001  amidase 
BCAM2153 2.68 0.002  putative cytochrome P450 oxidoreductase 
BCAL1359 2.67 0.000  hypothetical protein 
BCAM2743 2.67 0.000  hypothetical protein 
BCAM1780A 2.66 0.002  hypothetical protein 
BCAM2014 2.66 0.009  putative carbohydrate kinase 
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BCAM0149 2.65 0.000  putative phospholipase D protein 
BCAM2254 2.65 0.000 hypothetical protein 
BCAS0728 2.64 0.000 cdd cytidine deaminase 
BCAS0554 2.64 0.000 
Bcep
Mu1 
Mu protein C/ Mor gp17 transcription 
regulator 
BCAL0633 2.63 0.005  putative hydrolase 
BCAL3490 2.62 0.000  hypothetical protein 
BCAM1840 2.62 0.000  putative acetyltransferase 
BCAM1754 2.61 0.000  putative mechanosensitive ion channel 
BCAM0946a 2.61 0.006  hypothetical protein 
BCAM1779 2.61 0.000  putative beta-lactamase 
BCAL3313 2.60 0.000  hypothetical protein 
BCAM1189 2.60 0.000  LysR family regulatory protein 
BCAM1834 2.59 0.000  hypothetical protein 
BCAM1968 2.58 0.008  putative acetyltransferase 
BCAM2088 2.58 0.000  putative exported cell wall amidase 
BCAM1200 2.58 0.000  hypothetical protein 
BCAM0468 2.58 0.007  hypothetical protein 
BCAM1307 2.57 0.000  putative helicase 
BCAM0931 2.57 0.008  catalase precursor 
BCAM1494 2.57 0.000  
two-component regulatory system sensor 
kinase 
BCAM1826 2.57 0.000  
putative N-hydroxyarylamine O-
acetyltransferase 
BCAM0937 2.57 0.000  putative monooxygenase 
BCAM1680 2.56 0.000  hypothetical protein 
BCAM0805 2.56 0.000 catB1 muconate cycloisomerase I 1 
BCAM1481 2.56 0.000  hypothetical protein 
BCAL2301 2.56 0.000  hypothetical protein 
BCAL2685 2.55 0.007 cysI putative sulfite reductase 
BCAM1239 2.55 0.000  hypothetical protein 
BCAL0763 2.55 0.000  hypothetical protein 
BCAM0490 2.55 0.000  putative NADH oxidoreductase 
BCAM1415 2.54 0.000  AraC family regulatory protein 
BCAS0552 2.54 0.000 
Bcep
Mu3 single-stranded DNA binding protein 
BCAM2733 2.53 0.000  acylphosphatase 
BCAL2468 2.53 0.000  hypothetical protein 
BCAM1835 2.53 0.000  hypothetical protein 
BCAL2985 2.53 0.000  GntR family regulatory protein 
BCAM2080 2.52 0.000  
bifunctional nicotinamide mononucleotide 
adenylyltransferase/ADP-ribose 
pyrophosphatase 
BCAM1096 2.51 0.001  putative phage class 3 lipase 
BCAM1420 2.51 0.009  efflux system transport protein 
BCAL2684 2.50 0.003  hypothetical protein 
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BCAL2911 2.50 0.001  proline-rich exported protein
BCAM0377 2.50 0.000  putative thioredoxin 
BCAM0732 2.50 0.001  cysteine desulfurase 
BCAM1884 2.49 0.000  putative DNA-binding phage protein 
BCAM1421 2.49 0.000  RND family efflux system transporter protein 
BCAS0661C 2.49 0.000  hypothetical protein 
BCAS0730 2.48 0.000  
putative Na+ dependent nucleoside 
transporter family protein 
BCAM1787 2.47 0.001  putative porin 
BCAS0551 2.46 0.000 
Bcep
Mu4 HU DNA-binding protein 
BCAL1853 2.46 0.000 cystathionine beta-lyase 
BCAL1439 2.46 0.000 msdA 
methylmalonic acid semialdehyde 
dehydrogenase 
BCAM1700 2.45 0.001 putative acetyltransferase 
BCAM0804 2.45 0.000 catA1 catechol 1,2-dioxygenase 1 
BCAM0064 2.45 0.001  hypothetical protein 
BCAM1501 2.44 0.000  hypothetical protein 
BCAM1493 2.44 0.000  
two-component regulatory system response 
regulator protein 
pBCA063 2.43 0.003  hypothetical protein 
BCAM2837 2.43 0.000  pseudogene 
BCAM1581 2.42 0.000 pckG phosphoenolpyruvate carboxykinase 
BCAL3210 2.41 0.000  hypothetical protein 
BCAM2535 2.41 0.003  hypothetical protein 
BCAM0005A 2.40 0.001  hypothetical protein 
BCAM1695 2.39 0.007  subfamily S1B serine peptidase 
BCAM2449 2.39 0.000  putative metallophosphoesterase 
BCAL3315 2.39 0.000  
mammalian cell entry related membrane 
protein 
BCAM1482 2.39 0.000  hypothetical protein 
BCAM2000 2.39 0.000  hypothetical protein 
BCAL2683 2.38 0.003 cysH 
phosphoadenosine phosphosulfate 
reductase 
BCAM2038 2.38 0.001  putative oxidoreductase 
BCAM2003 2.38 0.000  AraC family regulatory protein 
BCAL1358 2.38 0.000  hypothetical protein 
BCAL0047 2.38 0.001  putative acyl-CoA dehydrogenase 
BCAS0239 2.37 0.000  
putative excinuclease ABC subunit A family 
protein 
BCAS0184 2.37 0.000  putative saccharopine dehydrogenase 
BCAM0238A 2.37 0.001  H-NS histone family protein 
BCAS0240 2.37 0.000  periplasmic solute-binding protein 
BCAM2350 2.37 0.000  ABC transporter ATP-binding protein 
BCAM0721 2.36 0.000  O-acetylhomoserine (thiol)-lyase 
BCAL3492 2.36 0.004  hypothetical protein 
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BCAS0749 2.36 0.000  putative lipoprotein 
BCAS0661A 2.35 0.001  hypothetical protein 
BCAL0948 2.35 0.004  
putative plasmid-related recombination 
enzyme 
BCAM2404 2.34 0.000  LysR family regulatory protein 
BCAL0412 2.34 0.004  pseudogene 
BCAM1580 2.34 0.003  hypothetical protein 
BCAM2621 2.33 0.003 pseudogene 
BCAM1459 2.33 0.002 atoE short-chain fatty acid transporter 
BCAM2090 2.32 0.000  hypothetical protein 
BCAM1485 2.32 0.000  ornithine cyclodeaminase 
BCAM1674 2.32 0.000  GntR family regulatory protein 
BCAM0887 2.32 0.002  putative tautomerase 
BCAM1446 2.32 0.001  LysR family regulatory protein 
BCAM1496 2.32 0.000  hypothetical protein 
BCAM1426 2.31 0.001  voltage-gated potassium channel 
BCAM0387 2.31 0.000 poxB pyruvate dehydrogenase 
BCAM0281 2.31 0.003  putative sulfate transporter family protein 
BCAM0883 2.30 0.005  putative ion transporter 
BCAM0722 2.30 0.000  putative O-methyltransferase 
BCAL1353 2.30 0.000  hypothetical protein 
BCAM2513 2.30 0.000  hypothetical protein 
BCAS0553 2.30 0.003 
Bcep
Mu2 Mu gp16 gemA 
BCAM0030 2.29 0.001  hypothetical protein 
BCAM2534 2.29 0.000  
two-component regulatory system 
Fis/response regulator protein 
BCAL1360 2.29 0.000  hypothetical protein 
BCAM2426 2.29 0.000  putative diguanylate phosphodiesterase 
BCAM0528 2.28 0.000  
putative oxidoreductase/short-chain 
dehydrogenase 
BCAM2644 2.27 0.000  putative glutathione S-transferase 
BCAL2300 2.27 0.002  hypothetical protein 
BCAM0696 2.27 0.002  
putative carboxymuconolactone 
decarboxylase 
BCAM1500 2.27 0.000  putative universal stress protein 
BCAM2709 2.27 0.000  hypothetical protein 
BCAM2067 2.26 0.002 uppS 
putative undecaprenyl pyrophosphate 
synthetase 
BCAM2742 2.26 0.000  hypothetical protein 
BCAL3316 2.26 0.000  putative lipoprotein 
BCAM2795 2.26 0.001  hypothetical protein 
BCAM2185 2.26 0.001  putative methyltransferase 
BCAM1678 2.25 0.000  putative lipoprotein 
BCAM0938 2.25 0.000  GNAT family acetyltransferase 
BCAL1552 2.25 0.001  putative extracellular substrate-binding 
Chapter III: Experimental work   Paper 3  
 157 
protein 
BCAS0241 2.25 0.000  
putative sodium:dicarboxylate symporter 
family protein 
BCAM2251A 2.24 0.003  hypothetical protein 
BCAM2433 2.24 0.000  putative acyl-CoA dehydrogenase 
BCAS0742 2.24 0.000  hypothetical protein 
BCAM0679 2.24 0.000  hypothetical protein 
BCAM2679 2.23 0.000  hypothetical protein 
BCAL2615 2.23 0.002  
putative exported outer membrane porin 
protein 
BCAM0752 2.23 0.000  putative hydrolase 
BCAM1498 2.23 0.000  pseudogene 
BCAM0511 2.22 0.001  putative esterase 
BCAM2639 2.22 0.009  hypothetical protein 
BCAL0915 2.22 0.001 ribB 
putative 3,4-dihydroxy-2-butanone 4-
phosphate synthase 
BCAM1781 2.22 0.000 LysR family regulatory protein 
BCAL2907 2.22 0.000 norM putative multidrug resistance protein 
BCAM2332 2.22 0.000  LysR family regulatory protein 
BCAM0031 2.22 0.000  hypothetical protein 
BCAM2558 2.21 0.000 selD selenophosphate synthetase 
BCAM1211 2.21 0.007  cysteine peptidase/transferase, family C45
BCAM0041 2.21 0.000  putative lipoprotein 
BCAM0520 2.20 0.000   
BCAM0748 2.20 0.000  putative diguanylate cyclase 
BCAM2102 2.20 0.004  putative IstB-like ATP binding protein 
BCAM0008 2.20 0.000  hypothetical protein 
BCAM2429 2.20 0.003  putative phospholipase C 
BCAM1285 2.20 0.000  hypothetical protein 
BCAL1356 2.20 0.000  hypothetical protein 
BCAS0235 2.19 0.000  
two-component regulatory system, response 
regulator protein 
BCAM1119 2.19 0.000  hypothetical protein 
BCAL3236 2.19 0.001  putative transposase 
BCAM0167 2.19 0.009  LysR family regulatory protein 
BCAM1514 2.18 0.000  putative outer membrane protein 
BCAL0832 2.18 0.000 phaA acetyl-CoA acetyltransferase 
BCAM2609 2.18 0.000  hypothetical protein 
BCAM0354a 2.18 0.005  pseudogene 
BCAM1259 2.18 0.004 sigJ RNA polymerase sigma factor 
BCAL0123 2.18 0.006  putative glycosyltransferase 
BCAM2643 2.17 0.003  beta-lactamase family protein 
BCAM2005A 2.17 0.000  putative entericidin 
BCAM0747 2.17 0.008  hypothetical protein 
BCAM1379 2.17 0.005  ABC transporter substrate-binding protein 
BCAM0015 2.17 0.000  hypothetical protein 
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BCAM2486 2.17 0.004  hypothetical protein 
BCAL1270 2.16 0.007 pstS 
phosphate transport system substrate-
binding exported periplasmic protein 
BCAM1495 2.16 0.000  putative universal stress protein 
BCAM1316 2.16 0.009  transport system outer membrane protein 
BCAM1342 2.15 0.000  
putative sigma-54 interacting transcriptional 
regulator 
BCAM0215 2.15 0.002 
RS048
11 putative peptidylprolyl isomerase 
BCAM0225 2.15 0.006  pseudogene 
BCAM2351 2.15 0.000  
putative ABC transporter transmembrane 
protein 
BCAM1168 2.14 0.000  hypothetical protein 
BCAM1479 2.14 0.004  hypothetical protein 
BCAM1395 2.14 0.004  putative sulfurtransferase 
BCAM2536 2.14 0.000  putative alpha-beta hydrolase 
BCAL3006 2.14 0.002 cspA cold shock-like protein 
BCAM1214 2.14 0.006  putative beta-hydroxylase 
BCAM2091 2.14 0.003  putative acetyltransferase 
BCAM0781 2.13 0.000  hypothetical protein 
BCAM2566 2.13 0.000  putative GCN5-related N-acetyltransferase 
BCAM1286 2.13 0.000  
putative betaine/carnitine/choline family 
transporter 
BCAL0200 2.13 0.001  putative lipoprotein 
BCAL2681 2.13 0.002 cysN 
putative sulfate adenylyltransferase subunit 
1 
BCAL2682 2.12 0.002 cysD1 sulfate adenylyltransferase subunit 2 
BCAM0148 2.12 0.001  hypothetical protein 
BCAM2782 2.12 0.000  putative acetyltransferase 
BCAM1480 2.12 0.000  hypothetical protein 
BCAM1213 2.12 0.005  hypothetical protein 
BCAM0529 2.12 0.008  putative hydrolase 
BCAL1921 2.12 0.000  hypothetical protein 
BCAM1359 2.12 0.000  putative efflux pump/antiporter 
BCAL0349 2.11 0.000  putative outer membrane protein 
BCAS0234 2.11 0.003  
hybrid two-component system kinase-
response regulator protein 
BCAM2084 2.11 0.002  hypothetical protein 
BCAS0107 2.11 0.001  LysR family regulatory protein 
BCAM2533 2.11 0.000  
two-component regulatory system sensor 
kinase 
BCAL1362 2.11 0.005  hypothetical protein 
BCAM1990 2.11 0.000  LysR family regulatory protein 
BCAM0521 2.11 0.001  putative IstB-like ATP binding protein 
BCAM1782 2.11 0.001  hypothetical protein 
BCAL0831 2.10 0.001  putative storage protein 
BCAL2680 2.10 0.003  uroporphyrin-III C-methyltransferase 
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BCAM0803 2.10 0.000 catC muconolactone delta-isomerase 
BCAM0639 2.10 0.000  LuxR superfamily regulatory protein
BCAL0003 2.10 0.000  MarR family regulatory protein 
BCAL0344 2.10 0.000  
putative type VI secretion system protein 
TssE 
BCAS0505a 2.09 0.001 
Bcep
Mu52 hypothetical protein 
BCAM0007 2.09 0.000  putative phage integrase 
BCAL1049 2.09 0.000  luciferase-like monooxygenase 
BCAM0687 2.09 0.000  putative threonine efflux pump 
BCAL1357 2.08 0.000  hypothetical protein 
BCAM1492 2.08 0.000  hypothetical protein 
tyrB 
(AM747721.1 
1643564..164
5067) 2.08 0.000 tyrB Aromatic aminoacid aminotransferase 
BCAM0522 2.08 0.000  putative integrase 
BCAM0277 2.08 0.001  hypothetical protein 
BCAM1789 2.08 0.000  putative esterase 
BCAM0216 2.06 0.000  hypothetical protein 
BCAM0516 2.06 0.000  putative exported glyoxalase 
BCAM2747 2.06 0.000  putative epimerase 
pBCA087 2.06 0.002  NUDIX hydrolase family protein 
BCAM0225A 2.06 0.000  pseudogene 
BCAM1435 2.05 0.000  putative hydrolase 
BCAM1088 2.05 0.006  hypothetical protein 
BCAL1355 2.04 0.000  hypothetical protein 
BCAM2085 2.04 0.000  hypothetical protein 
BCAM0050 2.04 0.001  universal stress-related protein 
BCAS0257 2.03 0.000  putative acetyltransferase 
BCAM1361 2.03 0.006  sugar-binding periplasmic protein precursor 
BCAL1354 2.02 0.000  hypothetical protein 
BCAM2687 2.02 0.000  MgtC family membrane protein 
BCAM0635 2.02 0.006  AnsC family regulatory protein 
BCAM0591 2.02 0.006  putative hydrolase 
BCAS0743 2.01 0.000  putative GNAT family acetyltransferase 
BCAM2568 2.01 0.000  beta-ketoadipyl CoA thiolase 
BCAM2245 2.01 0.002  hypothetical protein 
BCAM1212 2.01 0.002  hypothetical protein 
BCAM2722 2.01 0.000  hypothetical protein 
BCAM0048 2.01 0.000  
chromosome replication initiation inhibitor 
protein 
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ABSTRACT 
Bcc bacteria are opportunistic respiratory pathogens which are particularly difficult to eradicate from 
the lungs of CF patients because of their innate resistance to antimicrobials and their capacity to 
form biofilms. The goal of the present study was to evaluate the bacteriostatic and bactericidal 
activities of temocillin against planktonic and sessile Bcc bacteria. 37 strains belonging to 17 Bcc 
species were tested. 75.7% of the strains were susceptible when grown planktonically (MIC < 16 
μg/ml). The minimal bactericidal concentrations were higher than 128 μg/ml for most strains. No 
remarkable differences in resistance between exponentially growing planktonic cells and 4 h old 
biofilms were observed: when grown in a biofilm, 59.5% of the strains were susceptible. After 
treating 24 h biofilms with a concentration of 10×MIC, only a minor reduction was seen in the 
number of sessile cells, indicating a limited bactericidal activity against biofilms. Our data indicate 
that temocillin has a good bacteriostatic in vitro activity against planktonic and 4 h old biofilms, but 
seems of limited use to eradicate 24 h old biofilms. 
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INTRODUCTION 
The Bcc is a group of 18 different Gram-negative β-Proteobacteria [271]. These versatile 
microorganisms are opportunistic pathogens which can cause severe lung infections in CF patients 
and immunocompromised individuals [5]. In Bcc infected CF patients, infections with B. cenocepacia 
and B. multivorans are most common and are difficult to treat because of the high innate resistance 
of these species to antimicrobials [5]. This resistance is due to various mechanisms, including the 
presence of multidrug efflux pumps, β-lactamases and altered penicillin binding proteins [39]. 
Furthermore, it has been described that many Bcc strains readily form biofilms [272].  
In 2004, temocillin (a semisynthetic 6-α-methoxy β-lactam antibiotic) was granted orphan drug status 
for treatment of Bcc infected patients by the European Medicines Agency [5]. Unlike several other β-
lactam antibiotics, temocillin is not degraded by most classical and extended-spectrum β-lactamases 
and AmpC enzymes [273].  
Temocillin has been tested in a limited number of clinical studies. In a pilot study temocillin in 
combination with an aminoglycoside was given iv to five CF patients infected with both Bcc and P. 
aeruginosa. Improvement occurred after six of seven courses when temocillin was used as first-line 
therapy and after three of five courses when it was used after failure of other antibiotics [274]. 
Lekkas et al. (2006) also treated Bcc infected CF patients with iv temocillin in combination with an 
aminoglycoside [275]. In 18 of 32 courses of temocillin (56.3%) (given to 20 patients) improvement 
occurred, while in 2 courses (6.3%) there was a partial response and in 12 courses (37.5%) the 
treatment failed. In a retrospective study, Kent et al. (2008) showed that iv therapy with temocillin 
has the same effect on the lung function of Bcc infected patients as standard iv antibiotic therapy 
[276].  
To date, only few in vitro susceptibility data are available for temocillin [277]-[278]. A first goal of the 
present study was to evaluate the bacteriostatic and bactericidal effects of temocillin on planktonic 
Bcc cells. A second goal was to examine its growth-inhibitory effect on freshly adhered Bcc sessile 
cells (= 4 h old biofilms) and its bactericidal effect on mature biofilms (24 h old biofilms). 
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MATERIALS AND METHODS 
Strains and culture conditions 
The Bcc strains used are listed in Table 1. E. coli ATCC 10536 was included as a control strain. All 
strains were obtained from the BCCM/LMG Bacteria collection (Ghent, University, Belgium). Cells 
were stored at -80 °C using Microbank vials (Prolab Diagnostics, Richmond Hill, ON, Canada) and 
subcultured on Mueller-Hinton agar (Oxoid, Hampshire, UK, MHA). Overnight cultures were diluted 
in Mueller- Hinton broth (Oxoid, MHB). All cultures were incubated aerobically at 37 °C. 
 
Table 1. MICsa, MBCsb and MBICsc (μg/ml) for temocillin against 37 Bcc strains 
Strain Origin MIC  MBC  MBIC  
B. cepacia LMG 1222T Onion, US 8 64 16 
B. cepacia LMG 18821 CF patient, Australia 32 >128 32 
B. multivorans LMG 13010T CF patient, Belgium 32 >128 16 
B. multivorans LMG 17588 Soil rhizosphere, US 32 >128 >1024 
B. multivorans LMG 18822 CF patient, Canada 64 >128 4 
B. multivorans LMG 18825 CF patient (epidemic), UK 32 >128 >1024 
B. cenocepacia LMG 16656T CF patient (epidemic), UK 256 >1024 128  
B. cenocepacia LMG 18828 CF patient (epidemic), Canada 16  >128 16 
B. cenocepacia LMG 18829 CF patient (epidemic), US 4  > 128 4 
B. cenocepacia LMG 18830 CF patient (epidemic), Australia 16 > 128 32 
B. stabilis LMG 14086 Respirator, UK 8 >128 >1024 
B. stabilis LMG 14294T CF patient, Belgium 16 >128 16 
B. vietnamiensis LMG 10929T Oryza sativa, soil, Vietnam 8 >128 8 
B. vietnamiensis LMG 18835 CF patient, US 16 >128 64 
B. dolosa LMG 18941 CF patient, US 8 >128 8 
B. dolosa LMG 18943T CF patient, US 32 >128 32  
B. ambifaria LMG 19182T Pea rhizosphere, US 8 >128 2  
B. ambifaria LMG 19467 CF patient, Australia 4 8 4 
B. anthina LMG 20980T Soil, US 16 128 32 
B. anthina LMG 20983 CF patient, UK 4 >128 128 
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B. pyrrocinia LMG 14191T Soil, Japan 4 16 4 
B. pyrrocinia LMG 21824 CF patient, UK 2  >128 2 
B. ubonensis LMG 20358T Soil rhizosphere, Thailand 8 >128 4  
B. ubonensis LMG 24263 Nosocomial infection, Thailand 16 > 128 16  
B. latens LMG 24064T CF patient, Italy 8  32 8 
B. diffusa LMG 24065T CF patient, US 8 >128 4  
B. diffusa LMG 24266 CF patient, Canada 8 >128 32  
B. arboris LMG 24066T Soil, US 2 >128 2 
B. arboris R-132 CF patient, US 4  32 2 
B. seminalis LMG 24067T CF patient, US 32 >128 32  
B. seminalis LMG 24272 Nosocomial infection, Thailand 8 >128 4 
B. metallica LMG 24068T CF patient, US 16 >128 >1024 
B. metallica R-2712 CF patient, Canada 8  >128 16 
B. lata LMG 6992 Soil, Trinidad and Tobago 4 16 32 
B. lata R-9940 CF patient, Canada 16 512 1024 
B. contaminans LMG 16227 CF patient, Sweden 16 >1024 8 
B. contaminans R-12710T Sheep’s milk, Spain 8  >128 4  
a  minimal inhibitory concentration; breakpoint concentration = 16 μg/ml [279]. 
b  minimal bactericidal concentration 
c  minimal biofilm inhibitory concentration 
 
Determination of the minimal inhibitory concentration (MIC) and minimal bactericidal 
concentration (MBC)  
MICs and MBCs were determined in duplicate according to the EUCAST broth microdilution protocol 
using flat-bottomed 96-well microtiter plates (TPP, Trasadingen, Switzerland)[46]. Temocillin 
(Eumedica SA, Brussels, Belgium) concentrations tested ranged from 0.25 to 1024 μg/ml. The MIC 
was defined as the lowest concentration of temocillin for which no significant difference in optical 
density (λ = 590 nm) was observed between the inoculated and blank wells after 24 h incubation. 
Differences in absorbance were considered significant when the 95%-confidence interval (calculated 
using Microsoft Excel) did not contain zero. All MIC-determinations were performed in duplicate and 
replicates never differed by more than two fold. When a two fold difference was observed, the 
lowest concentration was recorded as the MIC. A 100 μl aliquot from the inoculated wells for which 
no significant difference in optical density was observed with the blank wells, was used to determine 
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the number of surviving cells by conventional plate counting. Two aliquots of 100 μl from two 
independent experiments (n = 4) were plated. The MBC was defined as the lowest concentration for 
which no colony forming units were recovered for all 4 replicates after 48 h incubation.  
 
Assessing the activity of antimicrobial combinations with temocillin 
To determine the activity of antimicrobial combinations a checkerboard approach in 96-well 
microtiter plates was used [280]. We tested 3 antimicrobial combinations (temocillin+ceftazidime, 
temocillin+meropenem and temocillin+tobramycin) against 4 strains (B. cenocepacia LMG 16656 and 
LMG 18829, B. multivorans LMG 18822 and LMG 13010). For each antibiotic the concentrations 
tested ranged from 0.25×MIC to 2×MIC in Mueller-Hinton broth (using twofold dilutions). We also 
included a well for each drug alone. Synergism was defined as a Fractional Inhibitory Index (FIC) of 
0.5 or less, a FIC of > 0.5 to ≤ 4 was considered nonsynergistic [281].  
 
Determination of the minimal biofilm inhibitory concentration (MBIC) 
To determine the MBIC a resazurin-based viability staining was used [46]. An inoculum suspension 
containing ±5×107 CFU/ml was added to the wells of a round-bottomed 96-well microtiter plate 
(TPP). Following 4 h of adhesion, the supernatant was removed and the plates were rinsed with 
physiological saline. Subsequently, 200 μl of antibiotic-containing MHB (using antibiotic 
concentrations identical to those in the MIC experiments) or 200 μl physiological saline (= 4 h 
control) was added and the plates were further incubated at 37 °C. After 24 h of treatment, the wells 
were again rinsed and finally 120 μl of a commercially available resazurin solution (CellTiter-Blue, 
Promega, Madison, WI, USA) was added to all wells. Fluorescence (λex 560 nm, λem 590 nm) was 
measured after 2 h of incubation. The lowest concentration for which there was no significant 
further growth after 4 h of adhesion was recorded as the MBIC. Further growth was considered 
significant when the 95%- confidence interval around the difference between fluorescence obtained 
after 4 h of adhesion and fluorescence obtained after 4 h of adhesion and 24 h of temocillin 
treatment did not contain zero. All MBIC-determinations were performed in duplicate and replicates 
never differed by more than two fold. When a two fold difference was observed, the lowest 
concentration was recorded as the MBIC. 
 
Evaluation of the bactericidal effect on mature biofilms 
To evaluate the bactericidal effect of temocillin on mature biofilms, 24 h old biofilms were exposed 
to a concentration of 10×MIC for 24 h. Biofilms were grown on medical-grade silicone discs (Q7-4735, 
Dow Corning, Midland, MI, USA) placed in the wells of a 24-well microtiter plate (TPP), as described 
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previously [46]. Three discs per strain were treated and three untreated discs served as controls. 
95%-confidence intervals were calculated to determine whether differences in the number of colony 
forming units were statistically significant between the conditions. 
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RESULTS AND DISCUSSION 
Treatment of pulmonary exacerbations in Bcc infected CF patients is often complicated by the 
resistance of Bcc isolates against many antibiotics. In the present study we investigated the 
bacteriostatic and bactericidal effects of temocillin on 37 Bcc strains grown both planktonically and in 
a biofilm.  
 
Determination of the MIC and MBC 
The distribution of the MICs for temocillin against 37 Bcc strains is shown in figure 1. Since there is no 
EUCAST breakpoint available, the clinical breakpoint for resistance (MIC>16 μg/ml) proposed by 
Fuchs et al. (1985) was used [279]. Although the MICs varied widely, based on this breakpoint 28/37 
strains (75.7%) were susceptible when grown planktonically. B. pyrrocinia LMG 21824 and B. arboris 
LMG24066 had the lowest MICs (Table 1), while B. multivorans LMG 18822 and B. cenocepacia LMG 
16656 had MICs of 64 μg/ml and 256 μg/ml respectively. While the majority of the strains tested 
were susceptible when grown planktonically, only two of the four tested B. cenocepacia strains and 
none of the four B. multivorans strains was susceptible. Peeters et al. (2009) tested six different 
antibiotics against the same strain panel [46]. Meropenem and ceftazidime, two other β-lactams, 
were among the most active antibiotics as for both antibiotics 60.5% of the strains showed growth 
inhibition at breakpoint antibiotic concentrations. Five strains (B. cepacia LMG 1222, B. cenocepacia 
LMG 18828, B. pyrrocinia LMG 14191 and B. metallica LMG 24068 and R-2712) were susceptible to 
temocillin but not to meropenem and ceftazidime.  
 
 
 
Figure 1. The distribution of the MICs for temocillin against 37 Bcc strains. The vertical line corresponds to the breakpoint of 
16 μg/ml [282].  
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Assessing the activity of antimicrobial combinations with temocillin 
CF patients often have mixed infections with Bcc and P. aeruginosa [283]. Since temocillin has no 
activity against P. aeruginosa [284], we examined the effect of a combination of temocillin with 
another β-lactam (ceftazidime and meropenem) and with tobramycin, a frequently used anti-
Pseudomonas antibiotic known to be synergistic with β-lactam antibiotics [285]. For the strains 
tested we could not detect synergy for temocillin and ceftazidime (B. cenocepacia LMG 16656 and 
LMG 18829: FIC=1, B. multivorans LMG 13010: FIC=0.75, and B. multivorans LMG 18822: FIC=0.625) 
or meropenem (B. cenocepacia LMG 16656: FIC=0.625, B. cenocepacia LMG 18829: FIC=1, and B. 
multivorans LMG13010 and LMG18822: FIC=0.75). For two strains (B. multivorans LMG 13010 and 
LMG 18822) minor synergistic effects were observed for temocillin and tobramycin (FIC=0.5 for both 
strains). β-lactams exhibit time-dependent antimicrobial activity and depending on the concentration 
they can act as bacteriostatic or bactericidal antibiotics [273,286]. For temocillin, MBC values (Table 
1) obtained in the present study were high (up to more than 64 times higher than the MICs). Only six 
strains had MBCs lower than 128 μg/ml, which falls within the range of achievable peak total 
concentrations (150–200 μg/ml), although not in that of the minimal total plasma concentration 
(28 μg/ml) [273,287]. Furthermore, the concentration of available temocillin is only 15–30% of the 
total values [273]. 
 
Determination of the MBIC and the bactericidal effect on biofilms 
While biofilms are typically considered more resistant than planktonic cells, our results confirm data 
obtained in a previous study in which no remarkable difference in the resistance was observed when 
exponentially growing planktonic cells and young biofilms were compared [46] (Table 1). Five strains 
(B. multivorans LMG 18825 and LMG 17588, B. stabilis LMG 14086, B. metallica LMG 24068 and B. 
lata R-9940) had MBICs above 1024 μg/ml, although the MICs were 32 μg/ml or less. However, for 
many strains biofilm growth was already considerably inhibited by concentrations lower than the 
MBIC. Surprisingly, for B. multivorans LMG 18822 the MIC was 16 times higher than the MBIC. A 
similar observation was made when this strain was treated with ceftazidime, another β-lactam [46]. 
After 24 h treatment with a concentration of 10×MIC, reductions varied between 0% and 90.2%. For 
19/37 strains the reductions were statistically significant (Fig. 2). The highest reduction (90.2%) was 
observed for B. contaminans LMG 16227. Similar reductions were previously observed for 
ceftazidime and meropenem [46].  
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Figure 2. Average number of cells present in untreated biofilms (grey bars) and in biofilms treated with temocillin (white 
bars) for 19 strains for which statistically significant reductions were obtained. Error bars represent standard deviations 
(n=3).  
 
In conclusion temocillin has a good bacteriostatic in vitro activity against Bcc planktonic and 4 h old 
biofilms, but seems of limited use to eradicate biofilms.  
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DISCUSSION 
Persisters are highly specialized cells, able to survive an antibiotic treatment that kills most of the 
population [288]. Persisters present in biofilms are thought to be responsible for the recalcitrance of 
infections [62]. However, despite their clinical importance, the mechanisms involved in persister cell 
formation are still largely unknown. There are several reasons for this. 
A first reason is that it is not exactly clear what persisters are. Although this seems obvious based on 
the definition given, there may not be just a single persister phenotype. For example, Gefen and 
Balaban (2009) described two different types of persister cells in E. coli [289]. While the first type is 
only formed upon exposure to stress (e.g. during the stationary phase), type II persisters are less 
abundant but are generated spontaneously. Stochastic fluctuations in persister gene expression may 
induce gradations in the level of persistence [98] and environmental triggers may not only influence 
the number of persisters in a culture, but also the mechanisms involved in their induction. In E. coli 
cultures, indole leads to persistence by inducing oxyR and phage shock responses [103], whereas 
(p)ppGpp is thought to activate TA-modules [84] and ciprofloxacin treatment specifically activates 
tisB [89]. Since sessile and planktonic cells are inherently exposed to different stresses, there may 
furthermore be subtle differences between persisters in both life styles. 
Persisters not only form a small subpopulation, persistence is also a temporary state, making the 
isolation of persister cells a serious challenge [51]. Besides the need for novel techniques appropriate 
for the study of a small, temporary population, various studies have indicated that the persister 
phenomenon is highly dependent on the culture conditions [70,71]. Not only the antibiotics used to 
kill non-persister cells play a major role, but also other factors like cell density, growth media, age of 
the inoculum and growth phase, indicating that it is important to accurately define the experimental 
parameters used.  
Screening knockout mutant libraries has not led to the identification of mutants completely lacking 
the ability to form persisters, and efficient anti-persister therapies only reduced the number of 
surviving cells in a culture instead of eradicating all persisters, which suggests that the mechanisms 
involved in persistence are redundant [51].  
Finally, most experiments are performed on planktonic cultures, not on biofilms, although persisters 
are especially problematic in a protected biofilm environment. Moreover, research on TA-modules 
thought to be involved in persistence has predominantly focused on E. coli.  
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1. PRESENCE OF PERSISTER CELLS 
B. cenocepacia is a member of the Bcc, a group of opportunistic pathogens which can cause severe 
lung infections in CF patients [2]. Since most Bcc species readily form biofilms, airway infections are 
thought to involve biofilm formation [25]. In the present study, we examined the presence of 
persister cells in B. cenocepacia J2315 biofilms. 
When a bacterial culture is treated with increasing concentrations of an antibiotic or when cultures 
are exposed for longer periods of time, survival curves show a biphasic pattern, with an initial rapid 
killing and a plateau of surviving cells, called persisters [51]. Since tobramycin and ciprofloxacin both 
display concentration dependent bactericidal killing [290], in the present study cells were treated for 
24 h with increasing concentrations of these antibiotics (up to 64 times the MIC) to determine the 
presence of persisters. 
A fraction of cells survived treatment with either antibiotic and as noted in previous studies the size 
of this fraction was highly antibiotic dependent. While approximately 0.1 % of the sessile cells 
survived treatment with high concentrations of tobramycin, up to 1 % survived treatment with 
ciprofloxacin. Although these results suggest that tobramycin is more efficient in killing, this may be 
due to the higher concentration of tobramycin used. Cells were treated with tobramycin or 
ciprofloxacin in equivalent concentrations relative to the MIC (i.e. 64 x MIC for the sessile cultures 
and 32 x MIC for the planktonic cultures). However, the absolute tobramycin concentration used was 
much higher than that of ciprofloxacin, since the MICs for tobramycin and ciprofloxacin are 256 
μg/ml and 8 μg/ml, respectively.  
The size of the persister fraction was furthermore found to be strain specific and influenced by the 
bacterial life style. These variables make comparison with results obtained in other studies in 
different organisms difficult, but generally it seems that these numbers are within the range reported 
for persisters recovered from biofilms and stationary phase planktonic cultures in previous studies 
(0.0001 % - 1 %) [62,67,78,100]. However, the relative number of persisters in B. cenocepacia J2315 
seems rather low compared to those observed in P. aeruginosa cultures treated with the same 
antibiotics. Like Bcc bacteria, P. aeruginosa is known to cause lung infections in CF patients. Spoering 
et al. (2001) reported a persister fraction between 1 and 10 % in P. aeruginosa PAO1 biofilms treated 
for 6 h with increasing concentrations of tobramycin up to 800 x the MIC [66]. Barraud et al. (2013) 
similarly found that up to 10 % of the sessile P. aeruginosa PAO1 cells survived treatment with 
tobramycin in a concentration of 64 x MIC for up to 3 h [122]. In B. cenocepacia stationary phase 
planktonic cultures, only up to 0.0001 % of the cells survived treatment with tobramycin and 
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approximately 0.001 % of the cells survived treatment with ciprofloxacin. In a stationary phase 
planktonic culture of a P. aeruginosa clinical isolate approximately 0.001 % persisters survived after 
treatment with tobramycin (20 x MIC) for up to 8 h [62] and almost 1 % of the cells survived in 
stationary phase planktonic P. aeruginosa PAO1 cultures treated with ciprofloxacin in concentrations 
up to 5 x MIC for 3.5 h [100]. The studies mentioned above indicate that the number of persisters 
found in B. cenocepacia is rather low compared to the number of persisters recovered from P. 
aeruginosa cultures. However, it should be noted that in these studies P. aeruginosa cells were 
treated for less than 24 h and that the absolute concentrations used were much lower than the ones 
used in the present study. In the study by Barraud et al. (2013), sessile P. aeruginosa cultures were 
treated with tobramycin in a concentration of 64 times the MIC (as was done in this work for B. 
cenocepacia), but the MIC for tobramycin is more than 200 times lower for P. aeruginosa (1.25 
μg/ml) compared to for B. cenocepacia (256 μg/ml) [46,122]. For ciprofloxacin, the MICs for P. 
aeruginosa (5 μg/ml) and B. cenocepacia (8 μg/ml) are comparable but in the study mentioned 
above, only concentrations up to 20 times MIC were used to treat the planktonic P. aeruginosa 
cultures. However, we used concentrations up to 32 times the MIC to treat planktonic cultures of B. 
cenocepacia. Overall, the maximal tobramycin and ciprofloxacin concentrations used to treat P. 
aeruginosa cultures were 1000 μg/ml and 25 μg/ml, respectively compared to 16 384 μg/ml and 512 
μg/ml, respectively for treatment of B. cenocepacia cultures [100]. 
Compared to the other Bcc species investigated in this study, the number of persisters in B. 
cenocepacia J2315 is relatively high. For example, in B. cenocepacia K56-2, another CF isolate 
belonging to the ET-12 lineage the persister fraction was approximately 10-fold smaller in biofilms 
treated with tobramycin or ciprofloxacin, whereas the concentrations used to treat both strains were 
similar.  
While the relative number of persisters was similar in planktonic and sessile P. aeruginosa PAO1 
populations [66], we recovered a significantly higher fraction of surviving cells from B. cenocepacia 
J2315 and K56-2 biofilms. However, it remains to be determined whether this is solely due to a 
higher persister fraction. Alternatively, other biofilm properties, e.g. the biofilm matrix can likewise 
facilitate biofilm cell survival [39]. 
Analyzing clonal pairs of early and late Bcc isolates, we did not observe an increase in the number of 
surviving persisters between late and early isolates. This is in contrast with results obtained in P. 
aeruginosa.  Mulcahy et al. (2010) analyzed longitudinal clonal isolates of P. aeruginosa from a single 
CF patient and found that cultures of late isolates contained increased numbers of drug-tolerant 
persister cells [62]. However, there was a lot of variation between the different isolates and it is not 
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entirely clear why 96 month was chosen as an endpoint. It is obvious that more research is needed to 
investigate whether there is a natural selection for high persistence mutants in the course of chronic 
infections.
2. MECHANISMS INVOLVED IN PERSISTENCE 
To investigate the mechanisms involved in persistence in B. cenocepacia biofilms, biofilms were 
treated with high concentrations of tobramycin (i.e. 4 x MIC), and RNA of surviving cells was 
extracted. Following extraction, RNA was amplified to obtain sufficient amounts for microarray 
analysis. Although this method is generally used to study persister cells, it has been criticized that it 
could lead to artefacts (i.e. induce changes in gene expression that are not solely due to the persister 
state) [51]. However, under in vivo conditions persisters similarly survive when the bulk of the 
population is killed by antibiotics. Biofilms were treated with tobramycin, an aminoglycoside clinically 
used to treat Bcc infections. While the concentration used (1024 μg/ml) may seem unrealistic high at 
first, similarly high concentrations can be achieved in the lungs through pulmonary administration 
[291,292].  
2.1. PERSISTENCE AND ANTIBIOTIC INDUCED ROS-MEDIATED KILLING 
Several reports have suggested that bactericidal antibiotics kill cells by a common mechanism 
comprising the generation of ROS [213,223]. Because of this, we first focused on protein coding 
genes involved in ROS production. We hypothesize that persisters survive because they 
downregulate pathways involved in antibiotic-mediated generation of ROS (Fig. 1). Only a few studies 
have focused on the link between persistence and antibiotic induced ROS-mediated killing [90,94]. 
Our results are in agreement with a previous study which indicated that upon antibiotic treatment of 
planktonic E. coli cultures the hydroxyl radical concentration did not increase in persisters, suggesting 
that persister cells have specific defense mechanisms against ROS [90]. Similarly, in M. smegmatis it 
was shown that persisters are less sensitive to antibiotic-induced hydroxyl radicals [94]. 
Remarkably, proteomic analysis of planktonic P. aeruginosa cultures, treated with sublethal 
concentrations of tobramycin or gentamicin indicated adaptive responses similar to the mechanisms 
observed in B. cenocepacia persisters. The oxidative steps of the citric acid cycle were partially 
bypassed and the production of proteins involved in iron uptake was downregulated [293]. It would 
be interesting to investigate whether gene expression in B. cenocepacia biofilms treated with 
sublethal concentrations of tobramycin is similarly influenced and/or whether pretreatment with 
tobramycin would increase the size of the persister fraction. We hypothesize that pretreatment with 
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tobramycin will increase the number of persisters, since pretreatment with tetracycline, another 
inhibitor of translation increases the number of persisters in planktonic E. coli cultures [86,294].  
The role of ROS in antibiotic-mediated killing has recently become the subject of al lot of debate. 
Although the arguments against the involvement of ROS seem convincing, numerous studies have 
demonstrated ROS induction upon antibiotic treatment. A major point of criticism is the use of 
hydroxyphenyl fluorescein as stain to demonstrate ROS production. However, various studies have 
used other direct (chemiluminescence, electron paramagnetic resonance) or indirect methods 
(quantification of protein carbonylation or expression of proteins involved in antioxidant strategies) 
to demonstrate ROS production [224,231,235]. Moreover, protection against ROS not only has a 
positive effect on bacterial cell survival after treatment with oxidizing agents but also after treatment 
with antibiotics [212,295]. 
Figure 1. Schematic overview of the TCA cycle and the glyoxylate shunt, illustrating how a decreased production of NADH 
can ultimately lead to lower levels of hydroxyl radicals. (note that not all reactions are shown) 
ROS most likely contribute to antibiotic-mediated killing, but the extent depends on the conditions 
[296,297]. Hence, differences in experimental procedures could be at the basis of the conflicting 
results. Species dependent variation, differences in aeration and density of the cultures, the 
antibiotics used and their concentration could all influence the observed results.  
Downregulation of genes encoding TCA enzymes points to a reduced metabolism. This would be 
consistent with a dormant and antibiotic tolerant state, and in line with recent studies demonstrating 
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that the addition of specific metabolites can eradicate persisters by increasing active aminoglycoside 
uptake [115]. However, we also observed an upregulation of various genes encoding proteins 
involved in ROS detoxification (thioredoxin, peroxiredoxin, gluthatione peroxidase) and genes 
involved in the production of NADPH. Furthermore, the importance of the protection against ROS 
was confirmed by the low numbers of persisters in two B. cenocepacia catalase mutants and after 
addition of a SOD inhibitor. However, besides ROS-mediated killing, additional pathways may be 
implied. Since ROS are generated through hyperactivation of normal cell metabolism, it may be 
difficult or even impossible to completely separate the effects caused by decreased ROS production 
and induction of dormancy (including reduced activity of antibiotic targets and reduced active uptake 
of antibiotics). 
It would be interesting to directly measure ROS production in B. cenocepacia using other methods, 
not only after treatment with tobramycin, but also with other antibiotics. Moreover, ROS production 
and the influence on persistence should be compared in planktonic and sessile cells. While most 
studies investigating the contribution of ROS in antibiotic-mediated killing have focused on 
planktonic cultures, cells in a biofilm may respond differently to antibiotic treatment. For example, 
higher bactericidal concentrations were needed to induce ROS production in P. aeruginosa biofilms 
compared to planktonic cultures [298] and it has been shown that ciprofloxacin only induces 
oxidative stress in planktonic Proteus mirabilis cells [299]. Biofilm cells had higher basal levels of 
oxidized lipids and proteins compared to planktonic cells, but these did not increase upon treatment 
[300]. 
2.2. PERSISTERS AND THE ROLE OF ISOCITRATE LYASE  
Irrespective of the role oxidative stress plays in antibiotic-mediated cell death in B. cenocepacia, an 
interesting observation is the upregulation of isocitrate lyase (ICL), the first enzyme in the glyoxylate 
shunt (Fig. 1). The glyoxylate cycle is an anaplerotic pathway of the TCA cycle, and changes in ICL 
activity have been shown to play a role in infections. High ICL activity is thought to facilitate 
adaptation of P. aeruginosa to the CF lung and in B. cenocepacia the glyoxylate shunt was identified 
as one of the pathways upregulated in “late” compared to “early” clonal isolates [258,301]. Van 
Schaik et al. (2009) found that in a rat model inhibition of ICL by itaconate converts latent B. 
pseudomallei lung infections into an acute state, which could then be treated with antibiotics [244]. 
Furthermore, a metabolic shift bypassing the TCA cycle has already been described in P. fluorescens 
upon nitrosative and aluminium-mediated stress. Upon exposure to toxic concentrations of 
aluminum this metabolic shift also included the upregulation of ICL [257,302].  
While inhibition of ICL by the addition of itaconate or 3-nitropropionate (3-NP) significantly reduced 
the number of persisters in different Bcc species, there were no differences in the number of 
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persisters in a double knockout mutant (ΔBCAL2118-ΔBCAM1588) compared to the B. cenocepacia 
WT strain. Since itaconate and 3-NP are succinate analogs, they will also inhibit succinate 
dehydrogenase (SDH). We therefore hypothesize that an upregulation of ICL in persisters not only 
limits the production of NADH (and thus limits ROS production), but also leads to an increased 
intracellular succinate concentration. Succinate can be oxidized by SDH, thereby generating FADH2 
which can lead to basal production of ATP in persister cells exhibiting downregulation of other 
energy-generating systems. This hypothesis is consistent with the observation that the ICL encoding 
genes present in B. cenocepacia J2315 and B. cenocepacia H111 were upregulated under low oxygen 
conditions, which suggests that B. cenocepacia uses the glyoxylate pathway to sustain the production 
of ATP under micro-oxic conditions [303,304]. Itaconate and 3-NP would kill persisters by shutting 
down the remaining ATP production through inhibition of both ICL and SDH. Addition of 2-
thenoyltrifluoroacetone (Then), which inhibits SDH by binding to the ubiquinone pocket reduced the 
number of persisters in the double ICL mutant. In line with these observations, addition of carboxin, 
another SDH inhibitor with the same mode of action as Then was shown to potentiate ampicillin-
mediated killing in E. coli [221]. Since the glyoxylate shunt is absent in humans, ICL would be an 
interesting target for antimicrobials. However, itaconate, 3-NP and carboxin are toxic for humans and 
influencing the TCA cycle may overall be difficult without toxic side effects. Nevertheless, the 
observation that inhibition of one or more specific targets can reduce the number of persisters, 
provides a novel way of looking at the molecular basis of persistence and may lead to novel 
approaches for treating persister-related infections. 
2.3. PERSISTENCE AND TA-MODULES 
The mechanisms responsible for persistence remain largely to be elucidated, but various studies have 
indicated that TA-modules may play an important role [84].  
2.3.1. Identification of TA-modules    
We have identified 16 TA-modules in B. cenocepacia J2315 and, compared with the number of TA-
modules identified in other bacteria, this is rather high. 126 prokaryotic genomes were screened for 
the presence of TA-modules by Pandey and Gerdes (2005) and 31 genomes did not contain TA-
modules at all [146]. In 64 genomes between 1 and 5 TA-modules were found, whereas only in 29 
genomes 8 or more TA-modules were identified. Two Pseudomonas species, P. syringae and P. putida 
contained 8 and 9 TA-modules respectively, whereas in P. aeruginosa only 3 modules were identified. 
Makarova et al. (2009) found that approximately 16 % of the 750 prokaryotic genomes investigated 
did not contain TA-modules, 60 % contained less than 8 modules and only in 17 % of the genomes 16 
or more TA-modules were found [305]. When investigating 797 bacterial genomes, Leplae et al. 
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(2011) found that the 20 bacterial strains with the highest predicted toxin or antitoxin sequences 
contained between 37 and 97 sequences [149].  
However, it is difficult to compare predictions on TA-modules. While the functionality of only a few 
toxins has been experimentally validated, the number of predicted TA-modules is highly influenced 
by the detection methods used. For example, in M. tuberculosis H37Rv 38 TA loci were identified by 
Pandey and Gerdes (2005), whereas Leplae et al. (2011) and Makarova et al. (2009) found 43 and 53 
TA-modules, respectively [146,149,305]. Pandey and Gerdes (2005) used a sequence dependent 
search method, while Makarova et al. (2009) used a computational strategy which takes into account 
both sequence dependent and independent characteristics. Using a combination of a sequence 
dependent method, a sequence independent approach based on the genomic organization and the 
inclusion of TA-modules and PIN-domain containing sequences identified in other studies, Ramage et 
al. (2009) even identified 88 putative TA-modules in M. tuberculosis [182]. Some were only distantly 
related to known homologs and 26 TA-modules encoded putative novel TA-modules. However, out 
of 88 identified potential modules, only 30 were found to encode a functional toxin and cognate 
antitoxin upon overexpression in M. smegmatis. Leplae et al. (2011) used a bioinformatics approach 
similar to the one used by Makarova et al. (2009), which enabled the identification of TA-modules 
with no similarity to TA-modules belonging to known TA families [149]. They tested the functionality 
of 23 toxins and for 15 of them, growth inhibition was observed upon overexpression in E. coli. Co-
expression of the cognate antitoxin was shown to relieve growth inhibition in 8 TA-modules.  
In the present study, we searched for TA-modules using RASTA bacteria software [164]. This tool uses 
a search method relying on the size of the genes, their genomic organization, and the presence of 
conserved functional domains. Since our goal was not to give a complete overview of TA-modules 
present in B. cenocepacia J2315, but to investigate whether they contribute to persistence in B. 
cenocepacia J2315 biofilms, only TA pairs for which the toxins were similar to known toxins were 
included. Because orphan toxins or toxins different from known toxins are presumably also present, 
we probably underestimated the total number of TA-modules present in B. cenocepacia J2315. Out 
of 13 toxins tested, 7 were found to inhibit growth upon overexpression in B. cenocepacia J2315. 
Since 5/6 toxins that did not influence growth were differentially expressed in physiologically 
relevant conditions (after treatment with tobramycin or when grown in a biofilm), it would be 
interesting to test whether these toxins can inhibit growth when they are more strongly 
overexpressed or overexpressed in a host deleted for homologous TA-modules. Moreover, it should 
be tested whether overexpression of the cognate antitoxins can restore growth.  
While Makarova et al. (2009) found a positive correlation between the number of detected TA pairs 
and genome size, Leplae et al. (2011) found no correlation between the number of predicted 
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toxin/antitoxin sequences and the total number of ORFs [149,305]. They found that more than half of 
the genomes which contain most toxin or antitoxin sequences, exhibit high plasticity, like the 
genome of B. cenocepacia. Five of these strains belong to the M. tuberculosis complex and are 
pathogenic. The association of TA-modules with pathogenic/virulent bacteria has also been 
described by Georgiades and Raoult (2011) [148]. Recently, 8 TA-modules were reported in B. 
pseudomallei K96243, a highly virulent Burkholderia species [306]. We identified 16 TA-modules in B. 
cenocepacia J2315 and four of them were found to be conserved in B. pseudomallei K96243. 
Although more research is needed, at first sight these data do not suggest a correlation between the 
number of TA-modules and pathogenicity in Burkholderia species.   
2.3.2. Link between TA-modules, dormancy and persistence 
In 7/13 toxin overexpression mutants investigated, the number of persisters was increased following 
treatment with tobramycin or ciprofloxacin, confirming the involvement of TA-modules in 
persistence [84]. Toxins which increased tolerance to tobramycin when overexpressed were induced 
in WT cultures treated with tobramycin, both in planktonic and sessile cells. However, despite an 
increased tolerance towards ciprofloxacin upon ectopic overexpression, none of them was found to 
be upregulated in WT cells after treatment with ciprofloxacin. The latter is in agreement with the 
observation that different TA-modules seem to respond to other types of stress [200]. Since the 
studied toxins primarily target translation, their induction after treatment with tobramycin would be 
expected.  
An obvious question when studying persisters is whether or not those cells can be considered as 
dormant. While genes involved in metabolism were found to be downregulated in persisters and 
while reduced levels of protein synthesis have been observed in several studies, suggesting a state of 
dormancy, other studies point to active responses to stress [60,69]. Interestingly, in the present 
study, only toxins which, upon overexpression significantly inhibited growth increased the number of 
persisters when overexpressed. This observation suggests that dormancy plays a role in persistence 
in B. cenocepacia J2315. 
It has been hypothesized that cells become dormant when the expression of “persister genes” 
exceeds a threshold and that induction of these genes by environmental factors influences how often 
this threshold is reached [98]. Since we found that the expression of various toxins was higher in 
untreated sessile cells than in untreated planktonic cells, this threshold may be reached more 
frequently in biofilms. This is another illustration of the difference between these two lifestyles and 
may explain the observed differences in the number of surviving persisters between biofilms and 
planktonic cultures. 
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2.3.3. TA-modules and ROS-dependent antibiotic induced killing 
TA-modules seem to mediate two opposing effects of stress. While different studies have indicated 
their involvement in persistence and hence survival [67,84], others have indicated toxin-mediated 
killing upon stress exposure [194,196]. Deletion of mqsR reduced the number of E. coli persisters 
[307], whereas deletion of mazEF (either alone or in combination with deletion of relBE) protected 
cells from hydroxyurea-mediated killing [308]. ROS-induced degradation of MqsA was shown to 
increase biofilm formation and low levels of the toxin PasT protected extra-intestinal pathogenic E. 
coli against oxidative and nitrosative stresses [147,309]. In contrast, overexpression of PasT turned 
out to be toxic. This has led to the suggestion that TA-modules play a central role in determining 
whether a certain stress exposure is mild enough and can be overcome by repair or is too severe and 
induces cell death [310]. While protective effects may for example arise from reversible translation 
inhibition, killing may involve the production of ROS. ROS induction may occur via toxin-mediated 
production of truncated proteins, which may insert in the cell membrane and activate Cpx and Arc. 
Wu et al. (2011) indeed found that deletion of NdoA, the sole toxin thus far identified in Bacillus 
subtilis suppressed peroxide accumulation following antibiotic treatment [310]. Similarly, Kolodkin-
Gal et al. (2008) observed MazF dependent ROS induction upon antibiotic treatment [235]. 
Intriguingly, in the latter study ROS dependent cell killing was only noticed upon treatment with 
bactericidal agents targeting translation, whereas DNA damaging agents induced ROS independent 
MazF-mediated killing.  
Since low oxidative stress conditions have been shown to induce persistence [92,93,233], low levels 
of toxin-induced ROS may have protective effects. The upregulation of different TA-modules in B. 
cenocepacia persisters and the differential expression of genes encoding proteins involved in the 
generation of ROS or the protection against oxidative stress, support a connection between TA-
modules and protection against antibiotic induced ROS-mediated killing. However, whether 
protection includes the generation of low levels of oxidative stress or is solely due to inhibition of 
cellular targets by toxins remains to be determined (Fig. 2). 
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Figure 2. Proposed mechanism by which persister cells in B. cenocepacia biofilms survive exposure to high concentrations of 
tobramycin. 
2.3.4. A regulator identified in the BCESM region 
A novel regulator was identified next to the BCESM, located on BcenGI11. BcenGI11 is present in B. 
cenocepacia strains belonging to the ET-12 lineage. Strains belonging to the ET-12 lineage have 
caused major outbreaks in CF patients worldwide and BCESM positive strains have generally been 
associated with high transmissibility, virulence and mortality [20]. However, no virulence factor has 
yet been identified in the BCESM region. We found that BCAM0257-8 is involved in persistence and 
that BCAM0258 functions as a transcriptional regulator influencing QS and activating cellular 
pathways related to iron acquisition and biofilm formation. Overexpression of BCAM0257 
significantly increased virulence in a G. mellonella infection model. BCAM0257-8-9 is found in all 
sequenced B. cenocepacia ET-12 genomes and these results may help explain why infections with 
strains of the B. cenocepacia ET-12 lineage are so difficult to treat.  However, more research is 
needed to further characterize the function of BCAM0257-8-9.  pppppppppppppppppppppppp
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SUMMARY 
B. cenocepacia J2315 is a member of the Bcc, a group of 18 closely related metabolically versatile 
microorganisms. These opportunistic pathogens can cause severe lung infections in CF patients. 
Infections are often difficult to treat due to innate resistance of Bcc species to antimicrobials and 
because of their capacity to form biofilms.  
One of the mechanisms thought to be involved in biofilm resilience is the presence of persister cells. 
Persisters are highly specialized cells able to survive antibiotic treatment. Persisters are no mutants, 
but phenotypic variants of the wild type. Although the molecular mechanisms involved in persistence 
are still largely unknown, TA-modules are thought to play a role.  
We confirmed the presence of persister cells in B. cenocepacia J2315 biofilms and planktonic 
cultures. The number of persister cells surviving treatment with high concentrations of tobramycin or 
ciprofloxacin was up to a 1000-fold higher in biofilms than in planktonic cultures, with approximately 
0.1 % of the sessile cells surviving treatment with tobramycin, and more than 1 % surviving treatment 
with ciprofloxacin. 
To investigate the molecular mechanisms of tolerance in this subpopulation, B. cenocepacia biofilms 
were treated with tobramycin in a concentration of 1024 μg/ml (= 4 x MIC). A transcriptome analysis 
showed that almost 20 % of the protein-coding genes were differentially expressed (p-value < 0.05, 
fold change ≥ 2) in treated compared to untreated biofilms. Various studies have indicated the role of 
ROS in antibiotic-mediated killing. We found that survival after treatment with tobramycin was 
decreased in catalase mutants as well as after addition of a SOD inhibitor, thus confirming the 
involvement of ROS in antibiotic-mediated killing. However, several genes encoding proteins involved 
in the generation of ROS, including enzymes of the TCA cycle or the electron transport chain were 
downregulated in persisters, whereas genes encoding proteins involved in the glyoxylate shunt were 
upregulated. Pretreatment of B. cenocepacia biofilms with itaconate, an inhibitor of ICL, the first 
enzyme in the glyoxylate shunt, reduced the persister fraction approximately 10-fold when the 
biofilms were subsequently treated with tobramycin. These results suggest that persister cells 
downregulate genes encoding proteins involved in the TCA cycle to avoid production of ROS and at 
the same time activate an alternative pathway, the glyoxylate shunt.  
Since TA-modules presumably play a role in persistence, we investigated whether TA-modules 
contribute to tolerance of B. cenocepacia biofilms towards different antibiotics. We found and 
analyzed 16 of these modules in the genome of B. cenocepacia J2315. They have sequence 
similarities with known TA-modules and are well conserved within the Bcc. Overexpression of these 
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toxins contributed to persistence in biofilms after treatment with tobramycin or ciprofloxacin. 
However, differences in toxin induction were observed between different treatments and depending 
on the mode of growth. Interestingly, only toxins the overexpression of which resulted in growth 
inhibition, had a positive influence on the number of surviving persisters. 
The majority of the toxins were upregulated in biofilms compared to planktonic cells, suggesting 
involvement of TA-modules in the higher number of persisters observed in biofilm compared to 
planktonic cultures. 
Searching for TA-modules we also identified an operon (BCAM0257-8) with no sequence similarities 
with known toxins. This operon is positively regulated by BCAM0259.  Although overexpression of 
BCAM0258 in E. coli has a growth inhibitory effect, this module is not a true classical TA-module, 
since coexpression of the putative antitoxin (BCAM0257) with the putative toxin (BCAM0258) cannot 
restore growth. This module plays a role in persistence and in addition, BCAM0258 functions as a 
regulator influencing QS and activating cellular pathways involved in iron acquisition and biofilm 
formation. On the other hand overexpression of BCAM0257 was found to increase virulence in G. 
mellonella. This module is located on the BcenGI11, also containing the BCESM genetic marker. This 
genomic island is predominantly present in B. cenocepacia strains belonging to the ET-12 lineage 
which has caused major outbreaks in CF patients worldwide. Genes similar to BCAM0257-8-9 are 
found in all sequenced B. cenocepacia ET-12 genomes and its presence may help explaining why 
infections with strains of the B. cenocepacia ET-12 lineage are so difficult to treat.  
Furthermore, we evaluated in vitro the bacteriostatic and bactericidal activity of temocillin, a 
semisynthetic 6-α-methoxy-penicillin against planktonic and sessile Bcc bacteria. Our data indicate 
that, although temocillin has a good bacteriostatic activity against planktonic cultures and 4-h old 
biofilms, it is of limited use to eradicate mature biofilms. 
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SAMENVATTING 
B. cenocepacia J2315 behoort tot het Bcc, een groep van 18 gerelateerde metabool veelzijdige 
microorganismen. Deze opportunistische pathogenen kunnen ernstige longinfecties veroorzaken in 
immuungedeprimeerde personen zoals mucoviscidose patiënten. Infecties met Bcc bacteriën zijn 
vaak moeilijk te behandelen, aangezien deze bacteriën resistent zijn tegen verschillende 
antimicrobiële middelen en biofilms kunnen vormen.  
Eén van de mechanismen die een rol spelen in de tolerantie van biofilms is de aanwezigheid van 
persister cellen. Persisters zijn gespecialiseerde cellen die een behandeling met antibiotica kunnen 
overleven. Het zijn geen mutanten, maar fenotypische varianten van het wild type. Hoewel de 
mechanismen die een rol spelen in persistentie nog niet goed gekend zijn, spelen TA-modules 
vermoedelijk een rol. 
We bevestigden de aanwezigheid van persisters in B. cenocepacia J2315 biofilms en planktonische 
culturen en vonden dat het aantal persisters sterk varieerde tussen planktonische en biofilm culturen 
en tussen verschillende behandelingen. Zo was het aantal persisters dat een behandeling met hoge 
concentraties tobramycine of ciprofloxacine overleefde tot 1000 keer hoger in biofilms vergeleken 
met planktonische culturen. Ongeveer 0.1 % van de cellen in een biofilm overleefde een behandeling 
met tobramycine en meer dan 1 % een behandeling met ciprofloxacine. 
Om de moleculaire mechanismen die een rol spelen in de tolerantie van deze subpopulatie te 
onderzoeken, werden B. cenocepacia biofilms behandeld met tobramycine in een concentratie van 
1024 μg/ml (= 4 x MIC). Transcriptoom analyse toonde aan dat bijna 20 % van de eiwit-coderende 
genen verschillend tot expressie kwamen na behandeling (p-waarde < 0,05, verhouding ≥ 2). 
Verschillende studies hebben reeds aangetoond dat reactieve zuurstof radicalen een rol spelen in 
antibiotica gemedieerde afdoding. Ook wij vonden dat de overleving na behandeling met 
tobramycine lager was in katalase mutanten en na toevoeging van een superoxide dismutase 
inhibitor. Hoewel de voorgaande observaties bevestigen dat reactieve zuurstof radicalen een rol 
spelen in het werkingsmechanisme van tobramycine, bleken verschillende genen die coderen voor 
proteïnen met een rol in de aanmaak van reactieve zuurstof radicalen, bv enzymen uit de citroenzuur 
cyclus of de elektronen transportketen, minder tot expressie te komen in persisters. Genen die 
coderen voor proteïnen die een rol spelen in de glyoxylaat shunt kwamen meer tot expressie. 
Voorbehandeling met itaconaat, een inhibitor van isocitraat lyase, het eerste enzym in de glyoxylaat 
shunt, reduceerde de persister fractie ongeveer met een factor 10, wanneer de biofilms hierna 
behandeld werden met tobramycine. Deze resultaten suggereren dat in persisters de expressie 
verminderd werd van genen die coderen voor proteïnen met een rol in de citroenzuurcyclus, om de 
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productie van reactieve zuurstof radicalen te vermijden, en dat tegelijk een alternatieve pathway, de 
glyoxylaat shunt, geactiveerd werd. 
Aangezien aangenomen wordt dat TA-modules een rol spelen in persistentie, onderzochten we ook 
of deze modules bijdragen tot de tolerantie van B. cenocepacia biofilms ten opzichte van 
verschillende antibiotica. We vonden en analyseerden 16 TA-modules in het genoom van B. 
cenocepacia J2315. Deze vertonen gelijkenissen met gekende TA-modules en zijn goed 
geconserveerd binnen het Bcc. In de meeste toxine overexpressie mutanten was het aantal persisters 
in biofilms behandeld met tobramycine of ciprofloxacine hoger dan in de vector controle. Er werden 
echter verschillen gezien in de inductie van deze toxinen tussen verschillende behandelingen en 
afhankelijk of B. cenocepacia planktonisch of in een biofilm gegroeid werd. Opmerkelijk was dat 
enkel overexpressie van toxinen die wanneer ze tot overexpressie gebracht werden, groei inhibitie 
veroorzaakten, een positieve invloed hadden op het aantal overlevende persisters.  
De meerderheid van de toxinen kwam sterker tot expressie in biofilm cellen vergeleken met 
planktonische cellen, wat suggereert dat TA-modules een rol spelen bij het terugvinden van een 
hogere fractie persisters in biofilms vergeleken met planktonische culturen. 
Op zoek naar TA-modules identificeerden we ook een operon (BCAM0257-8) waarvan de sequentie 
geen gelijkenissen vertoont met reeds beschreven toxines. Dit operon wordt positief gereguleerd 
door BCAM0259. Hoewel overexpressie van BCAM0258 in E. coli een negatieve invloed heeft op 
groei, is BCAM0257-8 geen klassieke TA-module aangezien co-expressie van BCAM0258 met 
BCAM0257 de groei niet kan herstellen.  Deze module speelt een rol in persistentie en bovendien 
beïnvloedt BCAM0258 quorum sensing en activeert hierbij onder andere cellulaire pathways met een 
rol in het verwerven van ijzer en biofilmvorming. Overexpressie van BCAM0257 bleek de virulentie 
van B. cenocepacia J2315 in G. mellonella larven te verhogen. BCAM0257-8-9 is gelokaliseerd op 
BcenGI11 dat ook de BCESM genetische merker bevat. Dit genomisch eiland is voornamelijk aanwezig 
in stammen die behoren tot de ET-12 kloon. Deze stammen zijn verantwoordelijk voor wereldwijde 
infecties in mucoviscidose patiënten. In alle gesequeneerde genomen van B. cenocepacia ET-12 
werden genen gelijkaardig aan BCAM0257-8-9 teruggevonden en hun aanwezigheid kan helpen 
verklaren waarom infecties met stammen die tot de B. cenocepacia ET-12 kloon behoren zo moeilijk 
te behandelen zijn.  
Ten slotte evalueerden we in vitro de bacteriostatische en bactericide activiteit van temocilline, een 
semisynthetisch 6-α-methoxy penicilline, ten opzichte van planktonische Bcc bacteriën en Bcc 
bacteriën gegroeid in een biofilm. Onze resultaten tonen aan dat temocilline van weinig nut is om 
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mature biofilms te eradiceren, hoewel het een goede activiteit vertoont ten opzichte van 
planktonische culturen en 4 u oude biofilms.   ---- 
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